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1 Summary 
Mechanical forces play a central role in biological systems. Many different 
biomolecules generate, transmit and sense forces. The most important group of 
such biomolecules are proteins which act as molecular force sensors. If they 
experience a force, which exceeds a certain threshold, they respond in a defined 
way. This response may either be a change in the binding affinity or in the 
enzymatic activity. 
The effect of external forces on the binding affinity has in the past already been 
characterized in detail for various classes of biomolecules. A change in binding 
affinity can be measured directly with the analytical device, which is used to apply 
the force. However, measuring changes in enzymatic activity requires more 
sophisticated experimental approaches, such as the ones described in this work. 
Once the response of a biomolecule to an external force has been characterized, 
this knowledge provides the blue print for the design of artificial force sensors, which 
act in a similar way as naturally occurring force sensors. As soon as a certain 
threshold force is reached, the artificial force sensors show a desired and defined 
response. 
Within the scope of this work two different artificial force sensors have been 
designed, characterized and applied to analyze biological systems: 
 Force sensors were designed based on DNA duplexes and antibody antigen 
interactions. The design is based on the unbinding force of the respective 
interaction. 
 Another important aspect, which was considered for the design of the artificial 
force sensors, was the availability of methods to connect the force sensor with a 
force transducer (analytical device) and the biological system of interest. Two 
different protocols were developed to establish the desired connections. 
 Two interesting candidates for artificial molecular force sensors - a DNA duplex 
consisting of a repetitive sequence and an antibody antigen interaction – were 
characterized. Their response to an externally applied force was determined for 
various different loading rates with dynamic force spectroscopy. 
 The first application utilized a DNA based force sensor for the analysis of 
receptor ligand interactions. The unbinding force of this force sensor was 
compared directly to the unbinding forces of different antibody antigen 
interactions. The experiment was implemented in a parallel format, the so-called 
differential force assay, which was developed within the scope of this work. 
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 It was shown that this new assay format could be used to solve specificity 
problems in multiplexed diagnostic assays, which employ antibody antigen 
interactions. This could be achieved by utilizing the force sensor for the local 
application of antibodies onto surface bound antigens. 
 For the second application an antibody antigen interaction was used as a force 
sensor for the force-based manipulation of the activity of an enzyme. For this 
experiment, the force sensor was required to prevent damage on the enzyme 
caused by too high forces. 
 A model system was established, which will allow the measurement of the 
formation of a product while applying the force to the enzyme. This included the 
preparation and immobilization of the enzyme and the attachment of the force 
sensor to the enzyme. 
The usage of artificial force sensors opens up new possibilities for the force 
based analysis and manipulation of biological systems. First, they can facilitate the 
analysis of naturally occurring force sensors by manipulating these with an artificial 
force sensor. Second, as has been shown within the scope of this work, an artificial 
force sensor can be applied for the analysis of other biological systems, which do 
not respond to forces in their natural environment. And finally, applications of 
artificial force sensors are not restricted to biological systems, but they could serve 
as building blocks for nanostructures. 
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2 Introduction 
The classical way of investigating the function of biological systems relies on the 
analysis of molecular interactions and molecular mechanisms under equilibrium 
conditions. From this point of view the regulation of cellular functions is based on the 
binding of a ligand to its receptor, which results in a change of the conformation of 
the receptor. This conformational change alters the rate of a biochemical reaction or 
can favor another reaction pathway. However, in the last few years many examples 
point out that tensile, compressive and shearing forces might play a similar and 
fundamental role for the regulation of biochemical pathways as the binding of a 
ligand to its receptor (Vogel and Sheetz, 2006; Wang and Thampatty, 2006). It is 
assumed that molecular force sensors detect the mechanical force and convert it 
into a biochemical signal. Furthermore, cells do not only convert mechanical 
information into biochemical information. They can also utilize biochemical 
information to generate forces (Fig.1). 
  
 
 
 
 Figure 1. Cells have many mechanisms to convert biochemical information 
into mechanical information (e.g. molecular motors) and the other way round 
(e.g. mechanosensitive ion channels). All these processes rely on 
conformational changes of certain proteins. 
 
This conversion of biochemical energy into mechanical work is done by 
molecular motors. The mode of action of molecular motors is well characterized. In 
contrast, almost nothing is known about the conversion of mechanical forces into 
biochemical information. (Fig.2). In many cases the whole process of force sensing, 
transduction and response is known in general, but the mechanism of the force 
sensor cannot be explained in detail. This is quite surprising because e.g. the 
receptors for hearing detect mechanical forces. The main reason for this lack of 
information is that only in recent years methods like the atomic force microscope, 
optical tweezers and molecular dynamics simulations have been developed for the 
analysis of these force sensors. 
Recently, a few reports have been published which describe a detailed 
characterization of the mechanism of a force sensor. In all cases the applied force 
leads to a conformational change of a protein. The external force can result in a 
change of the binding affinity (FimH), of the catalytic activity (titin kinase, 
fibronectin), or of the pore size of a channel protein (MscL). 
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 Figure 2. Process how cells react to mechanical forces. Specially adapted 
sensor molecules detect the force. This force is converted into a biochemical 
signal, which triggers or changes a signalling cascade. Finally, the cell 
processes the information and reacts in an appropriate way. (adapted from 
Vogel, 2006) 
 
In general, the binding affinity between a receptor and its ligand becomes weaker 
if an external force acts on the molecular bond (chapter 3.1). However, in certain 
cases the applied force can lead to a conformational change in the receptor 
molecule resulting in a strengthening of the respective bond (catch bond). This 
phenomenon was shown to be responsible for the adhesion of bacteria, which 
becomes stronger if the bacteria are subjected to shear forces (Thomas et al., 2002; 
Thomas et al., 2006). This is the case when they bind to surfaces under flow 
conditions. The adhesion is mediated by so-called fimbriae, which are hair-like 
structures on the surface of the bacterium. One fimbrium consists of many individual 
monomers, which assemble into the respective structure. The structural domain, 
which is responsible for the adhesion is located at the end of each fimbrium. In the 
case of type 1 fimbriae from the bacterium Escherichia coli this domain is called the 
FimH domain. It consists of a ligand binding part and another part, which connects 
FimH to the rest of the fimbrium. Both parts are connected with a linker. Mutational 
studies combined with molecular dynamics simulations suggest that the force-
induced extension of this linker regulates the affinity of the distally located ligand-
binding site allosterically. This mechanism allows the bacteria to adhere firmly to 
surfaces during periods of high flow, while still permitting reversible adhesion and 
bacterial spreading during periods of low flow. 
In the example described above the structure of the binding site is probably 
rearranged. More substantial conformational changes in the whole protein are 
required for the activation of titin kinase and fibronectin. Titin kinase is a catalytically 
active protein (enzyme) whose active site is hidden if no force acts on the molecule. 
Titin kinase is part of the muscle protein titin, which is responsible for the passive 
elasticity of the muscle. If a muscle is stretched titin takes up the load and can 
transmit force onto the titin kinase. As has been shown with molecular dynamics 
simulations this force can remove the so-called autoinhibitory tail and the active site 
becomes exposed (Gräter et al., 2005). After exposure of the active site the titin 
kinase is able to bind to other proteins, which are most probably involved in muscle 
gene expression (Lange et al., 2005). Whereas titin kinase is an enzyme, the 
physiological function of fibronectin is different. Fibronectin is a structural protein. 
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However, if fibronectin is stretched specific peptide sequences can change their 
conformation or become exposed. Some of these sequences are involved in binding 
to other proteins. Other sequences are considered to exhibit a possible catalytic 
activity. From this point of view fibronectin is extremely interesting. Force induced 
conformational changes might switch a protein with pure mechanical function into a 
protein with enzymatic activity. Unfortunately, no experimental data exists proving 
that this force induced exposure of these sequences indeed results in an enzymatic 
activity (Vogel, 2006). 
Another class of molecules which are activated by a force induced 
conformational change are mechanosensitive ion channels (MS channels). These 
channels are transmembrane proteins, which transduce a mechanical stimulus into 
an electrochemical response by opening a pore in the cell membrane. The large 
mechanosensitive channel (MscL) of bacteria normally exists in a closed 
conformation and can be activated directly by a mechanical stimulus. The channel is 
a pentamer consisting of five identical subunits. Each monomer consists of 2 
transmembrane helices and additional domains, which are not packed into the 
membrane. Upon changes in the tension profile of the membrane these helices 
move away from the central axis similar to the opening of an iris of a camera 
(Sukharev et al., 2001; Perozo et al., 2002). This movement generates a large water 
filled pore. Although the opening of the channel has been analyzed in detail, nothing 
is known about how MscL senses the force, which is generated by the membrane 
tension. It is considered that MscL possesses a defined force sensor. But the exact 
location and the mechanism is not known yet (Perozo, 2006). 
All of the above mentioned examples show that force can act as an allosteric 
regulator similar to biochemical inhibitors or activators. It is expected that many 
similar systems of force sensing and transduction will be discovered in the near 
future. These natural force sensors will require new methods for their 
characterization but they will also inspire the design of artificial force sensors. 
Artificial force sensors can find broad applications for the analysis of biological 
systems. They can be combined with existing technologies and expand their range 
of possible applications. For example, an artificial force sensor can provide a 
defined threshold force, which cannot be controlled accurately with a macroscopic 
device alone. 
The following sections will explain the basic principles for the force based 
analysis of biomolecular functions and will describe the required methods to apply 
and measure forces at the molecular level. One section deals with the design of 
artificial force sensors and describes examples of biomolecular interactions, which 
are good candidates for artificial force sensors. Finally, two examples are described 
which show the application of artificial force sensors for the analysis of biological 
systems. 
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3 Force measurements 
In order to understand the requirements for artificial molecular force sensors, this 
chapter summarizes the models describing the stability of receptor ligand 
interactions in the absence and presence of an externally applied force. 
Furthermore, the macroscopic devices used to apply forces to molecules are 
summarized and the two methods used in this work will be described in more detail. 
3.1 Thermodynamic and kinetic models 
Many transitions, which occur in biological systems, can be approximated with 
the simplest model system represented by only two states A and B. The states A 
and B are separated by a transition state T characterized by an energy barrier 
(Fig. 3a). The two states represent for example the folded and the unfolded state of 
a protein, a receptor ligand system in its bound and unbound state or two different 
conformations of a molecule. The transition between these two states occurs with 
the rate constants k12 and k21. 
 k12 
A    ⇄   B 
 k21 
The rate constants depend exponentially on the height of the energy barrier (ΔG1 or 
ΔG2 respectively) between these states: 
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with ν1 and ν2 the attempt frequency according to Kramers, 
kB the Boltzmann constant, 
and T the absolute temperature 
 
According to the law of mass action the equilibrium constant K can be calculated as 
follows 
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and therefore can be used to determine the free energy difference between the two 
states A and B: 
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 Figure 3. The effect of force on the free energy of a two-state system. a) 
Potential landscape of a two state-system without an externally applied force. 
A and B are two different states of a molecule or a molecular interaction. T 
represents the transition state. k12 and k21 are constants describing the rates of 
the transition from one state to the other. ΔG1 and ΔG2 describe the difference 
in free energy between state A or B and the transition state. Δx refers to the 
width of the potentials. b) Comparison of the system with (solid blue curve) and 
without an externally applied force (dashed black curve). The application of 
force lowers the free energy of both the transition state and state B relative to 
state A by –Fx (dashed blue curve). As a result, the rate k12 and therefore the 
population of state B increases. The positions of the free energy minima and 
the maximum shift along the reaction coordinate. Their relative shifts depend 
on the local curvature of the free energy surface. 
 
If a force is applied to the system, which acts along the reaction coordinate x, one 
has to distinguish two fundamentally different cases (Guthold et al., 2001). If the 
system can access all its energy states within the time scale of the experiment, the 
force does not shift the equilibrium of the transition and the transition is fully 
reversible. In this case the rate at which the force is applied (the “loading rate”) will 
not change the force at which the transformation occurs. For reactions, which 
proceed at equilibrium, the data obtained from the force measurements can be used 
to determine the free enthalpy of the reaction. If the time scale of the experiment is 
Force measurements 
Kerstin Blank  page 14 
faster than the time scales of the transformation the system is no longer in 
equilibrium. In non-equilibrium transitions the externally applied force causes a 
thermodynamically irreversible change. The influence of the external force on such 
a system was first described by Bell (Bell, 1978). The model was further developed 
by Evans (Evans and Ritchie, 1999). The now well-established Bell-Evans model 
can be applied broadly for the data analysis of force measurements. The most 
important aspects are summarized in the following. The model describes how the 
energy landscape is tilted by the externally applied force resulting in a reduction of 
the free energy of the transition state. For the reason of simplicity the potential width 
ΔxAT is assumed to be independent of the applied force. This assumption is valid for 
deep potentials. Based on this assumption eq. 3.5 describes the exponential 
increase of the rate k12(F) of the transition from state A to B with an externally 
applied force. 
! 
k
12
F( ) = "1 # e
$ %G
1
$F #%xAT( )
kBT         (eq. 3.5) 
The probability N(t) for the system to be in state A can be calculated by solving eq. 
3.6. 
! 
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This results in a distribution of unbinding forces 
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The most probable unbinding force can be given by 
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with the loading rate 
! 
˙ F =
dF
dt
 
Eq. 3.8 relates the measured force with the transition rate at zero force k12(0). For 
example, this transition rate can refer to the dissociation rate of a receptor ligand 
system. Additionally, the width of the potential ΔxAT can be obtained. Both values 
can be determined from a plot of the most probable unbinding force versus the ln of 
the corresponding loading rate. For a two level system this plot shows a straight 
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line. The potential width can be obtained from the slope and the transition rate from 
the intercept with the x-axis at zero force. 
The most important conclusion from eq. 3.8 is that the unbinding force depends 
on the loading rate. At slow loading rates the system has more attempts driven by 
thermal fluctuations to reach the energy barrier than at faster loading rates. 
Therefore, at slow loading rates, the transition will occur at lower forces and at fast 
loading rates the transition will occur at higher forces. 
3.2 Techniques for the application and detection of forces 
Having shown the influence of external forces e.g. on the binding potential of 
receptor ligand interactions this chapter will describe the most common techniques 
used to apply and measure forces. For all techniques the molecules of interest have 
to be connected to a macroscopic device. One binding partner is attached to the 
force transducer and the other to a translation stage, which brings the binding 
partner in the correct position for the establishment of an interaction. After a short 
overview of the techniques the working principle of the atomic force microscope is 
described in detail. Additionally, a technique developed within the scope of this work 
is introduced. 
3.2.1 Overview 
The techniques differ from each other mainly by the method of applying and 
detecting the forces, as well as the type of surface to which the binding partners are 
coupled. The most common techniques are: Atomic force microscopy (Florin et al., 
1994), optical tweezers (Ashkin, 1997), magnetic tweezers (Smith et al., 1992), the 
biomembrane force probe (Evans et al., 1995), glass microneedles (Kamimura and 
Takahashi, 1981) and hydrodynamic techniques such as the application of shear 
flow to the bond of interest (Tees et al., 1993; Alon et al., 1995). The forces 
generated and sensed are in the range of several pN up to several nN. None of 
these techniques can cover the whole range of possible forces. The force range and 
the working principle of the different techniques are summarized in table 1. For all 
these techniques except of the differential force assay the force acting on the 
molecular interaction is compared with the response of a micro-sized object such as 
a bead or a cantilever. In contrast, in the differential force assay the molecular 
interaction is compared with another molecular interaction. This exhibits several 
advantages, which will be described in chapter 3.2.3. 
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Table 1. Techniques used in single molecule force spectroscopy 
technique force range throughput working principle 
atomic force 
microscope 
(AFM) 
> 1 pN low The bending of a micro-fabricated cantilever is 
detected by the deflection of a laser beam. 
optical 
tweezers  
(OT) 
0.1 pN – 150 pN low A micrometer-sized bead is trapped in an electric 
field gradient of a laser focus by optical forces. 
Displacement of the bead from the center of the 
laser focus is converted into forces. 
magnetic 
tweezers 
10 fN – 100 pN medium Magnetic forces are applied through a 
micrometer-sized magnetic bead. The 
displacement of the bead is converted into forces. 
biomembrane 
force probe 
(BFP) 
0.5 pN -1000 pN low A red blood cell or a vesicle is aspirated by 
micropipette suction. The deformation of the 
cell/vesicle is used to quantify the force, which is 
acting on the cell/vesicle. 
glass 
microneedles 
> 0.1 pN low An optical fiber is deflected perpendicular to the 
fiber axis. The deflection can be converted into 
forces. 
hydrodynamic 
techniques 
1 – 250 pN medium Hydrodynamic flow or surface tension is used to 
exert forces directly on the sample molecules or 
on a bead. In contrast to other techniques, bond 
lifetimes are measured instead of forces.  
differential 
force assay 
0.1 pN – 1000 pN medium-
high 
The molecular bond of interest is compared 
directly with another molecular bond. After 
building up a chain of molecular bonds this chain 
is loaded with force and the weakest bond 
ruptures first.  
 
3.2.2 The atomic force microscope (AFM) 
Originally invented for the characterization of surfaces by Binnig, Quate and 
Gerber (Binnig et al., 1986) the technology has experienced many improvements. 
The AFM combines a high spatial precision with a high force resolution. Therefore, it 
was a logical consequence that the technology did not only find applications for the 
characterization of surfaces but also was used for the measurement of forces 
between individual biomolecules (Florin et al., 1994). Now, the AFM is one of the 
most common devices for the measurement of biomolecular interactions, also called 
force spectroscopy. A schematic setup of an AFM is shown in Fig. 4. 
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 Figure 4. Setup of an atomic force microscope. The sample is mounted 
onto an x-y piezo table, which allows the positioning of the sample relative to 
the cantilever. The cantilever is mounted in a way that it can be moved in z-
direction. The cantilever possesses a very sharp tip. This tip is brought in 
contact with the sample. When performing force spectroscopy, the contact time 
is sufficiently long to allow the tip itself or bound molecules to interact with the 
sample. Then, the cantilever is retracted. In the case of an interaction, the 
cantilever bends. This bending can be monitored with a laser, whose deflection 
is detected using a segmented photodiode. 
 
In a typical force spectroscopy experiment one binding partner is anchored to a 
surface mounted on the x-y piezo table whereas the other binding partner is 
immobilized on the tip of the cantilever. The tip of the cantilever is brought into 
contact with the surface to allow the binding partners to interact. In the next step the 
cantilever is retracted thereby applying a force to the molecular bonds resulting in 
forced-induced transformations or bond rupture. In the case of bond rupture the 
cantilever relaxes back into its equilibrium position. The force applied to the 
molecular interaction is known throughout the whole process. It is determined by the 
measurement of the deflection of the cantilever by means of the optical detection 
system. The force can be calculated from the deflection and the spring constant of 
the cantilever. As described in chapter 3.1 the unbinding force of a molecular 
interaction is dependent on the loading rate. This rate can be varied by changing the 
retract speed of the cantilever (dynamic force spectroscopy). 
As the dissociation is influenced by thermal fluctuations, one unbinding event is a 
stochastic process. Therefore, many rupture events have to be recorded to provide 
sufficient statistics to obtain the most probable rupture force. The measured force 
extension curves are analyzed to obtain the rupture force and the corresponding 
loading rate, which can be calculated form the retract speed and the slope of the 
force extension curve at the moment of the bond rupture. These values obtained 
from various force extension curves are plotted in histograms and fitted with a 
Gaussian distribution. The maxima of these distributions represent the most 
probable rupture force and the corresponding loading rate. To analyze the obtained 
data, the force is plotted versus the ln of the loading rate. From this plot the values 
for the potential width ΔxAT and the natural off-rate k12(0) can be obtained using 
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equation 3.8. (This method of evaluating the data can also be used for any other 
technique as described in chapter 3.2.1.) 
Although the measurement of unbinding forces with the AFM can be applied 
broadly and provides the desired information in many cases the technology still has 
some drawbacks. First, the throughput is relatively low. Only one molecular 
interaction can be characterized at one time and many force extension curves have 
to be recorded one after the other to provide the required statistics. Second, the 
instrument is susceptible to external perturbations, just as sound or temperature 
drift. Third, the force sensitivity is limited by the size of the cantilever (Viani et al., 
1999). Therefore, the comparison of two different molecular interactions yields huge 
errors. The differential force assay described in the next chapter represents an 
attractive alternative for the comparison of molecular interactions circumventing all 
the problems mentioned above. 
3.2.3 The differential force assay 
The differential force assay compares the molecular interaction of interest directly 
with either another known or an unknown molecular interaction. This is attractive for 
many reasons. The main advantage is the use of another molecular interaction as a 
force sensor. For AFM experiments it has been shown that smaller cantilevers have 
a higher force resolution and a better sensitivity. This is due to the fact that smaller 
cantilevers experience less thermal noise which is one of the main determinants of 
the signal to noise ratio. However, the use of smaller cantilevers is hindered by the 
limits of the optical detection system and the fabrication of the cantilevers. 
Therefore, the use of molecules as force sensors is a logical consequence and 
single molecules are the smallest force sensors one can think of. In addition the use 
of a molecular interaction as a force sensor provides a symmetric set-up. In AFM 
experiments the interaction of interest is compared with a spring (cantilever). In the 
differential force assay it is compared with another molecular interaction. This set-up 
resembles a balance. If one uses a balance the difference is measured directly 
(Fig. 5). A balance is less influenced by external disturbances and is therefore much 
more accurate. 
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 Figure 5. Comparison of the principle of a differential force assay with 
conventional methods (e.g. AFM) for the detection of intermolecular 
forces. In conventional methods the sample of interest is connected to a 
spring. In the case of an AFM, the response of this spring is detected as the 
deflection of the cantilever. If two samples have to be compared they have to 
be measured sequentially and each measurement is sensitive to external 
perturbations, e.g. temperature. If one uses a differential force assay, the two 
samples are compared directly. Influences from the environment influence both 
samples in the same way. Therefore, this type of measurement has a smaller 
error and allows the measurement of smaller differences. 
 
Besides these advantages described above, another aspect makes the 
application of a differential force assay extremely attractive. In the differential force 
assay the molecules are immobilized on a surface just as in the AFM experiments. 
The molecules, which form the force sensor, are coupled to the surface of an 
elastomer. The elastomer allows the contact of the two surfaces to establish a 
connection between all the molecules. This set-up allows the measurement of 
various identical molecular interactions in parallel. Therefore, the required statistics 
can be obtained from only one experiment. In addition, different molecular 
interactions can be localized on different positions on the surfaces allowing parallel 
measurements of many interactions of interest. Many different realizations of a 
differential force assay are possible. Two principally different set-ups can be 
distinguished. In one set-up many unknown molecular interactions are compared to 
a well-characterized molecular interaction providing a reference force. As a result 
the assay provides the information if the unbinding force of the unknown interaction 
is higher or lower than the reference force. This set-up is shown in Fig. 6. In the 
other realization two unknown molecular interactions are compared directly. 
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 Figure 6. Example of one possible experimental set-up of a differential 
force assay. The strengths of two different molecular interactions (blue; same 
receptor – different ligands) are compared with a reference bond (green). The 
two ligands to be analyzed are immobilized on a surface at different positions. 
The ligand of the reference bond is immobilized on another surface. The 
corresponding receptors are connected to the same fluorescence label. This 
fluorescent complex is bound to the ligand of the reference bond on the 
respective surface. The surfaces are brought into contact allowing the blue 
ligands to bind to their receptor. In the next step, the surfaces are separated. 
The assembled chain of molecular interactions is loaded with a force. This 
force is constant along the chain. After stretching the molecules of the chain, 
the weakest bond ruptures with a higher probability. The distribution of the 
fluorescent complex is finally measured and yields the desired information. For 
example, if the left bond is stronger than the right bond a higher fluorescence 
will be measured at this position on the surface. 
 
Two different examples have been realized within the scope of this work. The first 
example has been implemented to prove the high sensitivity of the differential force 
assay. In this set-up two different DNA duplexes have been compared with each 
other. It is described in more detail in the publication P9. In the second example a 
known reference force was used to detect the specificity of antibody antigen 
interactions. This set-up is described in chapter 6 in more detail. 
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4 Immobilization of biomolecules on surfaces 
A prerequisite for the force-based characterization of biomolecules is their 
immobilization on the macroscopic device, which is used to apply the external force. 
The immobilization procedure should be easy to carry out and possess a high 
specificity. The bond has to be stable over the time scale of the experiment. This 
also applies to the immobilized biomolecule. In addition, the biomolecule should not 
be destroyed by the immobilization procedure and have a good steric accessibility. 
The possibility of controlling the density of actively immobilized biomolecules is of 
great advantage. 
4.1 Overview 
In principle, three different strategies are feasible and have been used 
successfully: Physical adsorption was used to bind proteins, e.g. titin, to AFM 
cantilevers (Rief et al., 1997). The most commonly applied procedure is the covalent 
coupling to chemically activated surfaces (Hermanson, 1995). For example, 
antibodies can be coupled to glass surfaces using this approach (Neuert et al., 
2006). The third strategy is based on the specific recognition of different receptor 
ligand systems. In this case, the receptor is bound to the surface and the ligand is 
attached to the biomolecule. This attachment can either be achieved with chemical 
coupling of the ligand to the biomolecule or with the usage of fusion proteins. Fusion 
proteins are constructed on the genetic level by attaching the sequence of the 
affinity ligand to the sequence of the protein of interest. Then these recombinant 
hybrids can be expressed as fusion proteins with the attached “tag” at the N- or C-
terminus of the protein of interest (Hearn and Acosta, 2001; Terpe, 2003). The 
fusion protein approach has the advantage that the “tag” is attached at a well-
defined position. One prominent example is the so-called His tag, which binds to 
Ni2+-ions complexed with nitrilotriacetic acid (NTA). For example, this system was 
used to bind His tagged recombinant antibody fragments to AFM cantilevers 
(Berquand et al., 2005). Useful strategies for chemical coupling and suitable 
receptor ligand systems are summarized in table 2. 
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Table 2. Summary of methods for the immobilization of biomolecules 
surface biomolecule bond reaction 
conditions 
epoxy amino secondary amine 
   
reaction is            
pH dependent 
pH > 9 
epoxy thiol thioester 
   
reaction is           
pH dependent 
7.5 < pH < 8.5 
aldehyde amino Schiff base 
   
labile Schiff base 
interaction can be 
chemically 
stabilized by 
reduction 
aldehyde hydrazide hydrazone 
   
more stable than 
aldehyde + amine 
reduction is not 
essential 
activated esters amino amide 
 
 
 
reaction is           
pH dependent 
half life of NHS 
ester can be critical 
for the yield 
iodoacetyl thiol thioester 
   
specificity for SH-
groups is             
pH dependent 
slightly alkaline pH 
required 
maleimide thiol thioester 
 
 
 
specificity for SH-
groups is pH 
dependent 
at high pH possible 
reaction of amino 
groups 
thiol disulfide derivative disulfide 
   
bond is not stable 
under reducing 
conditions 
biotin (strept)avidin specific recognition 
non-covalent    
very low koff 
binding in a broad 
range of different 
buffers 
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surface biomolecule bond reaction 
conditions 
antibody antigen specific recognition 
non-covalent 
binding dependent 
on the respective 
antibody 
capture molecule 
e.g. Ni2+-NTA 
affinity tag 
e.g. his tag 
specific recognition 
non-covalent 
binding dependent 
on the system used 
suicide inhibitor enzyme specific recognition 
covalent 
reaction dependent 
on the enzyme 
  
All the methods summarized in table 2 have specific advantages and 
disadvantages. It has to be taken into account that a certain fraction of molecules 
could be inactivated as a result of their immobilization or previous chemical 
modification. Frequent problems are denaturation of the molecule, destruction of the 
active site by direct chemical modification, steric hindrance caused by neighboring 
molecules or the surface, strain induced by multipoint attachment or a shift of the 
isoelectic point of the biomolecule. Most of these problems can be overcome by 
means of a spacer between the biomolecule and by site-specific immobilization. The 
use of a spacer avoids direct contact between the biomolecule and the surface 
preventing potential denaturation and steric hindrance. Site-specific immobilization 
avoids multi-point attachment and ensures that the active site is located sufficiently 
far away from the point of attachment (Turkova, 1999). 
When an external force should be applied to the biomolecules it has to be 
considered that a thermodynamically stable bond is not necessarily stable, if an 
external force is applied to the bond. If no external force is applied to the 
biomolecule the free energy of the bond determines its stability. It is normally 
sufficient to consider only the type of spacer and the position of the attachment point 
on the molecule. Either covalent chemical coupling or receptor ligand interactions 
can be used. Most of the receptor ligand interactions possess a sufficient stability to 
ensure that the bond is stable during the experiment. However, if an external force 
is applied to these complexes, the lifetime of the complex is no longer dependent on 
the equilibrium free energy. The applied force changes the energy landscape (as 
described in chapter 3.1). Therefore, the bond might rupture at a relatively low force 
and result in a low yield of the measurement. Furthermore, dependent on the 
binding potentials of the interaction of interest and the receptor ligand interaction 
used for the immobilization it cannot be excluded that both interactions rupture with 
a certain probability (Neuert et al., 2006). From this point of view only covalent 
bonds are tolerable in experiments with molecular force sensors. The strength of 
covalent bonds is in the range of 1-2 nN (Grandbois et al., 1999), whereas the 
strength of typical receptor ligand interactions is in the range of 10-250 pN 
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(Florin et al., 1994; Rief et al., 1999). This difference is large enough to ensure that 
only the bond of interest breaks, if a force is applied. 
Considering all the aspects described above, two examples for immobilization 
procedures are described in the following sections, which fulfill many important 
criteria. One example describes a protocol for the covalent immobilization via 
heterobifunctional poly(ethylene glycol) spacers. The second example is based on 
the reaction of the enzyme hAGT with a so-called “suicide inhibitor”. It is particularly 
useful for the immobilization of proteins. hAGT fusion proteins have been shown to 
be active in many different applications. 
4.2 Covalent immobilization using hetero-bifunctional 
poly(ethylene glycol) spacers 
The usage of spacers for the attachment of biomolecules to surfaces has many 
advantages. First, it prevents the molecule from interacting with the surface. 
Especially if the surface is hydrophobic the biomolecule could adsorb non-
specifically and become inactivated. Second, the spacer allows the molecule to 
move relatively free in solution. Therefore the spacer prevents steric hindrance and 
reduces mass transport effects. Third, it can be used to change the surface 
properties and introduce the required functional groups for the attachment of the 
biomolecule. And finally it serves as an elastic module if a force is applied to the 
molecule. 
The molecule poly(ethylene glycol) (PEG) is an ideal spacer which shows all the 
above mentioned advantages. PEG has unique properties. If PEG is coupled to a 
surface at a sufficiently high density the surface becomes resistant to the adsorption 
of proteins and other biomolecules (Sofia and Merrill, 1997; Alcantar et al., 2000). 
PEG is a linear polymer with a relatively narrow length distribution. It is available in a 
broad range of different lengths allowing the adjustment of the distance between the 
surface and the biomolecule for the particular application. And finally, PEG can be 
synthesized with many different reactive groups (Veronese, 2001; Roberts et al., 
2002). Monofunctional PEGs are activated at one end and bifunctional PEGs carry a 
reactive group at both ends. Either these groups are identical (homo-bifunctional) or 
the PEG is synthesized with different reactive groups (hetero-bifunctional). Hetero-
bifunctional PEG spacers are especially useful for the immobilization of 
biomolecules. The spacer can be coupled to the surface with one reactive group. 
The free reactive group can be used to couple the biomolecule in the next 
step (Fig. 7). 
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 Figure 7. Example for the immobilization of a biomolecule on a surface 
using NHS-PEG-maleimide. First, the hetero-bifunctional NHS-PEG-
maleimide is coupled to an amino-modified surface. The NHS-group reacts 
with an amino group. As the maleimide group is not involved in the coupling 
reaction it can be used in the next step. Then, the thiolated biomolecule is 
coupled. Because thiol groups are very rare among the reactive groups on 
biomolecules this strategy allows a site-specific immobilization in most of the 
cases. 
 
The usage of the hetero-bifunctional NHS-PEG-maleimide is a very general 
strategy to achieve the site-specific immobilization of many different biomolecules. 
The NHS-group is coupled to an amino-functionalized surface. In the next step the 
maleimide group can be used to couple any type of biomolecule, which possesses a 
thiol group. Thiol groups on biomolecules are very attractive for coupling 
procedures. In the case of proteins, thiol groups of the amino acid cysteine are very 
rare on the surface of proteins. Therefore, the chance is high that a protein has only 
one cysteine on its surface. This single natural cysteine can then be used for 
coupling at a defined position. Alternatively, if the protein does not possess a single 
cysteine it can be introduced by mutation. In the case of other biomolecules, just as 
oligonucleotides or peptides, a thiol group can be introduced during the synthesis of 
the molecule. The application of this procedure for the site-specific immobilization of 
an enzyme is demonstrated in the publication P3. 
4.3 Covalent immobilization using “suicide inhibitors” 
Suicide inhibitors are a special group of enzyme inhibitors. They bind into the 
active site of the enzyme and are recognized as a substrate. In the next step the 
enzyme catalyzes the transformation of the inhibitor. But, in contrast to a normal 
substrate the product is not released from the active site but remains covalently 
bound in the active site thereby inactivating the enzyme. Because of the covalent 
nature of the attachment suicide inhibitors are interesting tools for various 
applications. Recently it has been shown that enzymes can be covalently attached 
to surfaces displaying an appropriate suicide inhibitor (Hodneland et al., 2002; 
Kindermann et al., 2003). If the enzyme is genetically fused to another protein this 
protein is attached to the surface together with the enzyme. This results in a highly 
specific and covalent attachment of the protein. Therefore, the usage of suicide 
inhibitors is an interesting option for the attachment of proteins for force 
measurements. 
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Most of the known suicide inhibitors are artificial substrate analogues, which have 
been synthesized for a special group of enzymes e.g. proteases and lipases. In 
contrast, the natural reaction of human O6-alkylguanine-DNA alkyltransferase 
(hAGT; EC 2.1.1.63) with its substrate yields a chemically modified active site 
resulting in an inactive enzyme (Rasimas et al., 2003). In its natural environment 
hAGT is a DNA repair protein. Many homologues in different species have been 
discovered indicating that hAGT plays a very important role in maintaining the 
integrity of the genome. It repairs alkylated guanine bases thereby preventing 
incorrect base pairing. This is achieved by transferring the alkyl group of the 
substrate O6-alkylguanine to one of its cysteine residues. This stoichiometric 
transfer results in dealkylated guanine and an alkylated enzyme. As hAGT lacks the 
ability to dealkylate itself it only participates in one single reaction. It is inactivated 
irreversible and undergoes a conformational change, which triggers its proteolytic 
degradation. 
hAGT is a monomeric protein of 207 amino acids. Its structure has been solved 
in 2000 (Daniels et al., 2000; Wibley et al., 2000). It consists of two domains. The 
function of the N-terminal domain is unknown. It possesses a binding site for a 
Zn2+ ion. Binding of Zn2+ is considered to be important for the stability of the protein. 
However, hAGT is also active without a bound Zn2+ ion. The C-terminal domain 
contains a DNA binding motif and the active site. hAGT possesses five cysteine 
residues of which Cys145 is the site of the alkyl transfer. Cys5 and Cys35 
participate in the creation of the Zn2+ binding site. For Cys62 and Cys151 no 
obvious structural or functional role is known. Both termini of hAGT are located far 
away from the active site. 
The substrate specificity of hAGT is relatively low. It also reacts with the 
nucleobase O6-benzylguanine (BG) either in its free form or incorporated into 
oligonucleotides. Furthermore, BG derivatives with substituted benzyl rings are 
accepted as substrates. In this reaction the substituted benzyl group is transferred 
to the active site of hAGT. The benzyl ring can be substituted at the 4-position with a 
wide variety of labels such as dyes, cross-linkers and affinity tags without 
significantly influencing the reaction (Keppler et al., 2003). The possibility of labeling 
hAGT with a variety of different labels and the option of making N-terminal and 
C-terminal fusion proteins allows the labeling of any protein via the reaction of hAGT 
with this label. Using this approach, hAGT can be used to attach a protein of interest 
to a force sensor or for the immobilization of a protein on a surface displaying BG 
(Fig. 8). 
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 Figure 8. Reaction of hAGT with O6-benzylguanine (BG) modified 
surfaces. hAGT (PDB no. 1QNT) reacts with different derivatives of BG. It 
cleaves the bond between the benyzl group and guanine. The reaction yields 
free guanine. The benzyl group remains covalently attached to a cysteine in 
the active site of hAGT. If BG has been attached to a surface beforehand, the 
enzyme remains bound to the surface. This mechanism can be employed to 
attach a protein of interest to the surface. For this purpose, fusion proteins can 
be produced with recombinant DNA techniques. The protein of interest can be 
attached at the N-terminus or the C-terminus of hAGT. 
 
Thereby hAGT reacts specifically with BG resulting in a covalent immobilization 
of the protein of interest on the surface (Kindermann et al., 2003; Sielaff et al., 
2006). As BG is chemically inert there are no side reactions and the immobilization 
is highly specific. Therefore only hAGT is involved in the immobilization reaction. 
hAGT acts as a spacer and leaves the protein of interest accessible for interactions 
with other molecules. Furthermore, because of the high specificity of the 
immobilization it can be performed in crude extracts eliminating the need for the 
purification of the protein of interest. Using the crude extracts directly can be of a 
certain advantage for applications where the density of the proteins on the surfaces 
in not relevant. The application of the immobilization of hAGT fusion proteins for 
AFM measurements is demonstrated in the publication P5. 
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5 Molecular force sensors 
Molecular force sensors have the potential to find broad applications either as 
tools to characterize the function of naturally occurring force sensors or alternatively 
as analytical tools for the measurement of molecular interactions or the systematic 
manipulation of biomolecules. As summarized in the last two chapters it is always 
necessary to attach the biological system of interest to various types of surfaces. 
Molecular force sensors can be designed in a certain way to allow the defined 
immobilization and to provide a defined reference force. For example, they can be 
used as force sensors in the differential force assay (chapters 3.2.3 and 6). 
Alternatively, they can be used to transmit forces between an analytical device just 
as the AFM and the molecule of interest. If the force reaches the threshold value, 
which is defined by the sensors, the bond will open and prevent damage on the 
molecule caused by to high forces (chapter 7). 
5.1 Requirements 
To fulfill these functions, force sensors have to accomplish the following 
requirements. They have to provide possibilities for the attachment of the force 
sensor to the surface and to the molecule of interest. In an ideal case the 
attachment to the molecule is achieved at a defined position and can be carried out 
easily. It is of capital importance, that the attachment of the force sensor does not 
change the structure and the function of the molecule of interest. Additionally, the 
stability of the force sensor has to be characterized at equilibrium conditions and at 
various different loading rates, e.g. with the AFM. 
5.2 Desoxyribo nucleic acid (DNA) 
The mechanical properties of double stranded DNA have been investigated with 
different methodologies and over a broad range of forces. These experiments 
revealed different regimes of the reaction of DNA to externally applied forces (Strick 
et al., 2000; Bustamante et al., 2003). Up to a force of 10 pN the process is 
governed by entropic forces. Between 10 pN and 65 pN DNA stretches like any 
spring. At 65 pN a phase transition from B-DNA to S-DNA occurs (B-S transition) 
(Rief et al., 1999; Guthold et al., 2001). If the force is increased further the double 
strand melts into two single strands (melting transition). These experiments have 
been performed with rather long DNA molecules (> 1000 bp). 
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However, short DNA sequences are required (< 50 bp) to use DNA as a force 
sensor. First, the DNA is required in a relatively high concentration and it needs 
specific reactive groups attached to its ends in order to couple it to the surface and 
to the molecule of interest. This can only be achieved with solid phase synthesis of 
oligonucleotides. Second, when using oligonucleotides the sequence and length of 
the DNA is known exactly and provides the possibility of fine-tuning the strength and 
orientation of the force sensor (Fig. 9). 
 
 
 
 
 Figure 9. Different unbinding mechanisms of DNA if an externally applied 
force acts on the duplex. The mechanism is dependent on the length and the 
sequence of the DNA as well as the direction and rate of the applied force. 
Every strand of the DNA has an orientation, which is given by the structure of 
the chemical bonds in the backbone of the DNA (linkages between 
desoxyribose and phosphate groups). Therefore, each DNA strand has a 
3’ end and a 5’ end. Looking at a relatively short DNA duplex (10 base pairs to 
approximately 30 base pairs), this duplex opens up in a zipper mode (bottom 
left) if one strand is pulled at the 3’ end and if the other strand is pulled at the 
5’ end. If both strands are loaded at the 5’ end all base pairs have to open up 
at the same time. The strands are sheared apart yielding a higher force 
compared with the unzipping mechanism (top left). For longer DNA duplexes, 
pulling at the 5’ end of both strands results in a structural change (B-S 
transition) before the strands finally dissociate. This structural change happens 
at approximately 65 pN (top right). In the case of repetitive DNA sequences 
loops can form and propagate along the DNA. This slipping mechanism can be 
observed with and without an externally applied force (bottom right). 
 
The mechanisms shown in Fig. 9 have been investigated in detail. It has been 
shown that for short oligonucleotides (10 bp, 20 bp and 30 bp) the force for DNA 
shearing depends on the stability (ΔG) of the DNA duplex and on the applied 
loading rate (Strunz et al., 1999). In these experiments, no B-S transition was 
observed because the rupture of the duplexes occurred at forces below 65 pN and 
the process of bond rupture followed the Bell-Evans model. Therefore, at a defined 
loading rate the holding force of the duplex can be tuned by changing the length and 
the base composition. Although the B-S transition has only been observed for long 
DNA molecules it is expected to occur also for short duplexes as soon as the 
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stability and the loading rate are so high, that the rupture force is in the range of 
65 pN. Above 65 pN the holding forces are expected to be less predictable as the 
B-S transition and the melting transition cannot be described with the Bell-Evans 
model. This has to be considered if DNA is used as a force sensor. 
If repetitive DNA sequences are sheared apart another unbinding mechanism 
has been predicted theoretically (Neher and Gerland, 2004). It is considered that the 
DNA can form bulge loops propagating along the DNA strand resulting in a 
displacement of the strands relative to each other. By applying a shear force to the 
duplex the displacement occurs favorably in one direction finally resulting in thermal 
unbinding of the two strands. Within the scope of this work, experiments have been 
performed with the AFM, which prove the existence of this unbinding mechanism 
(publication P2). The slipping process has been characterized in more detail for 
20 bp and 30 bp duplexes and provides another force sensor with a cut-off force in 
the range of 40 pN. 
Additionally, a principally different unbinding mechanism has been shown. DNA 
can be pulled apart in an unzipping process. In contrast to the shearing processes 
described above, the bases are separated sequentially. The forces required to 
separate the strands are also sequence dependent (Rief et al., 1999; Krautbauer et 
al., 2003) but are much lower compared with the forces needed for shearing the 
DNA. The forces required to unzip the DNA are independent of the loading rate. 
This might be an advantage if DNA is used as a force sensor especially if the 
loading rate is not known in the respective experimental set-up. The application of 
this kind of force sensor for the detection of receptor ligand interactions is 
summarized in chapter 6. 
In summary, the use of DNA as a force sensor has the advantage that the 
stability of many different configurations was characterized in many different types 
of experiments. Therefore, DNA interactions provide a range of different force 
sensors with well-characterized holding forces. However, the usage of DNA has 
some drawbacks. In the organism proteins are the molecules which perform most of 
the functions, e.g. in force transduction. In order to analyze the function of proteins it 
is not straightforward to attach a force sensor consisting of DNA to the molecule of 
interest. The attachment of DNA to a protein requires huge amounts of purified DNA 
and protein and sophisticated protocols for the chemical coupling. 
5.3 Antibody antigen interactions 
For the characterization of proteins it is much more convenient to utilize the 
interaction between different proteins as a force sensor. The main advantage of this 
approach is the possibility of preparing fusion proteins of the protein of interest and 
the force sensor. Antibody antigen interactions are ideal candidates for this purpose. 
Different antibody antigen interactions have been characterized with the AFM 
(Schwesinger et al., 2000; Neuert et al., 2006) and exhibit holding forces in a useful 
range. 
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Antibodies are available from various sources. Monoclonal antibodies are one 
possible source. Recombinant antibodies such as Fab fragments or single chain Fv 
(scFv) fragments provide more flexibility (Plückthun, 1994). The different formats are 
shown in Fig. 10. Recombinant antibodies are selected from large libraries using 
e.g. phage display (Winter et al., 1994) or ribosome display (Plückthun et al., 2000). 
They can be produced in large amounts in Escherichia coli providing the possibility 
of making modifications on the genetic level (Ge et al., 1995). 
 
 
 
 
 Figure 10. Different antibody formats. The IgG molecule represents the 
most common format of monoclonal antibodies. It consists of two identical 
heavy chains and two identical light chains. One light chain binds to one heavy 
chain. The chains are connected via disulfide bonds, which stabilize the 
molecule. The variable domain of one light chain VL and the variable domain of 
the corresponding heavy chain VH build the antigen binding site. Therefore, an 
IgG molecule possesses two identical binding sites for antigens. In more detail, 
each variable domain contains three hypervarialbe regions or CDRs, which are 
responsible for antigen binding. Therefore, the smallest antigen binding 
structure is the Fv fragment, which consists of VL and VH. The Fc part of the 
antibody is involved in the immune response in the body. For applications 
where only the antigen binding function is required, it can be an advantage to 
use smaller fragments of the antibody like Fab or scFv fragments. In the scFv 
fragment the VH and VL domains are connected via a peptide linker, which 
stabilizes the molecule. 
 
Especially well-suited as force sensors are antibody fragments, which bind a 
peptide antigen. The use of recombinant antibody technology offers the possibility to 
optimize the binding constants of the antibody to the antigen providing a range of 
different clones. The peptide antigen can be easily fused to the protein of interest on 
the genetic level. As the peptide is relatively small it is assumed that it does not 
interfere with the protein of interest. In addition, the peptide sequence can be 
modified. Therefore, the availability of different clones in combination with modified 
peptides most likely provides a series of molecular interactions spanning a range of 
different holding forces. The system shown in Fig. 11 is considered to be useful for 
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the generation of such a series of force sensors. Different antibody fragments have 
been selected and the equilibrium constants have been measured (Hanes et al., 
1998; Zahnd et al., 2004) in the group of Prof. Andreas Plückthun at the University 
of Zurich. Within the scope of this work three clones have been characterized with 
the AFM to obtain their holding forces at different loading rates. The results are 
submitted for publication (P1). In the future, modifications of the peptide will be 
analyzed to extend the number of combinations, which can be used as force 
sensors. One clone of this series is currently used as a force sensor for the 
manipulation of the activity of an enzyme (chapter 7). 
 
 
 
 
 Figure 11. Structure of the anti-GCN4 antibody fragment complexed with 
its antigen (PDB no. 1P4B). The framework regions of the two domains are 
shown in blue. The loops of the CDRs, which are responsible for antigen 
binding, are shown in red. The antibody fragment was crystallized with a 
truncated version of the original peptide. This truncated version binds to the 
antibody fragment in an α-helical conformation, lying flat in the binding site. It is 
shown in yellow. 
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6 Molecular force sensors for the detection of 
receptor ligand interactions 
Receptor ligand interactions are key processes in biological systems for example 
in the immune system or in cell signaling. Therefore, their analysis is of great 
importance for the understanding of biological systems. In addition, receptor ligand 
interactions can be utilized to detect biologically relevant molecules. For example, 
the presence of a certain DNA or RNA sequence in a sample of interest can be 
detected with hybridization assays like Southern or Northern blots. Immunological 
assays based on the specificity of antibodies for their respective antigen are 
commonly applied for the detection of proteins. 
6.1 Introduction to microarray technology 
Microarray technology is an advancement of the methods mentioned above. It 
allows the detection of many analytes in a highly parallel (multiplexed) fashion. In a 
microarray experiment many (20 to >1000) receptors (e.g. DNA oligonucleotides or 
antibodies) are immobilized at spatially defined positions on a surface. Therefore, 
the specificity of each receptor is exactly defined by the position of the respective 
molecule on the array. A sample with unknown content is incubated on this array 
and the ligands bind to the array at those positions where a specific interaction with 
a receptor can occur. The bound ligands are detected either by attaching a label to 
the ligand or with so-called label free detection methods such as surface plasmon 
resonance. 
The first report on microarray technology showed the specific detection of certain 
messenger RNAs from Arabidopsis thaliana (Schena et al., 1995). In the following 
years the area of DNA microarrays developed extremely fast. Today the detection of 
20.000 different DNA sequences on one microarray has evolved to a broadly 
applied standard technology. This is due to the fact that receptors can be easily 
fabricated and immobilized on the surface. In addition, the hybridization of DNA is 
highly specific. In contrast, microarrays for the detection of proteins are still a field of 
intensive research. 
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6.2 Protein microarrays 
The analysis of the protein content of a biological sample in a microarray format 
is far more complicated. Different proteins show very diverse physicochemical 
properties. Therefore, a general strategy for their production, purification and 
immobilization does not exist. As a result, the main bottleneck for the broad 
application is the availability of suitable receptors. With respect to this problem, 
protein microarrays can be divided into two different classes: protein detecting 
arrays and functional protein arrays. Functional protein arrays attempt to obtain 
information about the biological function of certain proteins such as enzymatic 
activity. Protein detecting arrays measure the abundance and/or the concentration 
of different analytes. In general, protein detecting arrays are easier to fabricate as 
they are related with immunoassays – a well established technology. 
6.2.1 Technological aspects 
In order to establish and to carry out a protein array experiment many different 
technological aspects (Fig. 12) have to be considered (Kusnezow and Hoheisel, 
2002; MacBeath, 2002; Cutler, 2003; Tomizaki et al., 2005; Kingsmore, 2006). 
 
 
 
 
 Figure 12. Summary of the different components necessary to establish a 
protein array experiment. For each component many different solutions have 
been developed. For each experiment a different combination of these 
components might be necessary to achieve the desired result. 
 
The choice of a certain technology, e.g. for the immobilization of the receptor 
molecules, depends on the demands on the experiment. To design a protein array 
experiment the following aspects have to be considered: number of receptors, 
specificity, sensitivity, dynamic range, stability, reproducibility, and ease of handling. 
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6.2.2 Protein microarrays based on antibody antigen interactions 
The most prominent realization of protein microarrays utilizes antibody antigen 
interactions. As immunoassays are a standard procedure many different antibodies 
and antigens are available for using them as receptors on an array. In principle the 
different forms of immunoassays can be realized on the array in a multiplexed 
fashion (Fig. 13). Depending on the particular application either the antibodies or the 
antigens are immobilized. Sandwich immunoassays are the most common format. 
In a conventional immunoassay optimized for the detection of one antigen a 
sandwich assay provides high specificity. Two antibodies are used, which bind the 
same antigen at different positions. Using this set-up, the probability that a different 
antigen is bound falsely by these two antibodies is extremely low. 
 
 
 
 
 Figure 13. Different formats of antibody based microarrays. Either the 
antibodies or the antigens can be immobilized on a surface. Immobilized 
antibodies allow for the detection of an antigen either in a direct assay or in a 
sandwich assay. In a direct assay the antigen is labeled directly with a marker. 
Alternatively the antigen can be detected with label free detection methods. In 
a sandwich assay the antigen itself is not labeled. Instead, a labeled detection 
antibody, which is specific for the antigen, is incubated on the surface. The 
binding of this antibody is detected with a so-called secondary antibody, which 
carries the label. In the third format the antigen is immobilized on the surface. 
And the presence of an antibody in a sample is detected after incubation with a 
labeled secondary antibody. 
 
However, it turned out that multiplexing of sandwich assays is associated with 
many problems. Whereas the detection antibody provides high specificity in a single 
assay, it yields an increasing number of false positives and an increasing 
background signal with a higher degree of multiplexing. This is the result of the 
experimental procedure: After binding the antigens to the receptors the array is 
incubated with a cocktail containing all the detection antibodies. This incubation step 
is followed by a second incubation step to bind the labeled secondary antibodies. 
The problems arise from the possibility of the detection antibodies and the 
secondary antibody to bind everywhere on the array. In more detail, the problems 
can be attributed to the following effects: First, antibodies are known to exhibit 
crossreactivity (Michaud et al., 2003). Crossreactivity is defined as the property of 
an antibody to bind not only to the antigen against which it has been elicited but also 
to other related or non-related antigens. Therefore, if either an antibody used as a 
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receptor or as a detection antibody is crossreactive it will be impossible to 
distinguish which antigen has been detected. Second, with an increasing degree of 
multiplexing more detection antibodies have to be added to the cocktail resulting in 
a higher total antibody concentration. With a higher antibody concentration more 
non-specific interactions with the surface will occur leading to a higher background 
signal and a reduced sensitivity. 
6.2.3 Force-based antibody microarrays 
These problems can be eliminated if the detection antibodies are applied to the 
position of the respective receptor only. Using this strategy, the detection antibody 
does not have any contact with other positions on the array. Therefore, it will only 
measure the presence and the concentration of the desired antigen on the 
respective position. This local application of detection antibodies was realized in the 
format of a differential force assay (chapter 3.2.3). The receptor and the antigen 
were bound to one surface. The detection antibodies were coupled to the second 
surface via force sensors. DNA duplexes in unzipping conformation were used as 
the force sensors. They provide a high thermodynamic stability and a low 
mechanical stability under an externally applied force. In addition the unzipping 
process is not dependent on the loading rate. This is a big advantage, as the 
loading rate is not known in the differential force assay. As the force, which is 
required for unzipping the DNA duplex, is always lower than the unbinding force of 
the antibody antigen interaction the set-up ensures that the force sensor will always 
open if a specific interaction between the detection antibody and the antigen is 
present. The opening of the force sensor results in the transfer of a fluorescent label 
on the antigen. This label is finally detected and the fluorescence intensity is 
proportional to the concentration of the antigen. The experimental realization of this 
set-up is shown in much greater detail in the publications P6, P7, P8 and P9. 
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7 Molecular force sensors for the manipulation of 
enzyme activity 
Enzymes are the catalysts in most biological processes. Enzyme catalysis can 
produce rate accelerations as large as a factor of 1019 compared with the 
uncatalyzed reaction (Garcia-Viloca et al., 2004). This high catalytic efficiency 
combined with a high substrate specificity is still a topic of intensive research for 
biochemists and recently biophysicists. In most of the cases enzymes are proteins. 
More than 100 years ago Fischer proposed that the substrate is bound to the active 
site of the enzyme in a “lock and key” mechanism. Later, Haldane suggested that 
the “key does not fit the lock perfectly but exercises a certain strain on it” (Haldane, 
1930). In 1946 Pauling`s explanation for the catalytic mechanism of an enzyme was 
that “the substrate molecule is attracted to the enzyme, and caused by the forces of 
attraction to assume the strained state which favors the chemical reaction” (Pauling, 
1946). The ideas of Haldane and Pauling lead to the conclusion that an enzyme has 
to be so flexible that it can bind to the substrate and undergo a conformational 
change after binding the substrate (induced fit). Indeed conformational changes 
have been shown for many different enzymes (Garcia-Viloca et al., 2004). Recent 
findings show that enzymes do not show an induced fit only but can fluctuate 
between many different conformations at every step of the reaction suggesting that 
an enzyme is a highly dynamical entity. 
7.1 Classical enzyme kinetics 
 
 
 
 
 Figure 14. Comparison of an uncatalyzed and an enzyme catalyzed chemical 
reaction. a) uncatalyzed reaction. The substrate S has to reach a transition state S* 
before it converts into the product P. The free energy difference  ΔG* between S and 
S* is relatively high. b) enzyme catalyzed reaction. The addition of an enzyme lowers 
the free energy difference  ΔG*kat but not the difference in the free energy  ΔG 
between the substrate and the product. This is the reason why an enzyme 
accelerates the reaction. An enzyme catalyzed reaction proceeds in three steps. 
First, the enzyme binds to the substrate and forms the complex ES. This complex is 
transformed into the activated complex ES*. After the substrate was converted into a 
product the product first remains bound to the enzyme to yield EP. Finally, the 
product is released from the enzyme and the enzyme can bind a new substrate 
molecule. 
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As mentioned above enzymes are able to speed up chemical reactions by many 
orders of magnitude. The origin of this huge rate acceleration lies in the effect that 
enzymes lower the activation barrier ΔG* to reach the transition state of the reaction. 
The difference in the free energy ΔG between the substrate and the product and 
therefore the equilibrium constant of the reaction remains unchanged (Fig. 14). 
As shown in Fig. 14 b) an enzyme-catalyzed reaction follows the following 
reaction scheme: 
 
 k1 k2 k3 
E + S   ⇄   ES   ⇄   EP   ⇄   E + P 
 k-1 k-2 k-3 
 
Assuming that the barrier between EP and E+P is low and that the reaction rate k-2 
is very small the reaction scheme can be written as follows: 
 
 k1 k2 
E + S   ⇄   ES   →   E + P 
 k-1 
 
The first step can be attributed to the binding of the substrate to the enzyme. 
Mostly, this step is rapid, reversible and does not result in any chemical changes. 
The second step – the catalytic step – refers to the chemical conversion of the 
substrate. This step follows the first order rate constant k2. 
The following equations describe the changes of the concentrations of the 
substrate [S], the enzyme [E], the complex of enzyme and substrate [ES] and the 
product [P] during the reaction: 
! 
d S[ ]
dt
= "k
1
E[ ] S[ ] + k"1 ES[ ]        (eq. 7.1) 
! 
d E[ ]
dt
= "k
1
E[ ] S[ ] + k"1 + k2( ) ES[ ]       (eq. 7.2) 
! 
d ES[ ]
dt
= k
1
E[ ] S[ ] " k"1 + k2( ) ES[ ]      (eq. 7.3) 
! 
d P[ ]
dt
= k
2
ES[ ]          (eq. 7.4) 
! 
E[ ] = ET[ ] " ES[ ] with the total concentration of enzyme ET 
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Assuming that the production and the turnover of the enzyme substrate complex 
proceeds with the same rate (steady-state conditions) 
! 
d ES[ ]
dt
= 0  
and that the binding of the substrate to the enzyme is not rate-limiting, which is 
given by [S]  [E], the Michaelis-Menten equation is obtained. The Michaelis-
Menten equation describes the hyperbolic dependence of the reaction velocity v 
from the concentration of the substrate [S]: 
! 
v =
v
max
S[ ]
S[ ] + KM
          (eq. 7.5) 
with vmax = k2 ⋅ [ET] the maximum velocity of the reaction 
and KM = (k-1 + k2)/k1 the Michaelis-Menten constant 
Whereas the Michaelis-Menten equation is a good phenomenological description 
of the production rate the underlying molecular mechanisms for the lowering of the 
activation barrier are still a topic of intensive research. Only in recent years it 
became possible to study the catalytic mechanism of enzymes in more detail. A 
detailed analysis of catalytic mechanisms requires information about the structure of 
the enzyme and the substrate. As more and more structural data is available it has 
been possible to explain the mechanisms for lowering the activation barrier for a 
number of enzymes (Garcia-Viloca et al., 2004). In most cases conformational 
changes are associated with changes in electrostatic interactions, hydrogen bonding 
or desolvation effects. Thereby the contacts between enzyme and substrate can be 
optimized by the conformational change or the interaction with the substrate can 
cause the conformational change. In some cases the conformational change can be 
caused by a strain, which is induced in the enzyme upon substrate binding. If this 
strain is only relieved at the transition state the conformational change contributes to 
the lowering of the activation barrier. This mechanism, called strain-induced 
catalysis, will be the topic of the next chapter. 
7.2 Influence of forces on enzyme catalysis 
The idea that strain is induced in the enzyme was already proposed by Haldane and 
Pauling. As mentioned above it was shown that the release of the strain in the 
transition state has a contribution to the lowering of the activation energy. Although 
there is clearly a contribution in some systems it is not considered to be a general 
mechanism. It is believed that enzymes are flexible molecules and cannot generate 
sufficient strain (Villa and Warshel, 2001). However, many enzymes undergo 
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conformational changes due to substrate binding. Furthermore, it is considered that 
the large size of enzymes is presumably a manifestation of the requirement to limit 
flexibility (Narlikar and Herschlag, 1997). Bustamante et al. (Bustamante et al., 
2004) believe that the generation of strain has a significant contribution. From their 
point of view the contribution is not evident because of the lack of methods for the 
direct analysis of the forces generated during enzymatic action. 
 
 
 
 
 Figure 15. Spring model of an enzyme substrate interaction. In the 
unbound conformation (left) the binding site of the enzyme has a defined 
geometry with the length lE. The substrate has the length lS. Formation of the 
activated enzyme substrate complex ES* induces strain between the binding 
pocket of the enzyme and its substrate. Both enzyme and substrate are 
distorted resulting in a new geometry of the bond. The effective lengths lE* and 
lS* are determined by the relative stiffnesses of the enzyme κE and the 
substrate κS. (adapted from Bustamante et al., 2004) 
 
The basic mechanical principle of strain-induced catalysis is summarized in 
Fig. 15. According to Bustamante et al. the process of lowering the activation barrier 
can be described as follows: Upon binding of the substrate, the enzyme is not 
perfectly complementary to the substrate. Therefore the enzyme undergoes a 
conformational change utilizing a gradient of binding energy (potential energy). This 
gradient of binding energy is translated in a series of motions. These motions 
generate a force, which acts on the enzyme and the substrate until the transition 
state is reached and the product can be formed. 
However, if it is really the generated force or the optimization of interactions 
between enzyme and substrate, which result in a lowering of the activation barrier, 
cannot be distinguished easily. But, even if the strain itself does not have a major 
contribution to the lowering of the activation barrier it is highly likely that an 
externally applied force will have an influence on the activity of the enzyme. In 
chapter 3.1 it has been shown that forces influence the conformations of proteins. If 
conformational changes are necessary for enzyme activity external forces will 
influence the equilibrium between the conformations. 
Molecular force sensors for the manipulation of enzyme activity 
Kerstin Blank  page 41 
7.3 Activity measurements with single enzymes 
In order to analyze the influence of external forces on the activity of enzymes 
single enzymes will have to be analyzed for example with the AFM. Therefore, the 
following chapter will introduce the basic concepts for the analysis of single enzyme 
data and give a short overview of the information, which can be gained from single 
enzyme measurements. 
At the single molecule level the concentration of an enzyme is no longer relevant. 
The enzymatic reaction is considered to be a stochastic event. Therefore, for single 
molecule experiments the probabilities for the enzyme to be in one of the possible 
states along the reaction pathway are considered. To describe one complete 
enzymatic turnover again the following reaction scheme is used. 
 
 k1 k2 
E + S   ⇄   ES   →   E + P 
 k-1 
 
The following equations can be used to describe the time dependent probabilities 
for the enzyme to be either in its free state E or to be bound in the enzyme substrate 
complex ES: 
 
! 
dP
E
t( )
dt
= "k
1
S[ ]PE t( ) + k"1PES t( ) + k2PES (t)     (eq. 7.6) 
! 
dP
ES
t( )
dt
= k
1
S[ ]PE t( ) " k"1PES t( ) " k2PES (t)     (eq. 7.7) 
The different states cannot be measured in a single enzyme experiment. The 
parameter, which can be measured, is the time the enzyme molecule needs for one 
complete turnover cycle. This time is also called the “waiting time” τ. If a huge 
number of turnover cycles is measured a waiting time distribution is obtained, which 
is the basis for the analysis of the dynamic behavior of the enzyme. 
Relating the waiting time distribution to the differential equations and solving 
them for the initial conditions PE(0) = 1 and PES(0) = 0 at t = 0 and the constraint 
PE(t) + PES(t) = 1 one obtains the following relationship between the mean waiting 
time〈τ〉and the substrate concentration [S] (Kou et al., 2005): 
! 
1
"
=
k
2
S[ ]
S[ ] + KM
         (eq. 7.8) 
Comparing this equation to the classical Michaelis-Menten equation it is evident, 
that the reciprocal of the mean waiting time is related to the enzymatic velocity 
measured in an ensemble measurement. This relation originates from the 
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equivalence between time averaging over a long time trace and ensemble 
averaging over a large number of identical molecules (English et al., 2006). 
The above relation shows that experiments with single enzymes can yield the 
same result as ensemble measurements. However, this is not always the case. 
Enzymes are dynamic entities exhibiting distributions and fluctuations of catalytic 
rate constants. These effects can be analyzed in single molecule experiments only. 
The most important features of enzymes, which are hidden in ensemble 
measurements, are static and dynamic disorder (Xie and Lu, 1999). Static disorder 
is the result of differences in the activity of individual enzyme molecules. The 
existence of static disorder was shown for lactate dehydrogenase first (Xue and 
Yeung, 1995). A solution of the enzyme and its substrate was filled in a narrow 
capillary. The enzyme concentration was adjusted to ensure that single enzyme 
molecules are separated by a relatively large distance. The accumulation of product 
was measured after an incubation time of one hour. The amount of the product 
varied by a factor of 4. This result could be reproduced with the same enzyme 
molecules showing that the enzymes indeed possess different activities. Dynamic 
disorder refers to fluctuations of the rate constants of the reaction caused by 
transitions among different enzyme conformers. Dynamic disorder has been shown 
for different enzymes. The first experiment proving the existence of dynamic 
disorder was carried out with cholesterol oxidase (Lu et al., 1998). Later it was 
shown for staphyloccal nuclease (Ha et al., 1999), horseradish peroxidase (Edman 
et al., 1999), bacteriophage λ exonuclease (van Oijen et al., 2003), lysozyme (Lu, 
2004), the lipase B of Candida antarctica (Velonia et al., 2005) and β-galactosidase 
(English et al., 2006). It is considered to be a general property of enzymes (Xie, 
2001). 
The fluctuations resulting in dynamic disorder can occur on a time scale 
comparable to or longer than the time scale of the enzymatic reaction, so that the 
rate of the product formation is no longer governed by a single rate constant but 
effectively by a distribution of rate constants. The simplest case is shown in the 
reaction scheme below where Ea shows very high catalytic activity and Eb shows low 
catalytic activity: 
 
 k1a k2a 
Ea + S   ⇄   EaS   →   Ea + P 
 k-1a 
⇅ ⇅ 
 k1b k2b 
Eb + S   ⇄   EbS   →   Eb + P 
 k-1b 
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Depending on the rates of the enzymatic reaction and the rates for the 
interconversion between the different conformations of the enzyme two general 
cases can be distinguished. If k2a is slow compared to the interconversion rates, k2a 
is rate limiting and no dynamic disorder will be observed. However, if the 
interconversion rates are slower than k2a the enzyme can remain in the highly active 
conformation for several turnovers and then convert into the less active 
conformation and remain in this conformation for a while. The effect that long 
waiting times are followed by long waiting times and short waiting times are followed 
by short waiting times is a non-Markovian behavior. Therefore, dependent on the 
combination of the rate constants memory effects can be observed. Interestingly, if 
the constants of the basic Michaelis-Menten equation are replaced by the weighted 
averages of the distributions of the conformers the equation is still valid. This has 
been shown theoretically and experimentally for the enzyme β-galactosidase 
(English et al., 2006). Information about dynamic disorder can be obtained from the 
time trajectories of the enzymatic turnover events. The rate constants can be 
obtained from a multiexponential fit to the probability density function of the waiting 
times. Alternatively the autocorrelation function of the waiting times shows the range 
of the timescales of the fluctuations (Xie, 2001; Kou et al., 2005; Min et al., 2005; 
English et al., 2006). 
7.4 Model system for force based manipulation 
Having established that it is highly likely that an enzyme will respond to an 
externally applied force and the theory for the analysis of single enzyme data, a 
model system is introduced in the next chapter, which will allow the observation of 
force induced changes of the enzyme activity. Lipase B from Candida antarctica 
(CalB) is an interesting candidate (Uppenberg et al., 1994, Uppenberg, 1995 #21; 
Anderson et al., 1998). The enzyme has low substrate specificity and can convert 
different fluorogenic substrates into fluorescent products (Fig. 16). Furthermore, it 
has been shown that CalB displays dynamic disorder (Velonia et al., 2005). 
Therefore, if an externally applied force can shift the equilibrium between the 
different conformations of CalB this effect should be immediately visible. The effect 
of the force can be analyzed by comparing time traces of the generated 
fluorescence signal measured with and without an externally applied force. 
In order to be able to monitor the enzymatic turnover during the application of the 
external force the enzyme needs to be immobilized on a glass surface in a site-
specific manner. This allows the measurement of the activity of surface bound 
enzymes with a total internal reflection fluorescence (TIRF) microscope. In addition 
a force sensor (chapter 5) is attached to the enzyme at a defined position. This force 
sensor transmits the force from the AFM cantilever to the enzyme and opens if the 
force reaches a certain threshold. This threshold force is assumed to prevent the 
unfolding of the enzyme. Using this set-up the enzyme can be manipulated with an 
Molecular force sensors for the manipulation of enzyme activity 
Kerstin Blank  page 44 
external force simultaneously monitoring fluorescence bursts on the surface, which 
are the result of single turnover events. 
 
 
 
 
 Figure 16. Model system consisting of CalB and the fluorogenic substrate 
carboxyfluorescein diacetate (CFDA). The lipase CalB (PDB no. 1LBT) has 
a low substrate specificity. It does not catalyze the hydrolysis of natural fat only 
but it also converts the artificial substrate CFDA. The substrate itself is not 
fluorescent. But, enzymatic cleavage yields the fluorescent product 
carboxyfluorescein. The generation of the product can be measured in bulk 
measurements and in single molecule measurements. The structure of CalB 
shows the termini of the protein. These can be used to modify the protein to 
achieve coupling to a surface or a force sensor. They are located in an 
appropriate distance from the active site. Additionally, two surface exposed 
disulfide bonds are shown. They can be modified genetically or chemically. 
 
In order to establish this complex set-up CalB had to be modified on the genetic 
level. First, it was necessary to clone and express CalB in Escherichia coli. The 
results of this study are summarized in the publication P4. Second, it was necessary 
to introduce a reactive site for the site-specific immobilization of CalB on the glass 
surface. This was achieved by introducing a cysteine residue at the C-terminus, 
which can be utilized for coupling to a surface displaying maleimide groups. The 
optimized protocol is summarized in the publication P3. Third, a peptide sequence 
was attached to the N-terminus. This peptide is one part of the force sensor. The 
force sensor is described in more detail in chapter 5.3 and in the publication P1. 
Due to the complexity of the set-up the fluorescence measurements (with and 
without an externally applied force) are not the subject of this thesis. First 
measurements without force again proved the presence of dynamic disorder. 
Measurements with an applied external force will be carried out in the near future. 
Therefore, the question if an enzyme reacts to an external force and how it reacts 
cannot be answered yet. 
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8 Outlook 
The results presented in this work demonstrate that receptor ligand interactions 
can be applied as molecular force sensors in a broad range of different applications. 
After their characterization with standard technologies like AFM they can be 
immobilized on surfaces and connected to different kinds of biomolecules. They 
provide a threshold force, which can be used as a reference in a differential force 
assay. Alternatively they can be applied to load molecules with a force allowing the 
observation of the response of this molecule to the applied force. It is believed that 
molecular force sensors will find broad applications for the analysis of the 
mechanisms of naturally occurring molecular force sensors. Especially the antibody 
peptide interaction presented here has a huge potential for this type of experiments 
as the peptide can be fused to the molecule of interest on the genetic level easily. 
Furthermore, force sensors cannot be used for the characterization of naturally 
occurring force sensors only but also for the analysis of molecules which are not 
responding to force in their natural environment. As has been pointed out for the 
manipulation of the enzyme, force can shift the equilibrium between different 
conformations of a protein. Therefore, the analysis of the effect of force on the 
function of a protein can reveal a more detailed picture of the energy landscape of 
the folded protein. In addition, the use of molecular force sensors is not restricted to 
the analysis of biomolecules. They are expected to play an important role in 
bottom up approaches in nanotechnology. Appropriately designed force sensors 
allow to pick up a molecule of interest and to release it at a defined position. If the 
force sensor is attached to an AFM cantilever, the procedure can be repeated many 
times and the accuracy of the positioning is in the nanometer range due to the high 
spatial resolution of the AFM. 
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Abstract 
In recent years the importance of recombinant antibodies has increased dramatically. For 
many applications high affinity antibodies are needed to fulfill desired functions. In general it 
is assumed that the dissociation rate of the antibody of interest has to be optimized. Using 
conventional methods just as surface plasmon resonance (SPR), the exact measurement of 
low dissociation rates however is critical due to the detection limit and the required time for 
the assay. Therefore, we applied dynamic force spectroscopy (DFS) to determine the 
dissociation rates of three clones of a recombinant antibody fragment and compared our 
values with the data obtained from SPR measurements. The three clones have been taken 
from different steps of an affinity maturation process and therefore are closely related. The 
antibodies exhibit very high affinities (KD of 2.6 nM to 5 pM). Within the experimental error 
both measurement methods yield the same values for the dissociation rates (koff between 
0.0039 s-1 and 0.00049 s-1). This proves that DFS is an attractive alternative to SPR if the 
unbinding process of a molecular interaction needs to be characterized. Many problems, 
which appear in SPR measurements just as rebinding and avidity effects cannot occur if DFS 
is used. Besides this advantage DFS further yields additional information about the width of 
the binding potential. In the study presented here, it was found that the potential width and 
therefore the unbinding pathway are not affected by the mutations whereas one mutation has 
a significant influence on the dissociation rate. 
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Introduction 
In recent years recombinant antibodies have become increasingly important as 
therapeutic agents, for proteomics applications and for diagnostic assays. In addition, they 
might prove usefulness as building blocks for the self-assembly of nanostructures. 
Depending on the particular application, antibodies with high affinity are needed in most of 
the cases. For example, virus, toxin or cytokine neutralizing antibodies require a high affinity 
to block the action of as many molecules as possible (1-4). In diagnostic assays, especially 
when low abundance proteins want be detected, the use of high-affinity reagents is 
necessary to obtain the required sensitivity (5). In principle, antibodies with a higher affinity 
(characterized by a lower dissociation constant KD = koff/kon) can be obtained either by 
increasing the association rate (kon) or by decreasing the dissociation rate (koff). Because of 
the diffusion control of the association reaction, the upper limit of kon is thought, in general, to 
be not faster than 106 M-1 s-1 to 107 M-1 s-1 for antibody antigen interactions in solution (6, 7). 
In contrast, koff can vary over several orders of magnitudes (10
-1 s-1 to 10-6 s-1). Therefore, it 
is considered that koff is the main determinant of the equilibrium constant for most antibody 
antigen interactions (8, 9). 
Many different approaches have been developed for the in vitro affinity maturation of 
recombinant antibody fragments such as single chain Fv (scFv) or Fab fragments (1-4, 10-
15). If a number of clones has been selected, they need to be characterized with regard to 
their affinity improvement. Mostly, the determination of the dissociation constant yields 
sufficient information. However, in selected cases it is necessary to measure the kinetic rate 
constants of the binding and unbinding process. This is of particular importance if the affinity 
improvement wants to be correlated with the position and type of the acquired mutation(s) of 
the clone of interest to obtain more detailed information on structure function relationships. 
Several different methods exist for the determination of the dissociation constant. It can be 
measured with ELISA (16), surface plasmon resonance (SPR) (17), fluorescence titration (9), 
and fluorescence activated cell sorting (FACS) (13). The exact measurement of the kinetic 
constants is far more complicated. Mostly, SPR is used for this purpose. To obtain exact 
S
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values, especially for koff, one has to take care about possible rebinding effects on the 
surface during the dissociation phase. In addition, in the case of slow dissociation rates (koff 
below 10-5 s-1) an accurate determination of koff is difficult due to the small amount of analyte 
dissociating. The measurement is disturbed by drift of the SPR instrument (18). 
Dynamic force spectroscopy (DFS) is an alternative method to obtain information about 
the unbinding process of receptor-ligand interactions. This measurement method has been 
used for a broad range of different biological systems including antibody-antigen interactions 
(9, 19). DFS makes use of the effect that koff is increased if an external force is applied. 
Measuring the rupture forces of a receptor-ligand interaction for different loading rates allows 
the extrapolation to the dissociation rate at zero force, which represents the natural koff. 
Furthermore, this measurement method yields additional information about the width of the 
binding potential "x. This additional information might be useful for the interpretation of the 
influence of different mutations of various antibody clones on the (un)binding kinetics and the 
geometry of the binding site. 
In this report we have analyzed three different clones of scFv fragments with DFS. They 
represent a series of clones obtained from different steps of an affinity maturation process 
using ribosome display (15, 20). They all bind the same peptide antigen, which is a random 
coil in solution. The crystal structure of a related clone complexed with the antigen is 
published (15). As the peptide forms an #-helical structure in the complex with the antibody 
the peptide is considered to undergo a conformational change upon binding and unbinding. 
To our knowledge, this is the first report describing a detailed structure based analysis of a 
system where both the antibody and the antigen can react to the externally applied force. For 
the DFS measurements an atomic force microscope (AFM) was used and the rupture forces 
were measured over a broad range of different loading rates. From these results koff and "x 
were calculated with two analysis methods, which are based on the well-established Bell-
Evans-model (21-23). The koff values from DFS were compared with the koff values 
determined with SPR. Based on these results one possible unbinding process is discussed 
with respect to the amino acid substitutions of the clones. 
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Materials and Methods 
Cloning, expression and purification of the antibody fragments 
The three clones were expressed with a C-terminal His tag followed by a cysteine to allow 
the site-specific immobilization of the scFv fragments. The plasmids for the periplasmic 
expression of the clones were based on the pAK series (24). The gene for coexpression of 
the periplasmic chaperone Skp was introduced (25). The His tag was replaced by a tag of six 
histidines followed by two glycines and a cysteine. For the expression and purification of the 
clones the protocol of Hanes et al. (20) was slightly modified. Briefly, the plasmids were 
transformed in the E. coli strain SB536. Cells were grown at 25 °C in SB medium (20 g l-1 
tryptone, 10 g l-1 yeast extract, 5 g l-1 NaCl, 50 mM K2HPO4) containing 30 !g ml
-1 
chloramphenicol. Expression was induced with 1 mM Isopropyl-!-D-thiogalactopyranosid 
(IPTG) at an OD600 between 1.0 and 1.5. The cells were harvested 3 h after induction by 
centrifugation. Cell disruption was achieved by French Press lysis. The scFv fragments were 
purified using two chromatography steps. After a Ni2+-NTA column (Qiagen, Hilden, 
Germany) using standard protocols the eluted fraction was directly loaded onto an affinity 
column with immobilized antigen. The fractions from the affinity column were dialyzed 
against coupling buffer (50 mM sodium phosphate pH 7.2, 50 mM NaCl, 10 mM EDTA) and 
concentrated using Centricon YM-10 (Millipore, Eschborn, Germany). The actual 
concentration of the purified scFv fragments was determined by measuring the absorbance 
at 280 nm. The extinction coefficients of the different clones have been calculated using the 
program Vector NTI (Invitrogen, Karlsruhe, Germany). The purified clones were adjusted to a 
final concentration of 0.8 mg ml-1 and stored in aliquots at -80 °C. 
Preparation of slides and cantilevers 
The scFv fragments were immobilized on an amino-functionalized slide using a hetero-
bifunctional poly(ethylene glycol) spacer (NHS-PEG-maleimide MW = 5000 g/mol; Nektar, 
Huntsville, Alabama). The peptide CGGGRMKQLEPKVEELLPKNYHLENEVARLKKLVGER 
(Jerini Peptide Technologies GmbH, Berlin, Germany) was coupled to the cantilever via the 
same PEG spacer (Fig. 1). The cantilevers (Bio-lever, Olympus, Tokio, Japan) were cleaned 
S
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and functionalized as described (19). Instead of epoxy-functionalized cantilevers, amino-
modified surfaces were prepared using 3-aminopropyl-dimethylethoxysilane (ABCR GmbH, 
Karlsruhe, Germany). Commercially available amino functionalized slides (Slide A, 
Nexterion, Mainz, Germany) were used. From now on, both surfaces were treated in parallel 
as described (26). Briefly, they were incubated in borate buffer pH 8.5 for one hour. This step 
was necessary to deprotonate the amino groups for coupling to the NHS groups of the PEG. 
The PEG was dissolved in a concentration of 50 mM in borate buffer at pH 8.5 and incubated 
on the surfaces for one hour. In parallel, the peptide and one of the scFv fragments were 
reduced using TCEP beads (Perbio Science, Bonn, Germany) in order to generate free 
thiols. After washing both surfaces with ultrapure water, a solution of the peptide (200 µM) 
was incubated on the cantilever and a solution of the scFv fragment (0.13 mg/ml) was 
incubated on the slide for one hour. Finally, both surfaces were rinsed with PBS (phosphate 
buffered saline) to remove non-covalently bound material and stored in PBS until use. 
Dynamic force spectroscopy 
All force measurements were performed with a MFP-1D atomic force microscope (AFM) 
(Asylum Research, Santa Barbara, USA) at room temperature in PBS. Cantilever spring 
constants ranged from 6 to 8 pN/nm (A-Bio-Lever) and were measured as described 
previously (27, 28). During one experiment the approach and retract velocity were held 
constant, whereas the applied force was adjusted by changing the distance between the 
cantilever tip and the surface to obtain single binding events. To achieve good statistics, 
several hundreds of approach-retract cycles have been carried out. To obtain a broad 
loading rate distribution, several experiments were performed each at a different retract 
velocity ranging from 50 nm/s to 10 !m/s. 
Data extraction 
The obtained data was converted into force-extension curves. From these force-
extension curves, the rupture force (the force at which the antibody-antigen complex 
ruptures), the rupture length and the corresponding loading rate were determined using the 
program Igor Pro 5.0 (Wavemetrics, Lake Oswego, OR) and a custom-written set of 
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procedures. The rupture force was determined as described previously (22, 23). The loading 
rate was determined using the freely jointed chain fit to the force-extension curve, according 
to previous studies (29). 
Data analysis 
To analyze the obtained data set of one experiment, which was recorded at a constant 
retract velocity, the rupture forces, lengths and logarithmic loading rates were plotted in three 
histograms. These histograms were analyzed with two methods based on the Bell-Evans-
model (21-23). Using the first method, the force and the loading rate histogram were fitted 
with a Gaussian distribution to determine the maximum of the respective histograms. The 
maxima of the experimentally received histograms were determined for each data set. Finally 
the maxima of the Gaussian distributions were plotted into a force versus logarithmic loading 
rate diagram. The maximum force Fmax (from the Gaussian distribution) represents the most 
probable force 
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Results 
The clones used in our study are closely related and have been published previously 
(15, 20). They all bind a peptide antigen, which has been derived from the transcription factor 
GCN4. For a better understanding, we briefly summarize the positions (Table 1) and the 
influence of the mutations. The antibody clones only differ in a few amino acids. The mutated 
amino acids do not directly interact with the antigen although three of them are located in the 
complementarity determining regions. Mutation L42 (N$S; AHo numbering scheme (30)), 
which as been introduced into clone C11L34 reduces the flexibility of CDR L1 and may allow 
a more favourable domain orientation. Mutation L107 (A$V) of clone 52SR4 lies in close 
proximity to mutation L42 and might therefore contribute to this effect. Therefore, these two 
mutations influence the loop and the relative domain orientation and thereby optimize the 
binding geometry. Most likely, mutation L135 (N$D; clone 52SR4) has a different effect. The 
exchange of asparagine to aspartic acid introduces a negatively charged residue. This 
charged residue might be able to establish an electrostatic interaction with the peptide as the 
peptide has a positive charge at the corresponding position. Mutations L13 (T$S; clone 
52SR4) and H30 (S$L; clone 52SR4) are considered to be neutral. 
To analyze the interaction of the clones with their antigen (peptide), DFS measurements 
were performed using an atomic force microscope (AFM). For this purpose the experimental 
system was designed to minimize the impact of non-specific interactions and to maximize the 
probability of detecting specific and single antibody-peptide interactions. An effective 
approach for differentiating between specific and non-specific interactions implicates the 
attachment of antibody and peptide to the elastic spacer PEG. Therefore the antibody was 
coupled to a surface with covalently attached PEG and the peptide was immobilized onto the 
cantilever tip in the same way (Fig. 1). In all experiments the surface was approached with 
the tip of the cantilever, allowing the antibody-peptide complex to bind. Subsequently the 
cantilever was retracted and the antibody-peptide complex was loaded with an increasing 
force until the complex finally ruptured and the cantilever relaxed back into its equilibrium 
position. The force applied to this complex was recorded as a function of the distance 
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between the cantilever tip and the surface. Figure 2 shows a force-extension curve of the 
interaction between clone C11 and the peptide. To obtain good statistics several hundreds of 
force-extension curves for all the three clones have been recorded, to determine the rupture 
force, the rupture length and the corresponding loading rate. Figure 3 shows the 
experimentally observed rupture force, length and loading rate distributions for the interaction 
of clone C11 with the peptide. Using the first analysis method (see Materials and Methods), 
the rupture force histogram in figure 3a exhibits a maximum force Fmax of 55.6 pN. Figures 3b 
and 3c show the rupture length and the corresponding logarithmic loading rate histograms. 
The histogram of the logarithmic loading rate was fitted with a Gaussian distribution, which 
refers to a maximum of 7.9 pN s-1. For a complete analysis of the experimental results, all 
data sets for the three clones were examined with the first analysis method. Figure 4 refers 
to this analysis method and therefore shows the maxima of the Gaussian distributions gained 
from the experimentally received force histograms plotted against the appropriate maxima of 
the logarithmic loading rate histograms. These data points were fitted with a linear fit. Using 
equation (1) "x and koff for the different clones were determined and listed in table 1.  
Additionally, the obtained rupture force distribution (Fig. 3a) was analyzed with the 
second analysis method based on the probability density function p(F) as described in the 
methods section. The two analysis methods were compared for all three clones. But only one 
data set of clone C11 measured at a low loading rate is shown here (Fig. 3). The values 
obtained for clone C11 are: "x = 0.9 nm and koff = 2%10
-3 s-1. Comparing the values for both 
methods we conclude that for small retract velocities the values for "x and koff are identical 
within the experimental error (19).  
Within the calculated error the "x values for the three clones are identical. Comparing 
the koff values, clone C11L34 has an 8 times slower rate than clone C11. This is the result of 
one single mutation at the end of CDR L1 of the VL domain. Clone C11L34 and clone 52SR4 
differ in four amino acids. These mutations do not have any significant influence on koff. The 
values for koff obtained from the SPR measurements are also summarized in table 1. Within 
the experimental error, both methods yield the same values for koff for all three clones. 
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Unfortunately, kon cannot be calculated from the obtained koff values and the published 
equilibrium constants. The samples for the measurement of the equilibrium constants KD 
have been equlibrated at 4 °C (15, 20) whereas the values for koff were determined at 25 °C. 
As the temperature dependence of the constants is not known, we can only qualitatively 
estimate differences in kon. Comparing clones C11L34 and 52SR4 we could not detect a 
significant difference in koff. However, clone 52SR4 has a lower KD than clone C11L34 
suggesting that kon has to be different. 
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Discussion 
The experiments described here were performed to obtain high statistics in order to be 
able to compare the koff values and their experimental error obtained from the DFS 
measurements with the achieved values from the SPR measurements. For this purpose, 
both binding partners, antibody and peptide, were immobilized site-specifically and covalently 
in the DFS measurements. The use of identical chemistry on both sides (cantilever tip and 
surface) and the use of PEG as a spacer reduces the probability of non-specific binding 
events to a minimum. Therefore, a high frequency of specific interactions allowed the 
measurement of a high number of force-extension curves at various different loading rates. 
As a result the koff values determined with the two different measurement methods (DFS and 
SPR) are identical within the experimental error. 
The data obtained from the DFS measurements was analyzed with two methods based 
on the Bell-Evans-model. The first method requires DFS measurements at various different 
loading rates whereas the second method analyzes the shape of the rupture force histogram 
at one loading rate. The three antibodies used in this study gained similar koff and "x values 
for both analysis methods for slow retract velocities. Using the second analysis method the 
experimental effort can be reduced significantly as the desired values can be obtained from 
one experiment at one loading rate. However, if the second analysis method is used retract 
velocities in the lower range should be used in order stay close to equilibrium.  
To summarize the above findings DFS is an attractive alternative to SPR if the unbinding 
process of a receptor-ligand interaction wants to be characterized. The measurements can 
be easily standardized and the experimental effort is similar. We believe that in certain cases 
DFS has several advantages compared to SPR measurements. SPR measurements 
become unreliable for very low values of koff. This is not the case for DFS measurements. In 
addition rebinding and avidity effects, which might result in lower koff values in SPR 
measurements, cannot occur in DFS measurements. These binding events can be excluded 
in DFS measurements by a carefully designed experiment and during data evaluation. 
Whereas the advantages described above are mainly of practical interest, the following 
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aspect is even more important. DFS yields additional information about the unbinding 
process. The width of the potential "x is another important parameter, which provides 
information about the unbinding pathway. 
In the study presented here, the clones have an identical potential width. The potential 
width is considered to represent a geometrical value, which is related to the distance how far 
the complex can be stretched until it finally ruptures. This leads to the conclusion that neither 
the geometry of the binding sites nor the unbinding pathways were affected by the mutations 
introduced during the affinity maturation process. Compared with other protein-ligand 
interactions the obtained value for "x is in the upper range. As the peptide is a random coil in 
solution and has an #-helical structure in complex with the antibody, the most likely 
unbinding path refers to a slow unfolding upon the forced unbinding process. During this 
process one or both binding partners can be deformed in the direction of the applied force. If 
a certain point is reached the deformation is so huge that the complex dissociates. This 
would mean that a more rigid binding site possesses a higher resistance to the applied force. 
This effect would then reflect a lower koff value. Indeed the only relevant mutation, which 
improves koff is the mutation in clone C11L34 which is considered to reduce the flexibility of 
CDR L1. This interpretation can also be supported with the fact, that the flexibility of the 
binding pocket is reduced during the affinity maturation process in vivo (31) This finding is an 
interesting aspect of the affinity maturation process. However, more data from more different 
clones would be needed to investigate if evolution generally results in more rigid binding 
sites.  
This particular antibody antigen interaction might be useful for a broad range of further 
investigations and applications. First, it is an ideal model system to investigate forced 
unbinding processes in more detail. It therefore would be interesting to analyze, if the site of 
attachment of the peptide changes the unbinding pathway. In addition the analysis of 
truncated or mutated peptides will yield additional valuable information. As the structure of 
the complex is known molecular dynamics simulations can provide further insights. Secondly, 
as the antigen is a peptide it can be fused to proteins at the genetic level. Using this strategy, 
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the peptide provides a handle for the immobilization of the protein just like any other tag. 
Therefore, it is an ideal candidate to replace e.g. the digoxigenin system (19). It is superior to 
established affinity conjugation systems used for force measurements: The handle will be 
attached at a defined position and the bond strength can be modified by simply choosing 
another antibody or by changing the peptide sequence. Thirdly, the system can be used for 
the self-assembly of nanostructures. The peptide can be fused to any other protein or can be 
bound to surfaces using so called “genetically engineered proteins for inorganics (GEPI)” 
(32). If in addition a bispecific recombinant antibody (33) is used antibody displaying surfaces 
for virtually any antigen can be produced by self assembly. 
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Figures 
 
 
 
 
Figure 1. Experimental setup. The antibody fragments possessing a C-terminal cysteine 
were covalently immobilized onto amino-functionalized glass slides using a hetero-
bifunctional poly(ethylene glycol) spacer. The same coupling chemistry was used for the 
immobilization of the peptide to the cantilever. 
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Figure 2. Example of a typical force-extension curve. The force-extension curve shows 
the rupture event of the antibody C11-peptide complex, experimentally recorded at a retract 
velocity of 1000 nm/s. The values for the rupture force, rupture length and corresponding 
loading rate were obtained from these force-extension curves. 
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Figure 3. Example of the obtained rupture force, length and loading rate distributions. 
(a) Rupture force histogram of the antibody C11-peptide complex. The rupture force 
histogram contains 859 rupture events and was fitted with a Gaussian curve (red). 
Additionally, the obtained rupture force distribution was compared with the calculated 
probability density function p(F) (dark blue) with "x = 0.9 nm and koff = 2%10
-3 s-1 as described 
above. To consider the detection noise, the probability density function p(F) was convolved 
with a Gaussian distribution. The standard deviation of the Gaussian distribution equals the 
typical noise value of the used cantilever (34). Within the experimental error the values for "x 
and koff are identical for both analysis methods (experimental data received from the first 
S
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analysis method is shown in figure 6). (b) Rupture length histogram of the antibody C11-
peptide complex. (c) Logarithmic loading rate histogram of the antibody C11-peptide 
complex. The logarithmic loading rate histogram was fitted with a Gaussian curve (red). 
Additionally, the obtained logarithmic loading rate distribution was compared with the 
calculated probability density function p(F) (dark blue). 
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Figure 4. Diagram showing the most probable rupture force Fmax against the logarithm 
of the appropriate loading rate for all three antibody-peptide complexes. Each data 
point in the diagram represents the maximum rupture force Fmax, gained from the Gaussian fit 
to the rupture force distribution and the logarithm of the appropriate loading rate, gained from 
a Gaussian fit to the logarithmic loading rate distribution. The black data points correspond to 
the antibody C11-peptide complex. These data points were fitted with a straight line. From 
this linear fit a "x = (0.88 ± 0.12) nm and a koff = (3.9 ± 5.7)%10
-3 s-1 were obtained. The blue 
data set was measured for the forced dissociation of the antibody C11L34-peptide complex. 
From the linear fit a "x = (0.90 ± 0.10) nm and a koff = (4.9 ± 7.2)%10
-4 s-1 were achieved. 
Finally, the antibody 52SR4-peptide complex, pictured with red data points and the red linear 
fit gained a "x = (0.92 ± 0.07) nm and a koff = (8.2 ± 7.9)%10
-4 s-1. 
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Table 1 
 
Summary of the binding constants of the different clones 
clone mutations "x in nm koff in s
-1 (AFM) koff in s
-1 (SPR) 
C11 none 0.88 ± 0.12 (3.9 ± 5.7)%10-3 2%10-3 
C11L34 L42 (N$S) 0.90 ± 0.10 (4.9 ± 7.2)%10-4 3%10-4 
52SR4 
 
 
 
 
L13 (T$S) 
L42 (N$S) 
L107 (A$V) 
L135 (N$D) 
H30 (S$L) 
0.92 ± 0.07 
 
 
 
 
(8.2 ± 7.9)%10-4 
 
 
 
 
1.5%10-4 
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INTRODUCTION 
 
DNA represents a popular building block for the assembly 
of nanoscale structures and devices (1). Despite the fact 
that the structure and dynamics of DNA were extensively 
studied, many of the discovered intra-molecular processes 
with complex dynamics and distinct biological function 
still lack satisfactory explanation. Microsatellites formation 
and bulge loop propagation in repetitive sequences are 
prominent examples (2). Two complementary DNA strands 
with a heterogeneous sequence, can only bind in a well-
defined, unique conformation. Thermodynamic fluctua-
tions lead to excitations in the double stranded DNA, 
which result in fast opening and closing of short stretches 
of base pairs (3, 4).These fluctuations remain localized and 
do not propagate. 
In contrast, double stranded DNA, containing short repeti-
tive sequences, so-called microsatellites, displays a more 
complex dynamic behavior (5-9) with potential applicati-
ons in nanotechnology. Two complementary strands can 
hybridize in a number of different conformations in which 
sufficiently long stretches are aligned to build up thermo-
dynamically stable structures. Rapid transitions between 
these different conformations may occur. This bulge loop 
formation and propagation (see Fig. 1) is called DNA slip-
page. It is considered to play a central role in the evolution 
of microsatellites, which can be found throughout the ge-
nome(10). 
The repeat units of these microsatellites usually consist of 
one to six bases e.g. (A)N, (GT)N or (GTT)N. The corre-
sponding length of the microsatellites, i.e. the number of 
consecutive identical repeat units N, changes rapidly in 
evolution, presumably due to DNA slippage events during 
replication. Because of this length variability, the microsat-
ellites are frequently used as genetic markers e.g. for foren-
sic purposes, or to determine the genetic similarity between 
different populations. On the other hand, certain human 
neurodegenerative diseases, such as fragile X or 
Huntington, are related to expansions of trinucleotide re-
peats of microsatellites beyond certain thresholds (11). 
 
FIGURE 1. Comparison of the behavior of repetitive (left) and heteroge-
neous (right) DNA sequences under an externally applied force. Repeti-
tive DNA sequences can form bulge loops. These bulge loops can propa-
gate to the other end of the DNA duplex and therefore cause a lengthening 
of the molecule. In contrast, this dissociation path is not available for 
heterogeneous DNA sequences. Heterogeneous DNA sequences simply 
dissociate in an all or none mode.  
 
DNA slippage has been studied in vitro (2, 12). It could be 
shown that DNA bulge loop formation at the end of the 
duplex occurs on a time-scale of microseconds. As a result, 
the two strands can be shifted relative to each other by the 
propagation of a bulge loop towards the other end of the 
duplex (comp. Fig. 1). In recent years, single molecule 
techniques have been successfully used to study the me-
chanical properties of single DNA molecules. For example, 
the elasticity (13-16) and unzipping of lambda phage DNA 
(17, 18), the interactions between proteins and double 
stranded DNA (19, 20) and the dissociation forces of short 
DNA duplexes (21, 22) have been measured using different 
experimental setups. Recently, a theoretical work sug-
gested to study DNA slippage using an atomic force micro-
scope (AFM) (23): The two complementary strands of a 
DNA duplex with a repetitive sequence are predicted to 
move relative to each other if the externally applied force 
exceeds a threshold force, the critical slipping force fc. The 
rate of this motion of the two DNA strands relative to each 
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other is determined by the diffusion of bulge loops from 
one end to the other, see Fig. 1. The critical force fc is 
given by the simplified relation 
(1) 
! 
fC =
"b
2ls # ld
 
,where εb is the binding free energy of one repeat unit, lS is 
the effective length of one unit when unbound and 
stretched by the force f and ld the length of the hybridized 
repeat unit. For a tri-nucleotide (GTT) the base pairing 
energy is εb≈7-8kBT, the length of three base pairs in the 
duplex is ld≈1 nm and the effective length of three single 
stranded bases is lS≈1.5 nm. Inserting these values in equa-
tion (1) a critical force fc of roughly 20 pN can be pre-
dicted. The slipping process can be characterized with the 
following parameters: the slipping rate, which describes the 
speed of the movement of the bulge loops along the DNA 
duplex; the slipping length, which describes the length 
increase or decrease, which is determined by the number of 
bases in one repeat unit; the critical slipping force, which 
describes the threshold for the appearance of slipping. 
Here we report on an investigation of the response of short 
DNA duplexes to an externally applied shear force and 
compare these repetitive sequences with heterogeneous 
sequences with respect to their slipping rate, slipping 
length and slipping force with the intent to test the concept 
of bulge loop mediated elongation. The dependence of the 
dynamics on the number of repeat units and the number of 
bases in one repeat unit is investigated. 
 
RESULTS 
 
For the AFM experiments, the complementary DNA 
strands were covalently anchored via poly(ethylene glycol) 
(PEG) spacers. One strand was bound to the surface of a 
glass slide (24) and the complementary strand was coupled 
to the cantilever tip, respectively (25).  
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FIGURE 2. Example of a force-extension curve of a heterogeneous DNA 
duplex. While retracting the cantilever from the surface the polymer 
spacer and the DNA duplex are set under stress. The elastic behavior of 
the polymer-DNA duplex is well described by the WLC fit (black dashed 
line). At a force of 62 pN the double stranded DNA dissociates and the 
cantilever drops back to its relaxed state. 
 
In all experiments the slide was approached with the tip of 
the cantilever, allowing the two single strands to hybridize 
and form a duplex. Subsequently, the cantilever was re-
tracted and the DNA duplex was loaded with a gradually 
increasing force until it finally ruptured and the cantilever 
relaxed back into its equilibrium position. The force ap-
plied to the DNA duplex via the PEG spacers was recorded 
as a function of the distance between the cantilever tip and 
the surface (Figure 2). This curve could be fitted with the 
Worm Like Chain (WLC) model, which describes the en-
thalpic and entropic behavior of polymers under an applied 
force (26). 
Since most biologically relevant interactions are compara-
ble in strength to thermal energies, force-induced processes 
such as the separation of receptor–ligand systems or in our 
case here DNA duplexes are fluctuation-assisted processes 
(27). The distribution of the unbinding forces is therefore 
significantly broadened (28). At a given force rate and at a 
fixed bond energy, a shift of the histograms directly re-
flects the difference in the effective width of the binding 
potentials (29, 30) and indicates different unbinding pat-
ways in the energy landscape. 
 
 
 
FIGURE 3. Histograms of the unbinding forces of DNA duplexes with a 
heterogeneous (X)30 and a repetitive (GT)15 sequence measured at similar 
pulling speeds. The duplex with the repetitive sequence dissociates at 
markedly lower forces, although it has the same binding energy as the one 
with the heterogeneous sequence. The force distribution of the repetitive 
DNA is truncated at a force of 40 pN. This gives evidence for an addi-
tional unbinding path, which is favored by the externally applied force. 
 
To investigate, whether DNA duplexes with repetitive 
sequences have different unbinding pathways and therefore 
show different unbinding forces than those with heteroge-
neous sequences, both kinds of systems were analyzed. 
Figure 3 shows the resulting distributions of the rupture 
forces of a heterogeneous and a repetitive DNA sequence 
(GT)15 recorded at approximately the same pulling speed. 
Although both sequences have similar thermodynamic 
properties, which correlate mainly with the GC content of 
the sequence, their rupture force distributions differ drasti-
cally. The histogram for the repetitive DNA sequence 
(blue) is shifted towards lower dissociation forces and is 
truncated for forces higher than 40 pN. We conclude, that 
an additional dissociation path is available for the repetitive 
sequence. Note that the repetitive sequence might also bind 
fractional and therefore result in lower dissociation forces. 
But without an additional unbinding path this effect would 
lead to a broadened force distribution containing also 
higher forces similar to those of the hetergenous sequence. 
 
Having established, that repetitive DNA has characteristics, 
which are absent in heterogeneous sequences, two repeti-
tive sequences with a different number of bases per repeat 
S18
 
Page 3 of 7                                                                      Kühner et al. 
 
unit were compared with a heterogeneous sequence. Study-
ing the unbinding mechanism of (GTT)10 and (GT)15 
should reveal a more detailed insight in the unbinding 
mechanism. 
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FIGURE 4. Force-extension curves for a heterogeneous (X)30 and the 
repetitive (GT)15 and (GTT)10 sequences. In contrast to the force-extension 
curve of the heterogeneous DNA sequence, which follows the WLC 
behavior, the repetitive DNA duplexes elongate at a force (slipping force) 
of about 35-40 pN before they finally dissociate (rupture force). 
 
The theoretically predicted unbinding path represents a 
stepwise elongation of the repetitive DNA duplex by mov-
ing both strands against each other (compare figure 1), as 
soon as the externally applied force exceeds a certain 
threshold (critical slipping force fc). Such an elongation can 
indeed be observed in the recorded force-extension curves. 
Figure 4 shows several typical force-extension curves ob-
tained for both the repetitive and the heterogeneous DNA 
sequence. From this data it is evident, that force-extension 
curves for repetitive DNA deviate from the WLC behavior 
at forces above 40 pN, whereas the curves for heterogene-
ous DNA follow the WLC fit up to much higher forces. 
Apparently, the repetitive DNA gets elongated at forces 
between 35 pN and 40 pN. In the following we will use the 
expression 'slipping' force for the value of the applied force 
beyond which the DNA duplex starts to slip or creep.  
While the results described above, show further proof that 
repetitive sequences slip, the following experiment was 
carried out to examine the dependence of the slipping proc-
ess on the length of the elementary repeat unit and the 
number of repeats. These experiments were carried out 
using (GTT)10, (GT)10 and (GT)15 sequences. These DNA 
duplexes were probed at different pulling speeds because 
the slipping forces are expected to be speed dependent. As 
they differ only by a few pN, each data set was recorded 
with one cantilever to avoid calibration errors. In figure 5 
the maxima of the slipping force distributions are plotted 
against the pulling speed of the cantilever. As can be seen 
in this figure, the slipping force shows a weaker depend-
ence on the pulling speed for di-nucleotide than for tri-
nucleotide repeat units. Furthermore, the slipping forces are 
lower for the shorter repetitive sequence (GT)10 than for the 
sequence containing 15 repeat units. Close to the critical 
force fc,  
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FIGURE 5. Pulling speed dependence of the slipping forces for different 
repetitive DNA sequences1. The maximum of the slipping force is plotted 
against the pulling speed of the cantilever. The slipping force is dependent 
on the pulling speed and shows a linear time dependency as a first ap-
proximation.  
 
theory predicts, that the slipping velocity v(f) increases 
linearly with force. We therefore expanded the velocity and 
neglected higher order terms according to v(f)=dv/df•(f-fc). 
The variable u0 = dv/df represents the effective slipping 
mobility, which depends on the microscopic slipping rate 
and the number of repeat units, fc is the critical force and f 
the externally applied force. In our experiments, we corre-
lated the slipping velocity v with the retract speed of the 
cantilever and measured the resulting slipping force.  
From a linear fit, we achieve a slipping mobility u0 of 
580 nm/s·pN for a di-nucleotide and 250 nm/s·pN for a tri-
nucleotide sequence. This is in agreement with the theo-
retical predictions and with bulk experiments that observed 
faster expansions for shorter repeat units. To form a bulge 
loop in a di-nucleotide sequence, fewer base pairs have to 
open up than in a tri-nucleotide sequence and hence the 
rate to create these defects is smaller for longer repeat 
units. However the additional length increase per step for 
longer repeat units does not compensate the lower rate. 
The experimental results so far confirm that repetitive 
DNA strands can slide against each other and that the slip-
ping force can be determined for different pulling speeds. 
The values obtained for the slipping mobility are in good 
agreement with theoretical predictions. However, the time 
resolution in an usual force-extension measurement is not 
sufficient to see individual steps, which would give direct 
evidence of the stepwise microscopic sliding mechanism.  
Initial force clamp (31) measurements (data not shown) 
performed with the AFM showed only a lengthening of the 
different DNA duplexes at forces of 35-40 pN, but failed to 
resolve the expected individual steps. Therefore, a new 
measurement protocol was implemented, whose time reso-
lution is limited only by the relaxation of the cantilever. 
These measurements were carried out as follows: i) The 
cantilever was lowered, to allow the DNA to hybridize and 
form a duplex. ii) The cantilever was gradually retracted 
from the surface allowing a certain force, well below the 
slipping force, to build up. iii) Then in one step, the canti-
lever was retracted additional 3-7 nm away from the sur-
                                     
1 To avoid spring calibration errors every data set for one se-
quence is performed in a single experiment with the same cantile-
ver.  
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face. As a result of this distance jump, the force acting on 
the DNA duplex rises almost instantaneously to a new 
higher value. Initially, the contour length, which gives the 
total length under force, does not change. If, in response, 
the DNA duplex elongates through slipping, an increase of 
the contour length is observed. In addition, the applied 
force drops, which can be detected by the cantilever. 
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FIGURE 6. Force versus time (red) and contour length versus time curve 
(black) of repetitive (GT)15 and (GTT)10 DNA duplexes, held initially at a 
force under the critical slipping force. After 0.5 seconds a distance jump 
of the cantilever was performed resulting in a forcestep above the critical 
force, but leaves the contour length of the molecule constant. In figure (a) 
the contour length of the GT-DNA complex relaxes in two discrete elon-
gation steps and the force acting on the duplex drops below the critical 
slipping force. In figure (b) the contour length (black curve) of the GTT-
DNA complex elongates in one discrete step and the force drops under the 
critical slipping force. 
  
Figure 6 (a) shows two curves, force versus time and dis-
tance versus time, for a 15 times repetitive di-nucleotide 
DNA duplex (GT)15 recorded with the measurement proto-
col described above. First, the force acting on the DNA 
molecule is fluctuating around 38 pN, a value close to the 
previously observed slipping force.  At the blue arrow in 
the force-time graph a 4 nm distance jump was performed. 
As a result of the distance jump the force (red) increases to 
nearly 57 pN, but the contour length stays constant. Within 
a fraction of a second the measured force decreases to a 
value below 40 pN in discrete steps. The final force is 
again close to the observed slipping force. This rapid and 
discrete decrease of the force can only be explained 
through the stepwise lengthening of the DNA molecule, 
compensating the performed distance jump. These observa-
tions show, that a single relaxation process increases the 
contour length of the di-nucleotide DNA system by ap-
proximately 1.4±0.3 nm which can be well explained by 
sliding of one repeat unit (dl = 2ls-ld = 4·0.5 nm - 2·0.34 nm 
= 1.4 nm). Regrettably, only a limited number of steps may 
be observed, since the probability to hold these DNA du-
plexes under such a high force for a long time is very low 
and decreases further with every step.  
Figure 6 (b) shows the equivalent experiment for a 
trinucleide (GTT)10 sequence. As expected, the contour 
length increase of approximately 2.1±0.3 nm is higher than 
for the dinucleotide sequence. Analogous experiments 
performed with the heterogeneous sequence did not show 
any discrete steps (data not shown). 
To exclude the possibility, that the observed steps are arti-
facts of multiple binding the following arguments are 
pointed out. First of all the overall elasticity of the meas-
ured PEG polymer spacer would be much stiffer. Secondly 
the presumption of three bound molecules in parallel mim-
icking the three steps of the single molecule shown in fig-
ure 5 would require the respective PEG polymer spacers to 
differ in length by less than 2 nm. This would mean that the 
total force acting on the cantilever would be distributed on 
three duplexes and as a consequence the lifetime for the 
duplexes would be much longer than our experimental 
findings. Dissociation of one duplex increases the split 
force applied to the remaining duplexes and reduces their 
lifetime drastically. For this reason multiple binding as 
potential artifact can be excluded with very high certainty.  
 
 
FIGURE 7. Gibbs free energy of a two state system under external force. 
The model describes the completely bound and the first lengthened state 
of a repetitive DNA duplex. The potential is tilted by an externally applied 
force. This results in an levelling of the energy of the two states, allowing 
the DNA duplex to fluctuate between the two states in equilibrium. 
 
Having shown that all characteristic parameters describing 
the slipping process can be determined experimentally, we 
wanted to obtain more detailed information on how the 
system behaves near the critical force. The system for the 
native and elongated conformation of the DNA duplex can 
be described with a two state potential illustrated in fig-
ure 7. Application of an external force allows the tuning of 
the potential, so that the Gibbs free energy of these two 
states is the same as shown by the dashed line in figure 7. 
If this force equals the critical force fc the system can fluc-
tuate in equilibrium. This was achieved in the measurement 
shown in figure 8. Using the above mentioned measure-
ment protocol a distance jump is performed and the force 
on the DNA duplex first increases over the critical force 
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limit fc. As a result the DNA duplex elongates and the force 
drops to the critical force. At this force the system starts to 
perform multiple back and forward slipping events. An 
additional distance jump forces the DNA duplex in its 
elongated conformation until it finally ruptures completely. 
These fluctuations of the DNA duplex between the two 
states can be analyzed with random telegraph noise analy-
sis similar to ion channel recordings (black curve in figure 
8). The hidden Markovian process is characterized by the 
transition rates from one state to the other (32). The data 
trace shown in figure 8 exhibits mean lifetimes of 0.031 s 
for the elongated and 0.022 s for the shortened state. The 
energy difference of these two states is fluctuating between 
the binding energy of the DNA duplex and the bending 
energy of the cantilever. Although, the energy was found to 
be ~7kBT, which is close to well-established values of 
about ~8kBT for a tri-nucleotide GTT repeat unit. The 
observed multiple forward and backward jumps in figure 8 
could only be detected with short polymer spacers with 
lengths between 15 and 20 nm. A possible reason for this 
finding could be that the fluctuations of the cantilever al-
low the duplex to form a bulge loop at lower forces, which 
eventually diffuses to the other end. For longer spacers 
these fluctuations are averaged by the elasticity of the 
polymer (33). The alternative scenario, that the observed 
shortening is a simple transient bulge loop formation at the 
stretched end can be ruled out, since the lifetime of these 
bulge loops, even if they travel some steps into the mole-
cule is orders of magnitude too small to explain the ob-
served frequencies. 
 
 
FIGURE 8. Example for the slipping of the DNA duplex between the 
elongated and the short state. A repetitive (GTT)10 DNA duplex is held at 
a constant force analogous to figure 6. A distance jump drives the force 
over the critical force limit. This results in a lengthening of the DNA 
duplex and the force drops to the critical force. Consequently, the duplex 
lengthens and shortens by forward and backward slipping. The measured 
time trace (red) of the fluctuation process was analyzed with a telegraph 
noise algorithm to extract the dynamics of the length changes (black). The 
mean lifetimes were found to be 0.031 seconds for the fully hybridized 
state and 0.022 seconds for the lengthened state.  
 
Discussion 
The data presented here show that repetitive DNA duplexes 
elongate under an applied shear force and dissociate at 
forces of about 38 pN2, which is significantly lower than 
for heterogeneous DNA sequences. This is due to an addi-
tional unbinding path that allows the repetitive DNA du-
                                     
2 Because of the possibility of fractional binding for repetetive 
sequences lower dissociation forces are possible in regular force 
distance curves (see figure 2). 
plex to increase its contour length without having to over-
come a large free energy barrier. It should be pointed out 
that this unbinding path is energetically not favored over 
other paths but gets populated by force. 
The theoretically predicted length increase takes place 
through discrete slipping steps. It could be shown that the 
resulting length increase of the whole DNA duplex is con-
sistent with the length increase obtained by shifting both 
strands of di- and trinucleid sequences by one repeat unit. 
Slippage is faster, for shorter repeat units and smaller re-
peat numbers. This is consistent with the theory of bulge 
loop diffusion, since the expected slipping velocity de-
creases with the energy needed to produce a bulge loop. In 
addition, the diffusion of a bulge loop through the molecule 
is faster for shorter duplexes. The mechanism of relative 
strand motion caused by the creation, diffusion and absorp-
tion of bulge loop defects is similar to defect propagation 
in crystal lattices. 
The critical slipping force determined in the measurements 
is larger than the theoretically predicted critical force fc. 
This could be due to the small number of repeat units used 
in the experiments and to the simplistic model used for the 
theory. For instance, deformations and conformational 
changes in the backbone of the DNA duplex resulting from 
an externally applied force are not included in the model. 
The slipping velocity is expected to scale inversely with the 
number of repeat units. This prediction could not be unam-
biguously confirmed, since only rather short sequences 
were available. Further experiments are necessary to quan-
tify the dependence of slipping dynamics on the repeat 
number and flanking sequences. More detailed experiments 
will shed some light on the kinetics of the processes in-
volved in expansion of microsatellites during replication. 
Because of its bi-directional property DNA slippage itself, 
is not the cause for the asymmetric increase effect of repeat 
units in the human genome. 
Besides the biological importance of repetitive sequences, 
the remarkable properties of repetitive DNA might also be 
useful for different nano-mechanical applications (34-36). 
Since, the rupture force distribution for repetitive se-
quences is truncated sharply at forces close to 40 pN, re-
petitive DNA could serve as a programmable force sensor, 
with a threshold force that can be fine tuned by sequence 
composition. Adjustable viscoelastic buildingblocks in 
DNA self-assembly structures can be realized with repeti-
tive sequences.  
Furthermore, the relaxation of a large force to a critical 
force fc with a time constant that can be chosen through 
length and sequence composition, could be used as a length 
independent force normal. Conversely, if extended, repeti-
tive double stranded DNA contracts until the force fc is 
built up, if the initial force is below fc. Complementary 
repetitive single stranded DNA could therefore be applied 
for self-tightening connenctions in nanostructures. After 
initial hybridization, two single strands tend to maximize 
their overlap, i.e. the number of base pairs, until a tension 
of the order of the critical force fc is built up. These adjust-
able induced force locations establish completely new 
features in nanoscale structures. 
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MATERIALS AND METHODS 
Oligonucleotides modified with a thiol-group at the 5’-
terminus (for details see table 1; IBA GmbH, Göttingen, 
Germany; metabion GmbH, Martinsried, Germany) were 
immobilized on amino-functionalized surfaces using a 
hetero-bifunctional poly(ethylene glycol) (PEG) spacer. 
One oligonucleotide was immobilized on the cantilever and 
the complementary sequence was coupled to the surface. 
The cantilevers (Bio-lever, Olympus, Tokio, Japan) were 
cleaned and functionalized (37). Instead of epoxy-
functionalized cantilevers, amino-modified surfaces on the 
cantilevers were prepared using 3-Aminopropyl-
dimethylethoxysilane (ABCR GmbH, Karlsruhe, Ger-
many). Commercially available amino functionalized slides 
(Slide A, Nexterion, Mainz, Germany) were used.  
 
TABLE 1 DNA sequences 
 
From this step on, the surfaces of cantilever and slide were 
treated in parallel as described in Blank et al. They were 
incubated in borate buffer pH 8.5 for one hour. This step 
was necessary to deprotonate the amino groups for cou-
pling to the N-hydroxysuccinimide groups (NHS) of the 
heterobifunctional NHS-PEG-maleimide (MW 5000 g/mol; 
Nektar, Huntsville, Alabama). The PEG was dissolved in a 
concentration of 50 mM in borate buffer at pH 8.5 and 
incubated on the surfaces for one hour. In parallel, the 
oligonucleotides were reduced using TCEP beads (Perbio 
Science, Bonn, Germany) in order to generate free thiols. 
After washing with ultra pure water, a solution of the oli-
gonucleotides (1,75 µM) was incubated on the surfaces for 
one hour. Finally, the surfaces were rinsed with PBS 
(phosphate buffered saline) to remove non-covalently 
bound oligonucleotides and stored in PBS until use. 
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The immobilization of proteins on solid surfaces has been a
topic of intensive research for many years. Numerous methods
have been developed to immobilize proteins for bioseparation,
biosensors, diagnostic tests and single-molecule experiments.[1]
With the growing need for miniaturization and parallelization,
new methods are needed for
the immobilization of proteins
with high functional density and
specificity.[2, 3] Most of the meth-
ods used so far do not allow the
covalent immobilization of a
protein at a well-defined posi-
tion. In this study, cysteines, in-
troduced by genetic engineer-
ing, have been used for site-spe-
cific immobilization of a model
enzyme to a glass surface by
means of a heterobifunctional
poly(ethylene glycol) (PEG)
spacer.[4] While PEG is used for a
broad range of applications to render surfaces protein resist-
ant,[5–7] only a few reports describe its use as a linker for attach-
ing proteins to surfaces.[8–13] However, the use of a heterobi-
functional PEG spacer would provide a protein-resistant surface
displaying reactive groups for the covalent attachment of pro-
teins in a controlled manner. In addition, the coupling of PEG
to proteins has been shown to increase the stability of the pro-
tein and maintain it in an active conformation.[14]
To evaluate the usefulness of this concept, Candida antarcti-
ca lipase B (CalB; EC 3.1.1.3) was used as a model enzyme.[15]
CalB is an industrially important lipase that is used for various
applications in bioorganic synthesis.[16] It is a 35 kDa monomer
with three disulfide bridges. CalB has been immobilized on sur-
faces for various applications, but these methods are mainly
based on the adsorption of hydrophobic or charged amino
acids to supports.[17] Site-specific immobilization of lipases
would be advantageous because it has been shown that the
properties of lipases depend on their orientation on a sur-
face.[18] In this study, mutants of CalB have been prepared that
display a free cysteine at a defined position on the molecule
(Figure 1). Based on recent results obtained for the expression
of CalB in Escherichia coli,[19] one mutant has been produced
that contains an additional cysteine at the C terminus of the
protein after the His tag (CalB-HisGGC). The other mutant is
based on the results of Velonia et al.[20] who were able to selec-
tively reduce one disulfide bond (Cys293–Cys311) on the sur-
face of the protein. In the following step, the reduced cys-
teines were used to couple the protein to polystyrene. Since
there is no way to control which cysteine is reacting with the
maleimide-functionalized polystyrene, another approach was
performed in this study here: Cys311 was replaced by alanine
(CalB-C311A-His) to leave only one free cysteine for coupling.
In addition, an N-terminal FLAG tag was attached to the lipase
variants for detection purposes.
The mutants and an unmodified CalB containing a C-termi-
nal His tag (CalB-His) were expressed in E. coli at 25 8C, as de-
scribed previously.[19] The expression levels of the mutants
were compared with the unmodified enzyme by Western blot
analysis by using two different antibodies (Figure S1). The free
cysteines reduce the yield of the functionally expressed lipase
by approximately a factor of 10. This effect is known for the ex-
pression of other proteins containing free cysteines in the peri-
plasm of E. coli.[21] The different lipase variants were purified
from periplasmic extracts by using Ni2+-NTA columns. A wash-
ing step with 1 mm Tris(2-carboxyethyl)phosphine hydrochlo-
ride (TCEP) was included to remove all impurities that might
have coupled to the free cysteine during expression and prep-
aration of the cell extracts.[22] The eluted fraction was dialyzed
against coupling buffer (50 mm sodium phosphate, pH 7.2,
50 mm NaCl and 10 mm EDTA) and concentrated afterwards.
The purity was analyzed by using reducing and nonreducing
SDS-PAGE (Figure S2). Pure enzymes can be obtained after just
one chromatography step. The purification procedure yields a
certain amount of dimers, which is dependent on the position
of the free cysteine on the molecule. Finally, the activity of the
variants was measured by using the substrate para-nitrophenol
butyrate. The tests showed that neither the additional cysteine
at the C terminus nor the mutated disulfide bridge has any sig-
nificant influence on the specific activity and the kinetic con-
stants of CalB (Table S1).
Before the CalB variants were coupled to the surface, the
proteins were reduced by using TCEP beads in order to gener-
[a] K. Blank, J. Morfill, Prof. Dr. H. E. Gaub
Lehrstuhl f r Angewandte Physik and Center for Nanoscience
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E-mail : hermann.gaub@physik.uni-muenchen.de
Supporting information for this article is available on the WWW under
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Figure 1. Mutants of the lipase CalB (PDB ID: 1LBT) possessing one free cysteine for the oriented coupling of the
enzyme to surfaces. For CalB-C311A-His, one cysteine from a disulfide bridge on the surface of CalB was mutated
to alanine. CalB-HisGGC contains an additional cysteine at the C terminus.
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ate free thiols. In parallel, amino-functionalized slides were in-
cubated with borate buffer (pH 8.5). This step was necessary to
deprotonate the amino groups for coupling to the N-hydroxy-
succinimide groups (NHS) of the heterobifunctional NHS-PEG-
maleimide (MW=3400 gmol
1), which was used as spacer for
the immobilization of the CalB variants. The PEG was dissolved
at a concentration of 50 mm in borate buffer and incubated on
the surface for 1 hour. After the surfaces had been washed
with ultrapure water, the CalB variants were spotted on them.
A sample containing a 10000-fold excess of free cysteine was
spotted as a negative control. In addition, these spotting solu-
tions were prepared with nonreduced enzyme variants. After
the spotted protein solutions had been incubated on the sur-
face for 1 hour, the density of the immobilized CalB variants
was detected by using an anti-FLAG antibody. The activity of
the immobilized lipase variants was tested by using agar
plates containing Tween 80 and CaCl2. The slide was put
upside down on the agar plates and incubated on the plates
overnight.
Both enzyme variants possessing the free cysteine could be
immobilized to the maleimide-activated surfaces in an oriented
and functional way (Figure 2). The binding of CalB-HisGGC and
CalB-C311A-His is highly specific. No significant binding was
detected for the negative controls : CalB-His without any free
cysteine shows only very little binding to the surface, and the
addition of free cysteine to the spotting solution blocks the
binding of the enzyme variants very efficiently. The fact that
only a very low signal is detected for CalB-His proves that the
enzyme variants do not bind through the cysteines of the
ACHTUNGTRENNUNGdisulfide bridges, which might be reduced during incubation
with the TCEP beads. The immobilization density of CalB-
HisGGC is much higher than that of CalB-C311A-His. As the
preparation of CalB-HisGGC contains a higher number of
dimers, we conclude that the cysteine is much more accessible
if it is located at the C terminus. In this case, the His tag serves
as a spacer between the surface of the protein and the reac-
tive cysteine. The image of the activity test with the Tween 80
plate shows an identical pattern. This corroborates the hypoth-
esis that both enzyme variants are immobilized on a surface in
an active conformation.
The use of PEG as a spacer for the oriented and covalent im-
mobilization of proteins to surfaces yields very good ratios of
specific to nonspecific binding. This method can be applied to
every material for which amino groups can be generated by si-
lanization or other procedures. Here, we have used a lipase as
a model system to prove the applicability of this procedure.
The site-specific immobilization of CalB represents a good
basis for the optimization of reaction conditions. Because each
enzyme is immobilized in the same orientation it should dis-
play identical characteristics. In addition, this method may be
used for many other biomolecules such as oligonucleotides,
peptides and other proteins. If the introduction of a cysteine is
not possible by genetic engineering, then thiol groups can be
introduced by chemical modification.[23] However, the attach-
ment of a cysteine to the C terminus of a protein is a very gen-
eral strategy that can be employed for a variety of different
proteins. An expression vector can be constructed that con-
tains the sequence of the His tag, the two glycines and the
cysteine, thus allowing convenient cloning of the proteins of
interest. Therefore, as no modification of the protein itself is
necessary, the strategy is particularly useful if many different
proteins need to be immobilized in parallel.
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Site-Specific Immobilization of
Genetically Engineered Variants of
Candida antarctica Lipase B Keep still ! A general strategy has been
developed for the site-specific and co-
valent immobilization of biomolecules.
The applicability of this protocol was
demonstrated by using the industrially
important lipase CalB. Two mutants that
possess a free cysteine (Cys293 or C-ter-
minal) were prepared and immobilized
in an active conformation at the desired
position.
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Abstract
Candida antarctica lipase B (CalB) is an important catalyst in bio-organic synthesis. To optimize its performance, either
the reaction medium is changed or the lipase itself is modified. In the latter case, mutants are generated in Eschericha coli
and subsequently expressed in fungal hosts for their characterization. Here we present the functional expression of CalB in the
periplasm of E. coli. By step-wise deletion of the CalB signal and propeptide we were able to express and purify two different
variants of CalB (mature CalB and CalB with its propeptide). A N-terminal FLAG and a C-terminal His tag were used for the
purification. For the substrates para-nitrophenol butyrate (p-NPB), para-nitrophenol laurate (p-NPL) and carboxyfluorescein
diacetate (CFDA) the specific activity was shown to be similar to CalB expressed in Aspergillus oryzae. The kinetic constants kM,
vmax and kcat were determined using the substrates p-NPB and p-NPL. Almost identical kcat/kM values (0.423–0.466 min−1 M−1
for p-NPB and 0.068–0.071 min−1 M−1 for p-NPL) were obtained for the CalB variants from E. coli and A. oryzae. The results
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S30learly show that CalB can be functionally expressed in E. coli and that the attachment of tags does not alter the properties of
he lipase.
2006 Elsevier B.V. All rights reserved.
eywords: CalB; Candida antarctica; Lipase activity; Periplasmic expression; Propeptide
. Introduction
Lipases (EC 3.1.1.3) are enzymes that catalyze the
ydrolysis of neutral lipids in biological systems. How-
ver many lipases have been found to catalyze a variety
∗ Corresponding author. Tel.: +49 89 21803172;
ax: +49 89 21802050.
E-mail address: Hermann.Gaub@physik.uni-muenchen.de
H.E. Gaub).
of reactions, which can be very different from the reac-
tion for which the enzyme has evolved to in nature.
As these enzymes are naturally acting at an oil–water
interface they are, generally, very compatible with
organic solvents. Their ability to accept a wide range
of substrates (lipids, sugars, alcohols, acids and esters)
and their capability to maintain activity and selectiv-
ity in organic solvents has enabled their wide use as
biocatalysts in industrial applications: In aqueous sol-
vents lipases are used for hydrolyzing esters and in
168-1656/$ – see front matter © 2006 Elsevier B.V. All rights reserved.
doi:10.1016/j.jbiotec.2006.04.004
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organic solvents they are catalyzing the reverse reaction
achieving esterification, transesterification, aminoly-
sis or thiotransesterification (Anderson et al., 1998;
Schmid and Verger, 1998).
Lipase B from Candida antarctica (CalB) (Patkar et
al., 1992) is one of the most widely used biocatalysts
(Anderson et al., 1998). Its structure has been resolved
1994 (Uppenberg et al., 1994, 1995). As many other
lipases CalB shows the typical / hydrolase fold. Its
active site is composed of a Ser-His-Asp catalytic triad.
The active site pocket is composed of two channels.
The structure of these channels is responsible for the
high regio- and stereo-selectivity of CalB towards sec-
ondary alcohols (Magnusson et al., 2005). In contrast
to other lipases CalB displays no interfacial activation
(Overbeeke et al., 2000; Rotticci et al., 2000) and does
not possess a typical lid domain (Martinelle et al., 1995;
Rotticci et al., 2000).
Because of the importance of CalB in organic
synthesis, especially for the kinetic resolution of
racemates, numerous approaches have been used
to optimize the activity, specificity, selectivity and
stability of CalB. This has been achieved either by
changing the microenvironment of the enzyme or
by optimizing the enzyme itself using random or
site-directed mutagenesis. Factors influencing the
microenvironment are, for example, supports for
immobilization (Fernandez-Lafuente et al., 1998), the
content of water in an organic solvent (Piyatheerawong
et al., 2004) or the nature of the organic solvent itself
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have been problems in expressing CalB in E. coli. Only
one recent report (Chodorge et al., 2005) describes
the use of E. coli expressed CalB for a screening
assay. However, the improved mutants are not puri-
fied and characterized in vitro. The possibility of using
E. coli expressed CalB directly for screening of the
mutants would greatly simplify the process of generat-
ing optimized variants. Especially the time span to get
from the cloned construct to the functional test of the
desired mutant would be much shorter if CalB could
be expressed in a functional form in E. coli.
Here, we report the soluble expression of CalB in
the periplasm of E. coli. The influence of the signal
and propeptide of CalB was analyzed by sequentially
removing these peptides. The possibility of attaching
a N-terminal FLAG tag and a C-terminal His tag to
allow the use of well-established protocols for purifi-
cation and detection was investigated. Finally, the spe-
cific activity and the kinetic constants of the purified
enzymes were compared with a reference sample of
CalB expressed in A. oryzae.
2. Materials and methods
2.1. Cloning of expression plasmids
The plasmids for the periplasmic expression of
CalB (Fig. 1) are based on the pAK series (Krebber
et al., 1997). The plasmid pAK400, which contains a
s
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S31Wescott and Klibanov, 1994; Ottosson et al., 2002).
alB mutants have been generated using site-directed
utagenesis (Patkar et al., 1997; Rotticci et al., 2001;
agnusson et al., 2005), circular permutation (Qian
nd Lutz, 2005) or directed evolution (Zhang et al.,
003; Suen et al., 2004; Chodorge et al., 2005).
While all cloning steps are always carried out in
schericha coli screening for the desired mutants, in
ost cases, involves expression in the fungal hosts
spergillus oryzae (Hoegh et al., 1995), Pichia pastoris
Rotticci-Mulder et al., 2001) or Saccharomyces cere-
isae (Zhang et al., 2003; Suen et al., 2004). In all cases
alB is expressed together with its own (Hoegh et al.,
995) or a host specific signal peptide (Rotticci-Mulder
t al., 2001), which directs the lipase to the medium.
ollowing the expression, the supernatant containing
he lipase is analyzed for enzymatic activity. The fact
hat different fungal hosts are used suggests that theretrong RBS, a pelB signal sequence and a His tag, was
sed. The NcoI site in the cat gene was removed and
n EcoRI site was introduced in front of the His tag
sing site directed mutagenesis. Based on this plasmid
pKB3) three different constructs of CalB were cloned.
he calB gene was amplified from a plasmid obtained
rom Novozymes using the following primers: For
alBSP-His the forward primer was chosen such that
he signal and propeptide of CalB remain attached
o the calB gene. For CalBP-His the primer included
he sequence of the propeptide. And for CalB-His
he sequence of mature CalB was amplified. All
orward primers contained the sequence of a short
LAG tag (Knappik and Plückthun, 1994) and a NcoI
ite as in the original pAK400 plasmid. The forward
rimers had the following sequences: CalBSP forw
′-CATGCCATGGCGGACTACAAAGATATGAAGC
ACTCTCTCTGACCGG-3′, CalBP forw 5′-CATG
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Fig. 1. Plasmids for the periplasmic expression of the different CalB
variants. The plasmid is a derivative of the pAK series. It contains
a lac promotor, the strong RBS T7G10 and the signal peptide pelB.
After cleavage of the signal peptide the CalB variants possess a
N-terminal FLAG tag in front of the respective calB sequence. To
obtain the construct pKB3CalBSP-His the calB sequence was cloned
together with its signal and propeptide. The construct pKB3CalBP-
His only contains the propeptide in front of the calB sequence. For the
construct pKB3CalB-His the sequence of mature CalB was cloned
after the FLAG tag. All constructs contain a C-terminal His tag.
CCATGGCGGACTAGAAAGATGCCACTCCTTTG
GTGAAGC-3′, CalB forw 5′-CATGCCATGGCGG
ACTACAAACATCTACCTTCCGGTTCGGACC-3′
(The NcoI site is underlined, the sequence of the
calB gene is written in italics.) An identical reverse
primer introducing an EcoRI site after the calB
gene was used for all constructs: CalB EcoRI rev
5′-CCGGAATTCGGGGGTGACGATGCCG-3′. The
PCR fragments were purified, cut with NcoI and
EcoRI and cloned into the pKB3 plasmid resulting in
the plasmids pKB3CalBSP-His, pKB3CalBP-His and
pKB3CalB-His.
2.2. Expression of CalB variants
The plasmids encoding the three different vari-
ants of CalB were transformed in the E. coli K12
strain TB1 (New England Biolabs, Frankfurt, Ger-
many). Small scale expressions for Western blot anal-
ysis were performed at 37 or 25 ◦C and 250 rpm
using 50 ml of SB medium (20 g l−1 tryptone, 10 g l−1
yeast extract, 5 g l−1 NaCl, 50 mM K2HPO4) contain-
ing 30 g ml−1 chloramphenicol. The cultures for the
purification of the lipase variants were grown in 200 ml
of SB medium at 25 ◦C and 250 rpm. These cultures
were inoculated from a 20 ml preculture to OD600 = 0.1.
Expression was induced with 1 mM isopropyl--d-
thiogalactopyranosid (IPTG) at an OD600 between
1.0 and 1.5. The cells were harvested 3 h after
induction by centrifugation at 5000 × g and 4 ◦C for
10 min.
2.3. Western blot analysis
The obtained cell pellets were resuspended in load-
ing buffer (50 mM sodium phosphate pH 8.0, 300 mM
NaCl, 10 mM imidazole), normalized to their end
OD600 using 2.5 ml buffer per 1 unit OD600. Whole
cell extracts were prepared by French Press lysis at
10,000 psi and 1 ml of the crude extract was centrifuged
for 60 min at 16,000 × g and 4 ◦C. The supernatants
containing the soluble proteins were transferred to a
new vessel and the pellet was resuspended in 1 ml
of buffer. These samples were analyzed using anti-
FLAG antibody M1 (Sigma, Taufkirchen, Germany)
and anti-His antibody Penta-His (Qiagen, Hilden, Ger-
many): SDS-PAGE was carried out under reducing
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S32onditions according to standard protocols using 15%
olyacrylamide gels. The proteins were transferred to
PVDF membrane (Millipore, Eschborn, Germany).
or the detection with the anti-FLAG antibody the
embrane was blocked with 5% bovine serum albu-
in (BSA) in FLAG–Ca2+ buffer (50 mM Tris/HCl
H 8.0, 10 mM NaCl, 1 mM CaCl2) for 30 min. The
nti-FLAG M1 antibody was diluted by a factor of
000 in FLAG–Ca2+ buffer containing 0.5% BSA and
.05% Tween 20. The membrane was incubated in this
olution for 60 min followed by washing the mem-
rane 3× 5 min in FLAG–Ca2+ buffer with 0.05%
ween 20. For detection purposes the secondary rab-
it anti-mouse antibody carrying a fluorescence label
Alexa Fluor 647; Invitrogen, Karlsruhe, Germany)
as diluted 1:2000 in FLAG–Ca2+ buffer containing
.5% BSA and 0.05% Tween 20. After shaking the
embrane with this solution for 30 min, the membrane
4 K. Blank et al. / Journal of Biotechnology xxx (2006) xxx–xxx
was again washed three times with buffer. Western
blots with the anti-His antibody were carried out using
an Alexa Fluor 647 labeled antibody according to the
manufacturer’s instructions. Fluorescence images were
taken using a LS300 scanner (Tecan, Crailsheim, Ger-
many).
2.4. Two-step purification
Cell pellets were resuspended in loading buffer.
After adding DNase I (Roche Diagnostics, Mannheim,
Germany), cell disruption was achieved by French
Press lysis. The suspension was clarified by centrifu-
gation at maximum speed for 60 min at 4 ◦C and fil-
tration through a 0.22 m filter. This crude extract
was loaded onto a Ni2+–NTA column (Qiagen, Hilden,
Germany) equilibrated with loading buffer. The col-
umn was washed with 30 column volumes of loading
buffer and 5 column volumes of a washing buffer
(50 mM sodium phosphate pH 8.0, 300 mM NaCl,
30 mM imidazole). Elution was achieved by adding
five column volumes of elution buffer (50 mM sodium
phosphate pH 8.0, 300 mM NaCl, 200 mM imidazole).
The eluted fraction was dialyzed against FLAG–Ca2+
buffer and loaded onto an anti-FLAG affinity col-
umn (M1 antibody; Sigma, Taufkirchen, Germany)
equilibrated with the same buffer. The column was
washed with 30 column volumes of FLAG–Ca2+ buffer.
The protein was eluted by adding 10 times 2 ml of
FLAG–EDTA buffer (50 mM Tris/HCl pH 8.0, 10 mM
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2.5. Activity measurements
To compare the activity of the different CalB
variants three different substrates were used: para-
nitrophenol butyrate (p-NPB; Sigma, Taufkirchen,
Germany), para-nitrophenol laurate (p-NPL; Sigma)
and carboxyfluorescein diacetate (CFDA; Invitrogen).
Before the measurements could take place, calibra-
tion curves were determined to correlate the absorp-
tion at 405 nm (p-NPB and p-NPL) or fluorescence
at 517 nm (CFDA) with the concentration of the gen-
erated product. The extinction coefficient for para-
nitrophenol determined for the buffer used was 9100
(l mol−1 cm−1). For the measurements with p-NPB
and p-NPL stock solutions of the substrates were pre-
pared with a concentration of 20 mM in isopropanol.
The assay mixture contained 50 mM sodium phosphate
pH 7.0, 150 mM NaCl, 0.5% Triton X-100, 5% iso-
propanol. The following substrate concentrations were
used: 1000, 200, 80 and 50 M. The reaction was
started by adding the respective lipase to a final concen-
tration of 100 nM. The temperature was kept constant
at 25 ◦C. The generation of the product could be fol-
lowed by measuring the increase in absorbance every
10 s for a total time of 300 s. For the CFDA measure-
ments a 25 mM stock solution was prepared in DMSO.
The assay mixture contained 50 mM sodium phosphate
pH 7.0, 150 mM NaCl, 10% DMSO and 100 nM lipase.
The reaction was started by adding CFDA to a final
concentration of 1000 M. Again the temperature was
k
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S33aCl, 10 mM EDTA). Finally, the fractions containing
he pure enzyme were dialyzed against assay buffer
50 mM sodium phosphate pH 7.0, 150 mM NaCl)
nd concentrated using Centricon YM-10 (Millipore)
o a final concentration of approximately 1 mg ml−1.
amples from each step were analyzed by reducing
DS-PAGE using 15% polyacrylamide gels. The actual
oncentration of the purified lipases was determined
y measuring the absorbance at 280 nm. The extinc-
ion coefficients of the different CalB variants have
een calculated using the program Vector NTI (Invit-
ogen). Finally, identical amounts of the lipase vari-
nts were compared to a glycosylated and deglycosy-
ated sample of CalB from A. oryzae using reducing
DS-PAGE. Deglycosylation was carried out using
NGase F (New England Biolabs, Frankfurt, Ger-
any) using the protocol supplied by the manufac-
urer.ept constant at 25 ◦C and the increase in fluorescence
as measured for 300 s in time intervals of 10 s. All
easurements were carried out in triplicate. Assay
ixtures containing BSA instead of lipase were used
s reference samples. The increase in absorbance or
uorescence of the BSA samples was subtracted from
he values obtained from the lipase samples. These
orrected curves were used to calculate the reaction
elocity v, which describes the concentration of the
enerated product per minute.
. Results
CalB is an extracellular protein, which contains
hree disulfide bonds. To allow the correct formation of
hese disulfide bonds in E. coli it is necessary to target
he protein to the periplasmic space. Therefore, the calB
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gene was cloned into an expression plasmid containing
a pelB signal sequence, which is recognized from the
E. coli transport machinery. In its natural host Candida
antarctica CalB is expressed in form of a preproprotein.
Its 18 amino acid long signal peptide targets the pro-
tein to the secretory pathway. The function of the seven
amino acid long propeptide is not known yet (Hoegh
et al., 1995). As nothing is known about the processing
of fungal preproproteins in E. coli three different con-
structs were cloned as described before (Fig. 1): One
construct contains the complete sequence of the pre-
proprotein (CalBSP-His), the second construct misses
the signal peptide (CalBP-His) and the third construct
represents the sequence of the mature protein (CalB-
His). In order to check if the respective peptides are
still present at the N-terminus of the expressed protein
the sequence of a FLAG tag was attached in front of
the respective lipase sequence. In addition, the FLAG
tag can be used to investigate if the protein is trans-
ported to the periplasmic space correctly (Knappik and
Plückthun, 1994): Since the anti-FLAG antibody M1
only binds to the tag if the tag is located at the N-
terminus, the protein can be recognized only if the
pelB signal peptide is processed during transport to
the periplasm. All constructs were cloned with a C-
terminal His tag to allow purification and detection of
the proteins.
The expression was carried out at 37 and 25 ◦C. At
37 ◦C precultures could be grown to a high density over
night and the expression cultures reached an OD600
o
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Fig. 2. Anti-FLAG blot showing the expression levels of the CalB
variants at 25 and 37 ◦C. E. coli cells expressing the different CalB
variants were grown at 25 and 37 ◦C. The cells were normalized to
their end OD600 and lysed. Soluble proteins (S) were separated from
the insoluble fraction (P) by centrifugation. The insoluble fraction
was resuspended in the original volume. The same volume of the
soluble and the insoluble fraction was loaded onto the gel. The CalB
variants contain a N-terminal FLAG tag. The blot shows one major
band proving that all variants are translocated to the periplasmic
space and that the CalB signal peptide and propeptide are not cleaved
by the E. coli transport machinery. Except for CalBP-His only little
degradation of the proteins occurs. For CalB-His (0) and for CalBP-
His (P) soluble protein is detected at 25 ◦C. CalBSP-His (SP) does
not show any soluble expression at this temperature. At 37 ◦C no
soluble expression can be seen for all three variants.
equals the amount of insoluble protein. No expression
can be detected for CalBSP-His.
Since CalB-His and CalBP-His are expressed as sol-
uble proteins at 25 ◦C the next step was to grow larger
cultures and purify these two variants of CalB. The
most convenient way to purify these proteins was to
make use of their His tag and FLAG tag (Fig. 3A and
B). The crude extract was loaded onto a Ni2+–NTA
column to remove most of the contaminants. After
dialysis against a buffer containing Ca2+ the eluted frac-
tions from the Ni2+–NTA column were loaded onto the
anti-FLAG column. Due to the Ca2+ dependent bind-
ing of the M1 antibody, the protein could be eluted
under mild conditions with a buffer containing EDTA.
The eluted fractions contain one single band with a
size of approximately 35 kDa, which refers to the size
of the cloned CalB variants with the two tags. After
concentrating the protein preparations, the concentra-
tions were determined by measuring the absorbance
at 280 nm. To analyze the purity of these two CalB
variants, the same amount of protein was analyzed
S34f 1.0 after 4 h (starting at OD600 = 0.1). At 25 ◦C the
rowth rate was much slower. The precultures needed
8 h and the expression culture had to grow over night
efore the culture could be induced (data not shown).
n both cases the cells grew for another 3 h after the
nduction took place. The cells were normalized to their
nd OD600 and lysed. The soluble and the insoluble
ractions were analyzed on Western blots using both
nti-FLAG (Fig. 2) and anti-His antibodies (data not
hown). Both blots are almost identical and show one
trong band of the same size indicating that the three
ifferent variants are full-length protein and that the
alB signal and propeptides are not cleaved in E. coli.
omparing the amount of soluble and insoluble protein
t the different expression temperatures, no protein can
e detected in the soluble fractions at 37 ◦C. In contrast,
t 25 ◦C the soluble fractions of CalB-His and CalBP-
is contain a certain amount of soluble protein, which
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Fig. 3. SDS-PAGE showing the fractions of the two-step purification procedure for CalB-His and the purified lipase variants. (A) For the first
step a Ni2+–NTA column was used: 1—crude extract, 2—flow through, 3—washing with 10 mM imidazole, 4—washing with 30 mM imidazole,
5—elution with 200 mM imidazole. (B) Fraction 5 was dialyzed against FLAG–Ca2+ buffer, Fraction 6 shows the sample after dialysis. Fraction
6 is loaded onto an anti-FLAG affinity column in the next step. Fraction 7 represents the flow trough, fraction 8 a washing step with FLAG–Ca2+
buffer. Fractions 9–15 represent the eluted fractions using FLAG–EDTA buffer. Fractions 10–15 were pooled for further analysis. (C) The
purity of the enzyme variants used for the activity tests (A+: CalB form A. oryzae, 0: CalB-His and P: CalBP-His) and of a deglycosylated
sample of CalB from A. oryzae (A−) was compared using SDS-PAGE. The references from A. oryzae (A+ and A−) show only one single band.
CalB-His (0) contains a very little amount of other proteins. In the preparation of CalBP-His (P) two other bands are present. The different bands
show slight differences in the size of the proteins. It can be clearly seen that P is larger than the version without the propeptide (0). Comparing
the size of the variants from E. coli (0) and A. oryzae (A−), CalB from E. coli has a higher molecular weight than the deglycosylated enzyme
from A. oryzae since it contains a FLAG and a His tag.
by SDS-PAGE. In addition, the size was compared to
glycosylated and deglycosylated CalB expressed in A.
oryzae (Hoegh et al., 1995) without any tags (Fig. 3C).
Whereas the preparation of CalB-His is almost pure,
the preparation of CalBP-His contains two additional
bands. As expected the variants with the attached tags
expressed in E. coli are bigger than the deglycosylated
CalB from A. oryzae. CalBP-His is larger than the con-
struct without the propeptide (CalB-His) again proving
that the propeptide is still attached to CalBP-His.
Using the preparations previously analyzed by SDS-
PAGE the specific activities of the enzymes were deter-
mined for three different substrates (Table 1). For CalB
from A. oryzae the glycosylated enzyme was used. To
determine the specific activities the reaction velocitiesv
at the highest substrate concentration (1000 M) were
divided by the amount of enzyme in the reaction mix-
tures. For all three substrates similar specific activities
were obtained for CalB-His and CalB from A. oryzae.
The specific activity of CalBP-His is a factor of 1.2
lower for all three substrates. This might refer to this
particular preparation, which contains a few contami-
nating proteins. The specific activities for p-NPB and
p-NPL have an error of approximately 10% of the mea-
sured value. The error for CFDA is much higher. This
is due to the fast auto-hydrolysis of the substrate, which
competes with the enzyme-catalyzed reaction.
Therefore, the kinetic constants for the different
enzyme variants have been measured only for p-NPB
and p-NPL (Fig. 4). Here the reaction velocity was plot-
ted against the substrate concentration. The data was
fitted with the Michaelis–Menten equation to obtain
Table 1
Specific activities of the different CalB variants
Specific activity p-NPB
(mol min−1 mg−1)
Specific activity p-NPL
(mol min−1 mg−1)
Specific activity CFDA
(nmol min−1 mg−1)
Aspergillus 10.52 ± 1.07 0.936 ± 0.136 1.69 ± 0.37
E. coli CalB 10.57 ± 0.28 0.941 ± 0.075 1.58 ± 0.85
E. coli CalBP 8.75 ± 0.24 0.746 ± 0.048 1.30 ± 0.73
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Fig. 4. Michaelis–Menten and Lineweaver–Burk plots for the p-NPB and p-NPL substrates. The big plots show the Michaelis–Menten plots
for the different substrates and enzyme variants. The points () show the measured values with their standard deviation. The dashed line
(- - -) represents the fit using the Michaelis–Menten equation. The small plots show the corresponding Lineweaver–Burk plots. The linearity
of the Lineweaver–Burk plots proves that the hydrolysis of the substrates is a first order reaction and therefore the data can be fitted with the
Michaelis–Menten equation to obtain the values for vmax and kM. For p-NPB (A, B, C) as a substrate the values for vmax and kM differ only
slightly for the different enzyme variants. This also applies for the substrate p-NPL (D, E, F).
the Michaelis–Menten constant kM and vmax. To deter-
mine whether the enzymatic hydrolysis of the different
substrates is a first order reaction, the data was analyzed
with the Lineweaver–Burk plot. For both substrates, the
three different enzyme variants show a straight line in
the Lineweaver–Burk plot proving that the reaction is a
first order reaction and therefore the achieved data can
be fitted with the Michaelis–Menten equation. Other
lipases, which are interfacially activated, do not follow
a first order reaction with the p-NPL substrate under
similar reaction conditions (Redondo et al., 1995). kcat
and the specificity constant kcat/kM were calculated
S36
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Table 2
Summary of kinetic constants of the different CalB variants
Substrate Enzyme vmax (M min−1) kM (M) kcat (min−1) kcat/kM (min−1 M−1)
p-NPB Aspergillus 194 4612 1949 0.423
E. coli CalB 237 5492 2378 0.433
E. coli CalBP 183 4930 2298 0.466
p-NPL Aspergillus 5.51 781 55.1 0.070
E. coli CalB 6.25 915 62.5 0.068
E. coli CalBP 4.97 877 62.1 0.071
based on the obtained values for kM and vmax (Table 2).
Having a more detailed look at the data one can see
that all constants are in the same range for the different
enzyme variants. The specificity constant is the same
for all three different enzymes.
4. Discussion
The data clearly shows that CalB can be function-
ally expressed in E. coli. The strategy of lowering the
expression temperature from 37 to 25 ◦C (Baneyx and
Mujacic, 2004) yields soluble and functional protein
for CalB with or without the propeptide. These variants
of CalB from E. coli show identical catalytic activity
compared with the enzyme from A. oryzae. This indi-
cates that the structures of their active sites are the same.
In addition, tags can be attached to the N-terminus and
to the C-terminus without changing the properties of
the enzyme. These tags can be used for detection and
purification of the enzyme.
Although CalB has been the subject of intensive
research, the function of some important structural fea-
tures is still not known. The propeptide, as has been
shown for proteases (Wiederanders et al., 2003) and
the lipase of Rhizopus oryzae (Beer et al., 1998), can
act as an inhibitor or assist in folding of the protein into
its native state. The experiments, which are presented
here, could not detect a difference between the variants
with and without the propeptide. This data and the fact
t
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ing kinetics and a higher stability. We cannot eliminate
the possibility of similar contributions of the propep-
tide since in vitro unfolding and refolding experiments
would be necessary to obtain more detailed informa-
tion. Furthermore, an inhibitory effect of the propeptide
principally cannot be excluded since the construct used
in this study does not possess the original propeptide
because of the presence of the FLAG tag. Based on the
data presented here, no conclusion can be drawn about
the function of the propeptide. This also applies to the
glycosylation. CalB from E. coli lacks the glycosyla-
tion. However, no difference in the enzymatic activity
can be seen compared to the glycosylated enzyme from
A. oryzae.
Further on it also remains unclear if the enzyme is
active within E. coli. In the other expression systems
used CalB is secreted to the culture medium. In E. coli
the lipase remains inside the cell and could in principle
degrade lipids in E. coli. This does not seem to be the
case since no difference in growth can be seen when the
lipase is expressed in soluble or insoluble form (data
not shown). Other lipases possess a lid, which shields
the active site from the solvent in an aqueous envi-
ronment. During contact with a hydrophobic interface,
the lipase undergoes a conformational change and the
active site becomes accessible. In contrast, CalB does
not have a typical lid domain and does not show inter-
facial activation (Overbeeke et al., 2000; Rotticci et al.,
2000). However, Velonia et al. (2005) could show that
one enzyme can exist in catalytically active and cat-
a
o
t
t
f
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S37hat propeptides involved in folding are normally much
arger (Beer et al., 1998; Wiederanders et al., 2003) lead
o the conclusion that the propeptide is not involved
n folding. The construct lacking the propeptide can
lso fold into a native and active conformation. How-
ver, for the lipase from R. oryzae it has been shown
hat the enzyme with the propeptide has improved fold-lytically inactive conformations. The question if CalB
nly exists in an inactive conformation in E. coli and if
his is actively regulated is going beyond the scope of
his study.
Having a more detailed look at the kinetic constants
or the different substrates, one can see that CalB has
higher specificity constant for p-NPB, a short fatty
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acid chain. This result is in contrast to other reports in
the literature. A similar specificity for C4 (p-NPB) and
C12 (p-NPL) fatty acid chains was observed in cyclo-
hexane (Garcia-Alles and Gotor, 1998). Another report
describes a preference for fatty acid chains longer than
10 carbon atoms in hexane (Kirk et al., 1992). Since the
specificity of the enzyme is dependent on the solvent no
conclusion can be drawn from these findings. Probably,
the reaction rates for different substrates are not only
a matter of specificity of the enzyme but also depend
on the solubility of the substrate in the respective sol-
vent. The solubility of the substrate is a critical point
for the activity tests, which were performed. The range
of concentrations is limited by the detection limit of the
generated product and by the solubility of the substrate
in the reaction buffer.
The possibility of expressing CalB in E. coli opens
up new ways for screening and rational design of
improved variants. For example, by using phage dis-
play (Danielsen et al., 2001; Fernandez-Gacio et al.,
2003) a higher number of mutants can be screened in
order to obtain the desired molecule. The use of phage
display would in addition circumvent the drawback that
CalB is expressed intracellularly in E. coli. Further-
more, the possibility to make fusion proteins will allow
numerous new options for the immobilization of the
enzyme. Especially methods for directed immobiliza-
tion will make the optimization of reaction conditions
more reliable since the enzyme will always be immobi-
lized in the same orientation with the active site point-
i
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i
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Abstract A genetically modified form of the human
DNA repair protein O6-alkylguanine-DNA-alkyltrans-
ferase (hAGT) was used to immobilize different re-
combinant hAGT fusion proteins covalently and
selectively on gold and glass surfaces. Fusion proteins
of hAGT with Glutathione S-Transferase and with
tandem repeats of Titin Ig-domains, were produced
and anchored via amino-polyethylene glycol benzyl-
guanine. Anchoring was characterized and quantified
with surface plasmon resonance, atomic force micro-
scope and fluorescence measurements. Individual fusion
proteins were unfolded by single molecule force spec-
troscopy corroborating the selectivity of the covalent
attachment.
Keywords Molecular recognition Æ SPR Æ AFM Æ
Suicide coupler Æ hAGT Æ SNAP-tag
Abbreviations hAGT: O6-alkylguanine-DNA-
alkyltransferase Æ GST: Glutathione S-Transferase Æ
PEG: Polyethylene glycol Æ BG: Benzylguanine Æ SPR:
Surface plasmon resonance Æ AFM: Atomic force
microscope Æ EDC: 1-ethyl-3-(3-diaminopropyl)
carbodiimide hydrochloride Æ NHS: N-hydroxy
succinimide Æ GST: Glutathione S-transferase Æ
CMC: Carboxymethylcellulose
Introduction
Various areas of modern biotechnology are in great de-
mand for strategies and protocols to attach recombinant
proteins permanently, selectively and in a defined man-
ner to solid surfaces. Especially in the field of single
molecule biophysics the need for such techniques is
emerging. For a broad range of conventional binding
studies at surfaces, physisorption of, e.g. a capture
antibody in an ELISA, is sufficient as long as the spon-
taneous off-rate is slower than the one of the target
molecule, a covalent attachment is essential for the rap-
idly growing number of experiments, where forces are
measured between molecules. In such experiments the
weakest of the bonds in series ruptures first and it must
not be the attachment. However, since the force required
to rupture a bio-molecular complex is not directly cor-
related to the binding energy, physisorption, although
thermally stable is in many cases insufficient. Various
strategies for a covalent attachment have therefore been
investigated and established, most of them based on
covalently binding the protein of choice either via amines
or the thiol group of a cysteine. Besides the limited life-
time due to hydrolysis, the low selectivity and the limited
yield of these coupling reactions motivate the search for
alternative strategies. Here, we investigated the possi-
bility of using fusion proteins with a mutant of O6-al-
kylguanine-DNA-alkyltransferase (hAGT) also known
as SNAP-tag in combination with its substrate polyth-
ylene glycol (PEG)–benzylguanine (BG) as a promising
strategy for the covalent and directed attachment of
proteins for single molecule force spectroscopy.
The natural role of hAGT is the repair of alkylation
damage of the DNA at the O6-position of guanine in a
unique, stoichiometric reaction (Daniels and Tainer
2000). Since hAGT also accepts free O6-benzylguanine as
a substrate it is possible to inactivate hAGT irreversibly
with this small molecule (Pegg et al. 1993). Interestingly,
oligonucleotides containing derivatives of O6-benzyl-
guanine with substituted benzyl rings are also accepted as
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substrates of hAGT (Damoiseaux et al. 2001). As a
consequence, various derivatives of BG were used to la-
bel hAGT fusion proteins with small molecules in vivo
(Keppler et al. 2003). A BG–PEG-amino derivative,
covalently attached to carboxy dextran gold surfaces
(Biacore) via EDC/NHS chemistry, was used in a pre-
vious study to immobilize GST-hAGT fusion proteins on
these BG activated slides (Kindermann et al. 2003).
Here we used the same BG–PEG-amino derivative as
an anchor (Fig. 1) and verified the immobilization of
Gluthathione S-Transferase (GST)–hAGT fusion pro-
teins on gold surfaces. In the next step, Titin–GFP–
hAGT fusion proteins (Fig. 2) were anchored on gold
and glass surfaces and were investigated with surface
plasmon resonance (SPR), fluorescence and single mol-
ecule measurements.
Materials and methods
If not stated otherwise, all chemicals used for the func-
tionalization of surfaces were of analytical standard and
purchased by Sigma (Taufkirchen, Germany). PBS
(10 mM PBS, 150 mM NaCl, pH 7.4) and MES
(10 mM MES, 150 mM NaCl, pH 6.3) were used as
buffer solutions. For the hAGT fusion proteins, we used
a genetically modified form of the wild type form of
hAGT, that has a 20-fold increased activity against BG
(Juillerat et al. 2003). In addition, the DNA binding site
was mutated (Gendreizig et al. 2003) and cysteine 62
was exchanged to alanine (unpublished data). The DNA
sequence of this hAGT mutant was C-terminally fused
to the sequences of GST and Titin–GFP using standard
molecular biology protocols. The recombinant proteins
were expressed in E. coli. The GST–hAGT fusion pro-
tein was expressed following the protocol in Kinder-
mann et al. (2003) and purified with a GST affinity
column following the instructions of the affinity medium
(Amersham Biosciences, Freiburg, Germany). Purified
GST–hAGT fusion proteins were stored in PBS or MES
Fig. 1 Immobilization principle of hAGT fusion proteins. The
BG–PEG-amino derivative is attached to carboxylized gold and
glass surfaces via EDC/NHS chemistry. The hAGT protein accepts
BG as a substrate and connects itself to the surface
Fig. 2 O6-alkylguanine-DNA-alkyltransferase fusion proteins used
for the immobilization experiments. a Titin–GFP–hAGT fusion
protein. Molecular weight about 100 kDa. GFP serves as a
fluorescence marker, the eight Ig-domains as molecular rulers for
unfolding forces and segment lengths. b GST–hAGT fusion
protein. Molecular weight about 45 kDa
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at 4C. The Titin-GFP–hAGT fusion protein was ex-
pressed exactly as described for Titin–GFP fusion pro-
teins (Dietz and Rief 2004b). The Titin–GFP–hAGT
fusion proteins were immobilized without prior purifi-
cation. Therefore BG functionalized slides were incu-
bated directly with crude extracts of E. coli cells
expressing this fusion protein.
Surface plasmon resonance measurements
To investigate the binding of hAGT fusion proteins on
gold-slides, we used a homebuilt multi-channel SPR
device that consists of several commercially available
SPR-sensor chips (Neuert et al. 2004). Spreeta Evalua-
tion Module software (version 5.21) was used to analyse
the SPR curves. All SPR experiments were performed at
constant room temperature with thoroughly degassed
PBS or MES buffer solutions at a constant flow-rate of
0.03 ml/min.
Cover slides were evaporated at a pressure of 1–
2·106 mbar with 1 nm chrome/nickel (GoodFellow,
GB) as adhesive layer and 50 nm high-purity gold
(purity degree: 99.99%, Leybold Optics, Germany).
Afterwards, the slides were incubated with cysteamine
(20 mM) for 12 h to obtain a cysteamine monolayer.
Carboxymethylcellulose (CMC) was bound to these
amino groups using standard EDC protocols to obtain
carboxylized gold surfaces. In addition to CMC sur-
faces, sulphur–PEG–COOH (M=20 kd) (Rapp Poly-
mere GmbH, Tübigen, Germany) gold coated surfaces
were prepared. For this purpose S–PEG–COOH mole-
cules were solved in H2O (3 mM). The COOH groups of
that polymers were activated in solution with EDC
(100 mM) and N-hydroxysuccinimide (NHS) (50 mM).
Those activated polymers were incubated with BG
(5 mM) for 12 h. All non-reacted COOH groups were
quenched with ethanolamine (1 M) for 30 min. Gold
coated cover slides were incubated with the BG activated
PEG for 4 h. The control sample was treated identically
except for the BG activation, which was omitted.
These gold slides were optically coupled to the SPR
sensors using indexmatching oil (518 C, Zeiss, Germany).
Fluorescence binding measurements
To verify the specific anchoring of Titin–GFP–hAGT
fusion proteins using the auto-fluorescence properties of
GFP, Titin–GFP–hAGT proteins were immobilised on
aldehyde-functionalised glass slides (Quantifoil Micro
Tools GmbH, Germany). The aldehyde groups were
oxidised with potassium permanganate to carboxyl
groups. After that, spots of BG (3 mM) were attached to
these groups using standard EDC/NHS protocols. All
non-reacted NHS groups were blocked with 1 M etha-
nolamine. Following this, the Titin–GFP–hAGT fusion
proteins were coupled to this surface by incubating the
whole slide with the crude extract of hAGT-expressing
E. coli cells. After an incubation time of 45 min all un-
bound proteins from the cell extract were removed by
extensive washing with PBS.
A fluorescence-scanner (LS100, Tecan, Austria) was
used to determine the amount of bound fusion proteins.
GFP was excited with a 488 nm laser and the emitted
light was filtered with a 500–570 nm band-pass filter.
The spatial resolution was 20 lm. Mean fluorescence as
well as background intensity was determined by using
NIH IMAGE software (National Institutes of Health,
Bethesda).
Single molecule force spectroscopy
All single molecule force measurements were performed
with a custom-built atomic force microscope (AFM)
(Oesterhelt et al. 1999). Cantilevers were calibrated in
solution using the equipartition theorem (Butt and Jas-
chke 1995; Florin et al. 1995). This method provides a
resolution, in force, of roughly 10%. Two types of gold-
coated cantilevers (Bio-Levers, Olympus, Japan) with
spring constants and resonance frequencies of 30 pN/nm
and 8.5 kHz or 6 pN/nm and 1.5 kHz, respectively, were
used. The force curves of the Titin–GFP–hAGT con-
struct were collected at pulling speeds ranging around
300 nm/s. All experiments were conducted at room
temperature in PBS buffer.
Titin–GFP–hAGT fusion proteins were immobilised
on BG activated aldehyde-functionalised glass slides as
described before (see fluorescence binding measure-
ments).
Results and discussion
Binding studies with surface plasmon resonance
In the beginning we describe an experiment on CMC
functionalized cover slides. The CMC layer in channel 1
was activated with BG (Covalys Biosciences AG, Swit-
zerland) using standard EDC/NHS protocols. As a
control for specific immobilisation of the fusion proteins
in channel 2 no BG, but also EDC/NHS was added. The
attachment of the BG–PEG-amino derivative causes an
increase of layer thickness of about 6 Å in channel 1
(Fig. 3). After blocking all non-reacted NHS groups
from both channels with 1 M ethanolamine, each
channel was incubated with GST–hAGT fusion protein.
The sensor response of channel 1 (BG activated) was
about four times higher than the response of channel 2
(non-activated with BG) (Fig. 4).
The SPR measurements show that a protein layer of
the same thickness as a GST–hAGT monolayer is bound
only to the BG activated surface. The result of this im-
mobilisation experiment is in good accordance with lit-
erature values (Kindermann et al. 2003).
With the anchoring protocol established for GST, in
the second experiment we now immobilised a Titin–
GFP–hAGT fusion protein on a S–PEG–COOH coated
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gold surface. The PEG of channel 1 was activated with
BG and the PEG of channel 2 was not. First the surfaces
were equilibrated in MES buffer. After 10 min the sur-
faces of both channels were incubated with crude cell
extract of Titin–GFP–hAGT expressing bacteria resus-
pended in MES buffer. We observed a sizable increase
(about 12 Å) in the measured adlayer thickness, which
we attribute to the high density of the cell content
(Fig. 5). The thickness of the surface in channel 2
slightly decreased in time to drop to nearly zero after
extensive rinsing with MES buffer. The thickness in
channel 1, however, slightly increased with time. After
rinsing, a final thickness increase of 4.5 Å remained.
Verification of anchoring with fluorescence
measurements
The specific binding of Titin–GFP–hAGT fusion pro-
teins on BG coated surfaces was verified by spotting BG
on EDC/NHS activated slides. Titin–GFP–hAGT fu-
sion proteins were anchored to these slides as described
above. The amount of bound fusion proteins was de-
tected by fluorescence measurements. The result is
shown in Fig. 6.
The result of the fluorescence-binding assay clearly
shows that Titin–GFP–hAGT fusion proteins are only
bound to BG activated spots of the glass slide. It also
proves the high selectivity of this immobilisation tech-
nique since the anchoring was carried out with crude cell
lysate.
Single molecule force spectroscopy on anchored proteins
The selectivity of the attachment of hAGT fusion pro-
teins was also investigated by single molecule force
spectroscopy. This method is complementary to SPR
and fluorescence measurements. Single proteins an-
chored between surface and AFM cantilever tip can be
Fig. 4 Surface plasmon resonance signal of GST–hAGT fusions
proteins. Surface of channel 1 was activated with BG. Surface of
channel 2 was not activated with BG. At time t=248 min the
surfaces of both channels were incubated with GST–hAGT fusion
proteins. After an incubation time of about 30 min all unbound
proteins were washed away with PBS buffer (t=276 min). The SPR
response of channel 1 was about four times higher than that of
channel 2
Fig. 5 Surface plasmon resonance signal of Titin–GFP–hAGT
fusion proteins. The surface of channel 1 was activated with BG.
The surface of channel 2; Å was not activated with BG. At time
t=10 min the surfaces of both channels were incubated with crude
cell extract of Titin–GFP–hAGT expression bacteria. After an
incubation time of about 35 min all unbound proteins were washed
away with MES buffer (t=45 min, channel 1; t=35 min channel
2). On the surface of channel 2 no protein was bound whereas in
channel 1 a film thickness of 4.5 Å remained
Fig. 3 Surface plasmon resonance signal of the BG-PEG-amino
anchor. Carboxylized gold surfaces were activated with EDC/NHS
(t=154 min). After a short washing step with H2O (Millipore,
Germany) (t=164 min) the BG-PEG-amino derivative was
anchored to the surface of channel 1. The immobilization of the
BG anchor causes an increase in layer thickness of about 6 Å
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identified via their specific mechanical unfolding pattern
(Rief et al. 1997). Recently, the mechanical unfolding of
single Titin–GFP proteins (lacking the hAGT domain)
has been investigated and their specific mechanical
unfolding pattern has been identified (Dietz and Rief
2004b). Those experiments were performed with unspe-
cific adsorbed proteins. Here we anchored hAGT–Titin–
GFP fusion proteins with BG on a glass slide in a site-
directed manner. For this purpose, one spot (upper spot
Fig. 7b) on the glass slide was activated with BG while
the other spot was not activated. Both spots were incu-
bated for 45 min with E. coli crude extract and after-
wards extensively rinsed with PBS buffer to remove all
unbound molecules.
Figure 7a shows typical force-extension traces col-
lected at the BG activated spot. They exhibit the typical
saw-tooth pattern due to sequential domain unfolding in
single Titin and Titin–GFP molecules as described be-
fore (Dietz and Rief 2004b; Rief et al. 1997). At exten-
sions below 100 nm all traces exhibit complicated force
patterns, which are most probably due to multiple
molecule interactions. Then, at higher extensions the
force gradually increases according to polypeptide elas-
ticity until one of the contained Titin domains unfolds.
This leads to a quasi-instantaneous increase in the con-
tour length of the polypeptide and the force drops rap-
idly. Then, subsequent stretching of the lengthened
molecule takes place until the next Titin domain unfolds.
These unfolding events are equidistant since the Titin
domains are identical in size. Then ultimately, the whole
molecule ruptures from the cantilever (reflected by the
last force peak in each trace) and the force drops to zero.
Titin domains exhibit a much higher unfolding force
than GFP and thus GFP unfolding always occurs at
small extensions. Therefore, this unfolding event will be
often masked by non-specific interactions (Dietz and
Rief 2004a). This can also be seen in our data—espe-
cially in the two topmost traces in Fig. 7a. There we note
at least seven Titin domain unfolding events and there-
fore, also expect a detected GFP unfolding event.
However, this event is obviously masked by the multiple
molecule interactions below 100 nm extension. The same
will most probably be true for the hAGT domain con-
tained in the investigated molecules. In our data we
could not find clear indication for an additional event
reflecting the unfolding of the hAGT domain. This also
supports the notion that hAGT loses partly its structural
integrity when it binds to its target BG (Daniels et al.
Fig. 6 Fluorescence signal of immobilized Titin–GFP–hAGT
fusion proteins. The whole area was activated with EDC/NHS
and six spots of BG were coupled to this surface. After blocking all
non-reacted NHS groups with 1 M ethanolamine the whole area
was incubated with Titin–GFP–hAGT fusion proteins. The
fluorescence signal between BG activated areas to non-activated
areas was typically 17:1
Fig. 7 Atomic force microscope experiments on immobilized
hAGT–Titin fusion proteins. The upper spot of the slide was
activated with the BG anchor while the lower spot was not
activated (b). Both spots were incubated with Titin–GFP–hAGT
fusion proteins. Before the AFM experiments, all unbound proteins
were washed away with PBS buffer. a Typical force-extension
traces collected at the BG activated spot. c Typical force-extension
traces collected at the non-activated spot
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2000). The mechanical contribution of the amino-poly-
ethylene glycol linker to the force-extension curves
should be negligible, since the PEG linker consists of
only three monomers. It will be an important task for
the future to further characterise the mechanical prop-
erties of this enzyme.
However, the traces in Fig. 7a clearly demonstrate on
the single molecule level the successful anchoring of the
Titin–GFP–hAGT molecules. In contrast, the traces
collected at spot B (Fig. 7c) exhibit only unspecific low-
force interaction patterns, which cannot be attributed to
the unfolding of modules contained in the Titin–GFP–
hAGT molecule.
To compare quantitatively the yield of force-exten-
sion traces exhibiting Titin unfolding patterns collected
on both spots, we performed an analysis based on pat-
tern recognition techniques as described in Dietz and
Rief (2004a). This method involves first definition of a
test pattern, then identification of the best matching
section with the test pattern in each force trace and fi-
nally calculation of a degree of coincidence c with the
pattern as defined in equation 10 in Dietz and Rief
(2004a). As a test pattern we chose a section of a mea-
sured single molecule force-extension trace exhibiting
three Titin domain-unfolding events (Fig. 8, inset). The
graph shows the distribution of the degrees of coinci-
dence with the given pattern as they have been assigned
to each force trace contained in the data sets collected at
the BG activated spot and at the non-activated spot. It is
clearly visible that at the BG activated spot the fre-
quency of partial (c>0.2) and good matching (c>0.35)
with the three Titin domain-unfolding pattern is by far
higher than at the non-activated spot. This testifies again
that proteins containing Titin domains are selectively
immobilised only on the BG activated spot.
We therefore conclude that the anchoring is indeed
performed via the hAGT–BG coupling mechanism.
However, from our single molecule experiments we
cannot infer directly if the binding is covalent since the
forces at which the molecules rupture from the cantilever
are compromised by the fact that the connection
between the stretched molecules and the cantilever was
still unspecific. It will be necessary to anchor single
proteins selectively and specifically on both the substrate
and cantilever. Then, from the rupture forces one would
be able to infer if the nature of the binding is covalent,
since rupture forces should then reach into the nN re-
gime (Grandbois et al. 1999).
Conclusion
Our study clearly shows that anchoring of fusion pro-
teins via hAGT to BG activated surfaces is a suitable
technique for single molecule force spectroscopy. The
results show that the hAGT in the fusion acts as an
anchor for the coupling and that it does not influence the
unfolding behaviour of the molecule of interest. This
technique offers several advantages: the first one lies in
the gentle coupling procedure (in particular no drying
required). There is no need for any (chemical) modifi-
cation on the protein of interest making it possible to
investigate the protein under native conditions. The
possibility to use different functionalized surfaces (here
CMC and S–PEG–COOH coated surfaces) is another
advantage especially in terms of investigations with the
AFM. The highly specific, self-searching coupling
mechanism, which relies on biological recognition, al-
lows the implementation of patterning experiments;
hAGT will direct the protein of interest to the desired
positions and anchor it on the surface covalently. Fur-
thermore, time-consuming purification steps could be
avoided and proteins can be coupled directly from crude
cell extract onto the BG coated surfaces. Due to the high
fidelity of this coupling method, covalent attachment of
recombinant proteins out of single cells expressing
hAGT fusion proteins should be possible.
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Fig. 8 Results of the search for
Titin domain unfolding events
on the activated and on the
non-activated spot with a
pattern recognition algorithm.
We searched all force-distance
curves from both areas for the
typical Titin fingerprint (inset).
It is clearly visible that at the
BG activated spot the frequency
of partial (c>0.2) and good
matching (c>0.35) with the
three Titin domain-unfolding
pattern is by far higher than at
the non-activated spot
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Protein arrays permit the parallel analysis of many different markers in a small sample volume.
However, the problem of cross-reactivity limits the degree of multiplexing in parallel sandwich
immunoassays (using monoclonal antibodies (mAbs)), meaning antibodies must be pre-
screened in order to reduce false positives. In contrast, we use a second chip surface for
the local application of detection antibodies, thereby efficiently eliminating antibody cross-
reactions. Here, we illustrate the potential advantages of using single-chain Fv fragments
rather than mAbs as capture and detection molecules with this double chip technology.
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1 Introduction
Chip-based protein assays facilitate parallel measure-
ments with large numbers of different diagnostic markers
in small sample volumes. With the increasing focus on the
proteomic state of the cell, robust antibody arrays are
becoming one of the most popular analytic tools. Cur-
rently, mAbs are the molecules of choice, but other mole-
cules such as recombinant antibodies offer many signif-
icant advantages [1, 2]. Recombinant antibodies have
already been used in various protein detection applica-
tions, e.g. sandwich immunoassays (IAs) [3–5] or func-
tional protein analysis, such as chromophore-assisted
laser inactivation (Xerion Pharmaceuticals, Martinsried,
Germany; unpublished data). Similarly, they have recently
shown promise as capture molecules for antibody arrays
[6, 7]. One critical aspect concerning antibody arrays is
their lack of specificity [8]. Generally, for single marker
assays a sandwich format increases the specificity [1],
but in multiplexed sandwich IA systems antibodies must
be prescreened for cross-reactivity [9, 10]. We recently
introduced a double chip format (Fig. 1A), which provides
a different solution [11, 12]. This format consists of a cap-
ture array containing spots of different capture antibodies
(capAbs) and a reference array. Fluorescently labeled
detection antibodies (detAbs) are coupled to this refer-
ence array via DNA duplexes and are applied locally onto
their corresponding spots on the capture array. Since this
format reduces the complexity of a multimarker assay to
the simplicity of a single marker sandwich ELISA, anti-
body cross-reactions are effectively eliminated and time-
consuming antibody prescreening is not necessary. Here,
we show that single-chain Fv fragments (scFvs) can be
used instead of mAbs in multiplexed sandwich IAs using
this double chip format. We could demonstrate this with
three different scFvs randomly chosen from a pool of
twenty.
2 Materials and methods
b-Galactosidase mAbs were purchased from Roche Diag-
nostics (Mannheim, Germany; capAb) and Dunn Labor-
technik (Asbach, Germany; detAb). b-Galactosidase was
purchased from Roche Diagnostics. Recombinant scFv
antibody fragments were made by phage display [13]. For
purification, they were expressed with a His-Tag. The
scFvs were biotinylated using the FluoReporter Biotin/
DNP Protein Labeling Kit (Molecular Probes, Leiden,
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Figure 1. Substituting mAbs by scFv fragments. A) Assay
setup: CapAbs were immobilized on the capture array by
random coupling via their amino groups. On the reference
array, the labeled detAbs were immobilized via DNA
duplexes in unzipping geometry. The two arrays were
brought into contact to allow binding of the detAbs to
the antigens. Whenever a detAb could bind to its antigen,
the DNA duplex opened and the detAb was transferred
onto the capture array, together with the Cy3 labeled
oligo. B) Stepwise replacement of mAbs by scFvs. In set-
up 1 mAbs were used as capAb and detAb; for setup 2, a
mAb was used as capAb and scFv clone 3A6 (KD = 5.5 nM)
was used as detAb; and for setup 3 scFv clone 3A6 was
used as capAb and detAb. Each setup was tested with
and without incubation of antigen on the capture array.
C) Fluorescence intensities of different combinations of
mAbs and scFv fragments. The gray bars show the Cy3
intensities measured when antigen was incubated on the
capture array, and the striped bars show the intensities
without antigen. The mean values and SD (error bars)
were calculated from at least 6 independent experiments,
all carried out on different slides. The highest Cy3 inten-
sity was measured when mAbs were used as capAb and
detAb, with a 1/2 antigen ratio of 22. When the detAb
was a scFv both the Cy3 intensity and the 1/2 antigen
ratio decreased. Substituting both antibodies by scFvs
resulted in a further decrease of Cy3 intensity and the
1/2 antigen ratio. But a ratio of 10 still shows highly
efficient specific transfer.
The Netherlands). Excess biotin was removed by gel filtra-
tion and dialysis. An amino-reactive surface for the capture
array was prepared by oxidizing QMT aldehyde slides
(Quantifoil Microtools, Jena, Germany) and activating the
resulting COOH-groups with 1-ethyl-3-(3-dimethylamino-
propyl) carbodiimide and N-hydroxysuccinimide. Antibo-
dies (mAb and scFvs) were spotted onto the activated
surface in a concentration of 200 mg/mL. After 1 h of
incubation, the slides were washed with PBS 1 0.05%
Tween 20 (PBST) and PBS. Free reactive groups were
blocked with a solution of 150 mM Tris, 1 M ethanolamine
and 2% BSA for 1 h followed by incubation with PBS 1
1% BSA overnight. A solution of b-galactosidase (1 mg/
mL in PBS 1 0.4% BSA or 20% fetal calf serum in PBS)
was incubated for 1 h, followed by a wash with PBST
and PBS. The reference array was prepared using a sup-
port of polydimethylsiloxane exactly as described [12].
For the conjugation of detAbs and DNA oligonucleotides,
NeutrAvidin (Perbio Science, Bonn, Germany) was used
instead of streptavidin. The biotinylated mAb was diluted
to a final concentration of 2 mg/mL and the biotinylated
scFvs were used at a concentration of 10 mg/mL. The
contact process of the reference and the capture array
was carried out as described [12].
3 Results and discussion
We have recently shown that our double chip format
enhances the specificity of multiplexed IAs using mAb
sandwiches [11, 12]. In the present study, we established
a model system using recombinant scFvs in place of
mAbs in the double chip format to detect b-galactosidase
(Figs. 1A and B). We started by replacing the monoclonal
detAb by an scFv detAb, to investigate whether biotinyla-
tion of the scFv alters its functionality. In the next step we
also replaced the mAb on the capture array to obtain an
scFv sandwich. Each setup included a negative control
where no antigen was incubated on the capture array.
The fluorescence intensities measured on the capture
array, as well as the calculated ratios for specific/non-
specific transfer (1/2 antigen) for the three different set-
ups are shown in Fig. 1C. Each setup showed a high
specific/nonspecific ratio. Both the biotinylated and the
immobilized scFvs maintained their functionality. How-
ever, the fluorescence intensity for the sandwich contain-
ing scFvs as capAb and detAb reached only 62% of the
intensity obtained with the mAb sandwich. This may be
due to the fact that scFvs are smaller in size resulting in a
higher chance of binding sites being inactivated during
random coupling or immobilization procedures [5]. How-
ever, this problem can be easily solved by expressing
fusion proteins where the tag can be utilized for directed
immobilization [4, 5].
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Figure 2. Fluorescence intensities for different combina-
tions of antibodies. A) Combination of different scFvs as
detAbs with a monoclonal capAb. The values represent
the mean of at least 6 independent experiments. The error
bars represent inter-slide SD. Using the scFv clone 3A6 as
detAb resulted in the highest absolute Cy3 intensity and
the highest 1/2 antigen ratio (right). Both additional
scFvs tested showed less specific transfer (1 antigen;
gray bars) and also higher nonspecific transfer (2 antigen;
striped bars). However, the specific transfer is still signifi-
cantly higher than the nonspecific transfer (ratios of 6.6
for clone 1D10 and 5.6 for clone 1G11). B) Different sand-
wiches of scFvs (6 independent experiments, inter-slide
SD). The best clone (3A6) from experiment A) was used
as detAb in combination with different scFv clones as
capAbs. Again clone 3A6 showed the highest absolute
intensity and the best 1/2 antigen ratio (14.2). The abso-
lute intensities for clones 1D10 and 1G11 show the same
pattern as measured in experiment A). However, since the
nonspecific transfer for clone 1D11 is extremely high, this
clone gives the lowest 1/2 antigen ratio (4.7). Neverthe-
less, the specific transfer is still significantly higher than
the nonspecific transfer for all combinations. C) Assay
performance in complex biological fluids: The same sets
of scFvs as used in B), were used to detect antigen
diluted in 20% fetal calf serum. The results (mean values
of 2 experiments) are comparable to the results obtained
in PBS 1 BSA.
Finally, we investigated the performance of three different
randomly chosen scFvs in the sandwich setup (clones
1D10, 1G11 and 3A6). For these scFvs, BIAcore measure-
ments yielded KDs of 558 nM for 1D10, 7.3 nM for 1G11
and 5.5 nM for 3A6. Again, the monoclonal detAb was
replaced first by the different scFvs. All scFvs showed
high specific/nonspecific ratios when used as the detAb
(Fig. 2A). Subsequently, the same three scFvs were tested
as capAbs in combination with clone 3A6 as the detAb
(Fig. 2B). The comparison of the intensities obtained with
the scFv sandwiches, now using different capAbs, re-
sembled the data in Fig. 2A, although the specific/non-
specific ratios differ slightly. Again, similar results were
obtained, when the antigen was diluted in 20% fetal calf
serum (diluted with PBS) instead of PBS 1 0.4% BSA
(Fig. 2C), showing that the antigen can be detected in
complex biological mixtures with the same intensity as
the purified antigen.
The specific to nonspecific ratios of the scFvs perfectly
match the ratios these fragments showed in direct bind-
ing assays with fluorescently labeled b-galactosidase
(data not shown). Comparison to BIAcore data indicates,
however, that although clone 1G11 has a KD similar to
that of clone 3A6, it is not as efficient in binding in our
experiments, as well as in the direct binding assay. This
might be the result of activity losses of the antibodies after
chemical modification and immobilization. In contrast to
the protein array setup, where the antibodies are either
immobilized or biotinylated, in the BIAcore measure-
ments, the antigen is immobilized and the antibodies
are used without chemical modification.
4 Concluding remarks
We could clearly show that scFvs specifically and effi-
ciently function as capAbs and detAbs in combination
with our double chip technology, even with random coup-
ling and immobilization chemistries. In the above experi-
ments the performance of each scFv is a product of the
affinity, stability and percentage of functional molecules
after chemical modification. Consequently, several strat-
egies exist to enhance the overall performance of the
assay: high affinity scFvs can be generated using stand-
ard procedures [13]. The use of a single, stability opti-
mized framework [6] should reduce nonspecific binding
to hydrophobic antibody residues. Finally, fusion proteins
enable directed immobilization resulting in a high percent-
age of functional scFvs [4, 5]. The use of scFvs with the
double chip format ideally combines the specificity of a
sandwich ELISA with the advantages of recombinant anti-
body technologies, namely, high-throughput production
and affinity optimization. In particular, the ability to gener-
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ate binders with different affinities is of great value for
antibody-based arrays. As protein concentrations in the
proteome vary over a broad range the use of recombinant
antibodies with different affinities will considerably extend
the dynamic range of such an assay [2, 8]. In summary,
the double chip assay based on recombinant antibodies
can provide high specificity and a high dynamic range for
the detection of diagnostically relevant markers in a multi-
plexed format.
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Abstract Protein assays provide direct access to biologi-
cally and pharmacologically relevant information. To ob-
tain a maximum of information from the very smallest
amounts of complex biological samples, highly multiplexed
protein assays are needed. However, at present, cross-reac-
tions of binding reagents restrict the use of such assays to
selected cases and severely limit the potential for up-scal-
ing the technology. Here we describe a double-chip format,
which can effectively overcome this specificity problem
for sandwich immunoassays. This format consists of a cap-
ture array and a reference array with fluorescent labeled
detection antibodies coupled to the reference array via
DNA duplexes. This format allows for the local application
of the labeled detection antibodies onto their corresponding
specific spots on the capture array. Here we show that this
double-chip format allows for the use of cross-reactive an-
tibodies without generating false positive signals, and an
assay for the parallel detection of seven different cytokines
was set up. Even without further optimization, the dynamic
range and the limit of detection for interleukin 8 were
found to be comparable to those obtained with other types
of multiplexed sandwich immunoassays.
Keywords Sandwich immunoassay · Protein array · 
Cytokine · Specificity · Cross-reactivity · Multi-analyte
Introduction
Today, it is widely accepted that the parallel analysis of
proteins, their abundance, their modifications, and their
interactions, reveal unique insights into complex biologi-
cal systems, such as immunology and cell signaling [1, 2].
An ideal assay to answer both the questions posed in the
drug development process and those posed in diagnosing
disease should be able to measure many proteins in a
small amount of sample with high specificity and sensi-
tivity. Two formats are typically used: microarrays and
sandwich immunoassays. Microarray formats are em-
ployed for the parallel measurement of proteins [3, 4, 5, 6,
7], and are well suited for the analysis of small sample
volumes, whereas sandwich immunoassays have the po-
tential for the specific detection of proteins [8], even at
low concentrations. Both technologies are well established,
and different groups have shown encouraging proof of
principle experiments, which combine the two formats [9,
10, 11, 12, 13, 14, 15, 16].
One of the most serious drawbacks of multiplexed
sandwich immunoassays is lack of specificity caused by
antibody cross-reactions. In conventional sandwich-ELISAs
the secondary detection antibody (detAb) improves the
specificity of the assay [17]. However, in a multiplexed
microarray format the use of a detAb is actually an addi-
tional source of false positive signals. When a cocktail of
detAb is incubated on the array, each detAb can interact
with any antigen bound somewhere on the surface of the
array [9, 10, 13, 18]. As a result, the chance of false posi-
tives increases geometrically with the number of spots on
a protein array [19]. For this reason it is no coincidence
that all published capture array formats that employ a
sandwich format measure cytokines [9, 10, 11, 12, 13, 14,
15, 16]. Cytokines are the only group of molecules for
which sets of cross-reactivity optimized antibodies are
commercially available from different suppliers [4, 8].
A common strategy to overcome this specificity prob-
lem is prescreening of antibodies for cross-reactivity [9,
10, 13, 14, 15, 16]. Alternatively, one can optimize assay
conditions (e.g., buffers, blocking, use of detergents, and
concentrations of detection molecules). These approaches
can improve the specificity of the assay; however, they
are time-consuming and expensive. Another approach is
the use of more specific capture reagents [20], such as re-
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combinant antibodies [21, 22], affibodies [23], or photo
aptamers [24]. But in this approach, too, the entire process
of prescreening the capture reagents and optimizing assay
conditions has to be carried out for each new capture
reagent.
Here, we employ a double-chip format [25, 26], which
can effectively overcome the specificity problems of mul-
tiplexed sandwich immunoassays. The concept relies on
using a conventional capture array coupled with a refer-
ence array, which is used to locally apply the detAbs. The
detAbs are coupled to the reference array via DNA du-
plexes which serve as molecular force sensors. After the
antigens are bound to the capture array, the reference ar-
ray (with the detAbs arranged such that each detAb is
right opposite the corresponding capAb) is brought into
contact with the capture array. If the specific antigen is
present, the detAb will bind, and the DNA duplex will
open when the two chip surfaces are separated. As the
detAb carries a fluorescence label, the transfer of this la-
bel onto the capture array is finally measured.
By using this format, we demonstrate that cross-reac-
tive capAbs do not lead to false positive results and that
commercially available antibody sandwiches can be used
for a multiplex assay without any previous antibody test-
ing. Finally, we give an example which demonstrates that
both the dynamic range and the limit of detection (LOD)
of this new format are comparable to that obtained by
other sandwich immunoassays. For better comparison of
the data with other types of assays, all experiments were
carried out with cytokine antibodies.
Experimental
Three different series of double-chip experiments have been carried
out using the same assay principle, which is illustrated in Fig. 1.
The preparation of capture and reference arrays follows the same
procedure for the different experiments. Briefly, the capture array
was prepared by spotting solutions of capture antibodies onto a
glass microarray slide. After blocking, the slide was incubated
with a sample containing the antigens. The reference array was
prepared in a two-step procedure. First, the components of the
force sensor complex (including the detAbs) were bound sequen-
tially to 10 mm×10 mm pads of poly(dimethylsiloxane) (PDMS),
covering the whole surface homogenously. Second, disks were
punched out of the different PDMS pads (each containing one of
the detAbs) and assembled as an array such that the detAbs were
right opposite to their corresponding cabAbs during the contact
process. Both arrays were aligned and brought into contact using
the contact device shown in Fig. 2A. Finally, the fluorescence on
the slide was measured using a microarray scanner. In the follow-
ing sections the description of one series of experiments (cross-re-
active model system) is given in detail. For the other series only
the differences are described.
Materials
All monoclonal antibodies used as capAbs as well as the biotiny-
lated monoclonal antibodies used as detAbs were commercially
available (see Table 1 for details). Purified human cytokines were
purchased from the following suppliers: interleukin 2 (IL-2), inter-
leukin 12 (IL-12), and monocyte chemoattractant protein-1 (MCP-1)
from BD Biosciences Pharmingen (Heidelberg, Germany); tumor
necrosis factor α (TNF-α), interferon γ (IFN-γ), and interleukin 8
(IL-8) from Perbio Science (Bonn, Germany); and interleukin 5
(IL-5; human and mouse) from R&D Systems (Wiesbaden, Ger-
many). β-Galactosidase (β-gal) was purchased from Roche Diagnos-
tics (Mannheim, Germany). Lyophilized antibodies and antigens
were reconstituted as recommended by the supplier. Antibody so-
lutions were divided into aliquots and stored as recommended by
the supplier. Bovine serum albumin (BSA) was purchased from Roth
(Karlsruhe, Germany), Perfect-Block from MoBiTec (Göttingen,
Germany), and fetal calf serum (FCS) from Biochrom (Berlin,
Germany). Unless stated otherwise, chemicals for the modification
of the surfaces were purchased from Sigma (Taufkirchen, Ger-
many).
Preparation of antibody spotting solutions
Most capAbs were supplied in phosphate-buffered saline (PBS)
without any additives (see Table 1 for details). These antibody
stock solutions were diluted to a concentration of 200 µg mL–1 in
10% glycerol to obtain the spotting solution. The anti-MCP-1 and
anti-IFN-γ antibodies were purified by using magnetic protein G
Beads (Dynabeads; Dynal Biotech, Hamburg, Germany), as they
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Fig. 1 Principle of a double-chip assay. CapAbs are immobilized
on the capture array by random coupling via their amino groups.
The detAbs are immobilized on the reference array via DNA force
sensors hybridized in unzipping geometry and carrying a Cy3 la-
bel. NeutrAvidin is used to connect the biotinylated detAb to the
DNA force sensor. The assembly of the DNA force sensor Neutra-
Vidin and the biotinylated detAb results in the force sensor com-
plex. The two arrays are brought into contact to allow binding of
the detAb to the antigen. If the antigen is present and the detAb can
bind this antigen, the DNA duplex opens, and the detAb and the
unzipping oligo (including the Cy3 label) are transferred onto the
capture array
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were supplied in Tris or BSA, which can react with an amino-re-
active surface and influence the coupling efficiency. Binding and
washing steps were carried out as recommended by the supplier.
Bound antibodies were eluted with 10 mM citrate buffer, pH 2.5,
and neutralized to pH 7 with NaOH. Finally, the antibody was di-
luted to 200 µg mL–1 in an aqueous solution of 10% glycerol.
Preparation of capture arrays
For the cross-reactive model system CSS aldehyde slides (Genetix,
Hampshire, UK) were incubated with 6 mM HCl·NH2-PEG-COOH
(3,400 g mol–1; Shearwater Polymers, Huntsville, AL) for 1 h un-
der a 24 mm×60 mm cover slip (300 µL) and rinsed with ddH2O.
The Schiff bases were reduced in 1% aqueous NaBH4 for 30 min
and again rinsed with ddH2O. For the activation of the carboxy
groups, the slides were treated with 50 mM each of 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDC) and N-hydroxysuccin-
imide (NHS) for 30 min under a 24 mm×60 mm cover slip in a hu-
mid atmosphere at room temperature (RT). The slides were rinsed
with ddH2O and dried. The freshly prepared antibody spotting so-
lution of the anti-IL-5 capAb was manually spotted (1 µL spot–1)
onto the slides using a standard 10-µL pipette. The 5-spot layout of
Fig. 2C was used. After 1 h incubation in a humid atmosphere at RT
the spots were removed by aspiration, and the slides were washed
in PBS+0.05% Tween 20 (PBST)+1% PerfectBlock for 3 min. Fi-
nally, the slides were blocked in PBS+3% PerfectBlock+1% BSA
at 4°C overnight.
976
Fig. 2A–C Schematic of the contact device and the array layout.
A The contact device consists of an element to position a glass
slide (containing the capture arrays) and a unit, which holds the
reference array and allows for the contact of the arrays. A Teflon
well, which can be filled with buffer solution, containing the glass
slide is adjusted on the base plate. The reference array is put onto
the stamp support. This assembly is mounted onto the stamp sled,
which runs on two guiding rods. The contact device has two stamp
sleds, which can be used in parallel. B Detailed view of the refer-
ence array. The reference array consists of 5 or 16 individual mini
stamps, which are assembled on a plain silicone pad in a pre-de-
fined layout. To maintain an appropriate pressure, the diameter of
one mini stamp is 2 mm for the 16-spot layout and 3.2 mm for the
5-spot layout. These mini stamps are manually positioned on the
stamp support. The silicone pad between the mini stamps and the
stamp support is necessary to compensate for local unevenness.
C Layout of capture and reference array. One glass slide contains
two capture arrays, which are either spotted with 16 or 5 spots. The
reference array uses exactly the same layout to ensure an overlap
of the corresponding spots during the contact process
Table 1 Capture and detection antibodies used for the protein array experimentsa
Sandwich Capture Detection
Supplier Conc. Buffer Purified Supplier Conc. Buffer
(mg ml–1) (mg ml–1)
Interferon γ Calbiochem 5.06 PBS+BSA Protein G BD 0.5 PBS 
Interleukin 2 BD 0.5 PBS No BD 0.5 PBS 
Interleukin 5 (hu) R&D 1.0 PBS No R&D 0.5 TBS+BSA 
Interleukin 5 (mu) R&D 0.5 TBS+BSA 
Interleukin 8 Perbio 1.0 PBS No Perbio 0.21 PBS+BSA 
Interleukin 12 BD 1.0 PBS No BD 0.5 PBS 
TNF-α Perbio 1.0 PBS No Perbio 0.5 PBS+BSA 
MCP-1 BD 0.5 TBS Protein G BD 0.5 PBS 
β-Galactosidase Biotrend 10 PBS No Dunn 0.2 PBS+BSA 
All capture antibodies listed are specific for human cytokines, ex-
cept the anti-IL5 capture antibody, which is specific for human and
mouse IL-5. All detection antibodies are specific for human cy-
tokines, except one IL-5 antibody, which is specific for the murine
antigen. R&D R&D Systems; BD BD Biosciences Pharmingen;
Perbio Perbio Science; Dunn Dunn Labortechnik, Asbach, Ger-
many; Biotrend Biotrend, Köln, Germany
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Immobilization of the force sensor complex on the PDMS pads
PDMS (poly(dimethylsiloxane), Sylgard 184, Dow Corning, Wies-
baden, Germany) was prepared according to the manufacturer’s in-
structions. For casting, a 4” microstructured silicone wafer glued
to a glass plate (NMI Natural and Medical Sciences Institute, Reut-
lingen, Germany), a 1-mm spacer ring with a casting gap, and a
plain glass plate were clamped together to form a mold. This mold
was placed vertically, filled with the degassed elastomer/curing
agent mixture (10:1), and left at RT for 24 h. The resulting PDMS
slab was transferred to a plastic dish and allowed to terminate
polymerization for 24 h at 50°C. Pads of 10 mm×10 mm, a suitable
size for efficient binding and hybridization processes, were cut out
manually. The PDMS surface microstructure was composed of
150-µm squares separated by channels of 50-µm width and 5-µm
depth. These 10 mm×10 mm PDMS pads were cleaned ultrasoni-
cally in 50% abs. ethanol for 3 min, and rinsed with ethanol and
ddH2O. Surface activation was carried out by water plasma treat-
ment. The pads were put into a plasma cleaner (Harrick Scientific
Corporation, Ossining, NY) together with a glass petridish filled
with ice. The chamber was evacuated until constant pressure was
obtained. The plasma was applied at “low” for 60 s. The pads were
immediately transferred to an ethanolic solution of 2% 3-amino-
propyldimethylethoxysilan (ABCR, Karlsruhe, Germany)+10%
ddH2O. After 30 min incubation at RT, the pads were rinsed with
ethanol and ddH2O and dried under N2. An aqueous solution (25 µL)
of 18 mM NHS-PEG-NHS (MW=3,000 g mol–1; Rapp Polymere,
Tübingen, Germany) was incubated for 1 h on the pads under a
cover slip in humid atmosphere at RT, rinsed with ddH2O, and
dried. The amino-labeled receptor oligonucleotide (5′-NH2-AAA
AAA AAA AAT CTG TCT CCG GCT TTA CGG CGT AT-3′;
metabion, Martinsried, Germany, 1.5 µM) and 50 mM EDC were
bound to the PEG surface under a cover slip in humid atmosphere
at RT for 1 h. The pads were washed (2×15 min) with saline-so-
dium citrate buffer (1×SSC) containing 0.5% sodium dodecyl sul-
fate (SDS). The pads were blocked in an aqueous solution of 2%
BSA for 1 h at RT to reduce non-specific binding. Cy3-labeled un-
zip oligonucleotides (5′-Cy3-ATA CGC CGT AAA GCC GGA
GAC AGA TAA GAC GCT ACA TGA AAA AAA AAA AA-bi-
otin-3′) were diluted to 0.5 µM in 5×SSC and hybridized under a
cover slip (15 µL) in humid atmosphere at 4°C overnight. The pads
were washed (3×5 min) in 1×SCC+0.1% SDS, and rinsed with
PBS. NeutrAvidin (Perbio Science) was used as linker between the
3′-biotinylated unzip oligonucleotide and the biotinylated detec-
tion antibody. The pads with the attached DNA were incubated in
4 mL of 2 µg mL–1 NeutrAvidin in PBS containing 0.4% BSA
(PBS-BSA) for 1 h at RT and washed with PBST and PBS. The bi-
otinylated detAbs against human IL-5 (huIL-5) or murine IL-5
(muIL-5) were diluted to a concentration of 2 µg mL–1 in PBS-
BSA. Each PDMS was incubated with 150 µL of one of the detAb
solutions, rinsed with PBST, PBS, and dried.
Sample incubation and reference experiment
The capture array was either incubated with a solution of 10 nM
huIL-5, 10 nM muIL-5, or a mixture of both in PBS-BSA (10 nM
of each antigen). Each slide was gently shaken with 4 mL of one of
the sample solutions for 1 h at RT and washed with PBST and PBS
immediately before the contact process.
For the reference experiment using a conventional sandwich
setup the capture arrays were prepared, and the incubation of the
antigens was carried out exactly as described above. A cocktail of
detection antibodies (2 µg mL–1 of each biotinylated anti-IL-5 anti-
body) in PBS-BSA was applied to the capture arrays. This step
was followed by incubation with Cy3-streptavidin.
Assembly of the reference arrays and contact process
Since conventional spotting was found to be poorly reliable on the
PDMS surface, an alternative method was employed. After the force
sensor complexes had been immobilized on pads of PDMS homo-
genously, as described above, disks were cut out of these 10 mm×
10 mm pads and reassembled in the desired order (see Figs. 2B and C).
For this process, the shaft of a disposable surgical biopsy punch
(Stiefel Laboratorium GmbH, Offenbach, Germany) was hollowed
out with a drill, and its back end was attached to a conventional dis-
posable 5-mL syringe. With mild pressure, disks (mini stamps) of
3.2-mm diameter were punched out of one freshly coated 10 mm×
10 mm PDMS pad. Deposition onto plain silicone pads was ef-
fected by an air pressure pulse (i.e., by pressing the syringe).
Two pre-assembled reference arrays (each consisting of 5 mini
stamps) were then positioned on the two stamp supports of the
contact device (see Fig. 2A). For each of the two reference arrays,
two mini stamps containing the anti-muIL-5 and two mini stamps
containing the anti-huIL-5 antibody were used. The fifth mini
stamp in the middle contained either anti-muIL-5 or anti-huIL-5.
The slide containing the two capture arrays was positioned in the
Teflon well under pre-cooled PBS. The stamp sled was cranked
down slowly onto the slide until its weight resulted in a pressure of
1.6 N cm–2 in the contact areas. After 10 min the arrays were sepa-
rated carefully, and the slide was rinsed with ddH2O and dried.
Multiplexing experiment (7 cytokines)
For the multiplexing experiment a different protocol was used to
prepare an amino-reactive surface for the spotting of the capAbs.
QMT aldehyde slides (Quantifoil Microtools GmbH, Jena, Ger-
many) were oxidized in a 0.5% solution of KMnO4 in 150 mM
Na2HPO4, pH 9.1 at 70°C for 20 min and dried. The generated car-
boxy groups were activated with EDC/NHS and used for spotting
immediately. In a 16-spot layout the spotting solutions of 8 differ-
ent capAbs were applied (0.3 µL spot–1) as shown in Fig. 4A. The
reference arrays were prepared as described using the 16-spot lay-
out. The diameter of individual mini disks was reduced to 2 mm to
maintain the pressure in the contact area in the appropriate range.
FCS was used as a matrix for three different “sample solu-
tions”. A single, partial, or complete mixture of all 7 antigens was
prepared by diluting the stock solutions in 20% heat-inactivated
FCS in PBS (20% FCS) to a final concentration of 10 ng mL–1. The
complete mixture contained all 7 cytokines, namely, IFN-γ, IL-2,
IL-5, IL-8, IL-12, TNF-α, and MCP-1. (The β-gal antibody sand-
wich served as a negative control.) The partial mixture contained
IL-8, TNF-α, and MCP-1, the “single mixture” only IL-8.
Dilution series of interleukin 8
Dynamic range and limit of detection were determined for one of
the cytokine sandwiches (IL-8) in the 5-spot layout. On the capture
array (based on QMT slides), 4 identical spots (1 µL) of the capAb
were applied in the corner positions, and the center was left empty.
The reference arrays were prepared with 5 mini stamps, as de-
scribed above using only anti-IL-8 detAbs.
Seven identical capture arrays were incubated in 4 mL IL-8 so-
lution of 0, 0.1, 1, 10, 100, 1,000, or 10,000 pg mL–1 (diluted in
PBS-BSA) at RT for 1 h. The slides were stored at 4°C and washed
with PBST and PBS one by one immediately before the contact
process.
A reference experiment was carried out as described for the
cross-reactive model system using the biotinylated anti-IL-8 anti-
body and Cy3-streptavidin.
Fluorescence measurement and data evaluation
The capture array slide was transferred to a GenePix 4000B mi-
croarray reader (Axon Instruments, Foster City, CA, USA) and
measured in the Cy3 channel. Mean fluorescence transfer was de-
termined with the NIH Image (NIH Bethseda, MD, USA) analysis
software. Mean background fluorescence, measured in the grid be-
tween the printed microstructure squares, was subtracted from the
mean value of the squares to obtain the mean fluorescence transfer.
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Results
Cross-reactive model system
The following system was chosen to investigate and com-
pare the effects of a cross-reactive capAb in a conven-
tional protein array experiment and in a double-chip as-
say. An antibody binding both murine (mu) and human
(hu) IL-5 was used as capAb. While this antibody was
100% cross-reactive for both antigens, the detAbs were
specific for either muIL-5 or huIL-5. The specificity was
tested in simple binding experiments (data not shown).
Spots for the detection of either huIL-5 or muIL-5 were
defined by their x,y position on the capture array. Two
spots were defined as anti-mu and two spots were defined
to be anti-hu. The capture array was incubated with a so-
lution of muIL-5, huIL-5, or a mixture of both in a con-
centration tested to be below saturation of the IL-5 capAb.
Bound antigens were detected using a cocktail of both
detAbs. The results are shown in Fig. 3A. If only muIL-5
was incubated on the array, it could be detected on the
anti-mu and on the anti-hu spots with the same intensity.
This was also true if only huIL-5 was used. For the mix-
ture of the antigens, again the same signal was measured
on the anti-mu and on the anti-hu spots. Here, the signal
was the sum of the signals generated when only one anti-
gen was present. With this setup, it was not possible to
discriminate between the two antigens resulting in false
positive signals. In addition, the signal of one particular spot
was not correlated to the concentration of the antigen to
be measured on this spot, but to the total amount of all
antigens bound to this spot, making a precise quantifica-
tion of the different antigens impossible.
By using the double-chip format to detect the antigens,
each capture spot was brought into contact with only one
sort of detAb. The anti-mu capture spot was opposite to
an anti-mu detAb, and similarly, the anti-hu spot was
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Fig. 3 Cross-reactive model system. Spots for the detection of ei-
ther huIL-5 or muIL-5 were defined by their x,y position on the
capture array. The capAb at the different positions was cross-reac-
tive between the human and the murine antigen. A If this capture
array is incubated with huIL-5 (left), muIL-5 (middle), or a mixture
of both antigens (right) and a cocktail of detAbs is used as in a tra-
ditional format, a signal is measured on the anti-hu and anti-mu
spots. The scan shows that discrimination between the two anti-
gens is not possible, as each detAb will interact with its antigen,
regardless of where it is bound. The resulting signal is not depen-
dent on the species and amount of antigen in the sample. Mean flu-
orescence intensities of 4 spots for each antigen are summarized in
the diagram. B If the double-chip format is used, where the detAbs
are immobilized at defined positions on the reference array, label-
ing of the antigen will only take place at the allocated spot on the
capture array. The measured signals where detAb and capAb do
not form a specific sandwich (intensity of 352 or 320) represent
non-specific transfer which is also measured when a detAb is
brought into contact with the blocked capture array containing no
antigen (data not shown). In addition, precise quantification of
antigen is now possible. Both antigens are measured independently
when the second chip is used for specific encoding. The diagram
shows the mean fluorescence intensities of four spots
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probed only with an anti-hu detAb. The results of this lo-
cal application of detAbs are shown in Fig. 3B. Although
it was possible for muIL-5 to bind to the anti-mu and the
anti-hu spots, it was only detected if it was bound to the
anti-mu spot. Similarly, the human antigen was only de-
tected on the anti-hu spot. If both antigens were present,
both types of capture spots were labeled; however, in this
case, the signal on the anti-mu spot, for example, was not
influenced by the presence of the human antigen, and vice
versa.
Multiplexing experiment
Six antibody pairs, which were optimized for sandwich
ELISAs (IL-2, IL-5, IL-8, IL-12, TNF-α, and MCP-1)
and one non-optimized pair (IFN-γ; capAb and detAb
from different suppliers, see Table 1) were arbitrarily cho-
sen from different suppliers, without considering possible
cross-reactivities. All seven sandwiches were functional
in our assay format and could directly be used for a mul-
tiplexing assay for the detection of 7 different cytokines in
parallel. To investigate interferences of the cytokines with
other proteins, the cytokines were used in a rather high
concentration (10 ng mL–1) and in a complex biological
sample (20% FCS). The capAbs were spotted in dupli-
cate, and an antibody directed against β-gal was used as a
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Fig. 4A–C Detection of 7 different cytokines with a 4×4 array.
A Layout of one capture array. The capAbs against 7 different cy-
tokines (IFN-γ, IL-2, IL-5, IL-8, IL-12, TNF-α, and MCP-1) were
spotted in duplicate. The anti-β-gal antibody (bottom right) was
used as a negative control. After the incubation of this capture ar-
ray with a mixture of different cytokines, it was brought into con-
tact with the reference array. The reference array contained detAbs
for the respective antigens, which were assembled in a way such
that each capture and detection antibody formed a specific anti-
body sandwich. B Fluorescence scan of one capture array. On this
array a complete mixture of all 7 cytokines was incubated. All po-
sitions containing an anti-cytokine antibody are brightly illumi-
nated (intensities between 16,052 for IL-8 and 4,106 for IFN-γ).
Only a faint signal (max. intensity 860) is measured on the two
negative control spots. C Diagram showing the fluorescence inten-
sities determined for 3 different mixtures of cytokines. The mean
values and standard deviations for each mixture were calculated
from 12 spots (3 independent experiments with 2 identical capture
arrays containing duplicates). The black bars show the intensities
determined for a complete mixture of all 7 cytokines, the dark gray
bars show a partial mixture with only IL-8, TNF-α, and MCP-1
and the light gray bars show the intensities when only IL-8 was in-
cubated on the array
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negative control. For each spot on the capture array, there
was a corresponding detAb spot on the reference array.
For a detailed layout of the assay see Fig. 4A. The capture
arrays were incubated with 3 different mixtures of cy-
tokines, brought into contact with the reference arrays,
separated, and fluorescence intensities were recorded. The
results are summarized in Figs. 4B and C. Figure 4B shows
a fluorescence scan of a capture array where the complete
mixture of all 7 cytokines was used. All spots show a sig-
nal significantly higher than the negative control (bottom
right). In the diagram of Fig. 4C, the average fluorescence
intensities of the three different mixtures are quantified.
The black bars represent the complete mixture and again
show that a signal significantly above the negative control
is measured for all 7 cytokines. If only one (light gray) or
three (dark gray) cytokines were present, only the corre-
sponding capture spot(s) show(s) a high signal, while the
other signals are in the same range as the negative control.
For IL-8 in the different mixtures, the differences in fluo-
rescence intensity are well within the respective error
bars. The same is the case for MCP-1 and TNF-α. The re-
sults demonstrate that the presence of other proteins in the
mixture does not interfere with the measurement of one of
the cytokines and that all 7 cytokines can be detected specif-
ically.
Dilution series of IL-8
The results from the previous experiments demonstrate
that the specific detection of antigens is possible with this
new assay format. However, in most protein assays a reli-
able measurement of different concentrations of an anti-
gen is also important. Therefore, for one of the cytokine
sandwiches (IL-8), the dynamic range and LOD were de-
termined and compared to a conventional protein array
setup. Figure 5 shows the measured data points for the
double-chip and the conventional setup, where a biotiny-
lated detAb and Cy3-streptavidin was incubated on the ar-
ray. The LOD determined from the experimental data is
below 1 pg mL–1 (125 fM) for the double-chip assay and
above 10 pg mL–1 for the conventional setup.
The double-chip standard curve can be fitted by using
logistic regression (5PL fit function), which is a standard
curve-fitting algorithm for ELISA data [27, 28]. A dy-
namic range over 4 orders of magnitude (from 1 pg mL–1
to 10,000 pg mL–1) could be determined. Unfortunately, the
standard curve for the conventional setup does not reach
saturation and cannot be fitted with the above equation.
Nevertheless, the measured data points clearly show that
the performance of the double-chip assay is comparable to
standard ELISA formats or conventional protein arrays,
especially for low analyte concentrations.
Discussion
Both the cross-reactive model system and the multiplex-
ing experiment show that a multiplex sandwich im-
munoassay in the double-chip format can be easily set up
without time-consuming prescreening of antibodies for
cross-reactions and optimization of assay conditions. The
problem of cross-reactive antibodies can be overcome by
the local application of detAbs, which is achieved by the
attachment of the detAbs in a complementary pattern on
the reference array. In this format, the second chip surface
provides a second dimension of specific encoding.
The detAbs are bound to the reference array via mo-
lecular force sensors consisting of DNA duplexes in un-
zipping geometry. Since the unzipping force is indepen-
dent of the length of the duplex, the latter may be chosen
such that the spontaneous off-rate of the duplex by far ex-
ceeds the time required for the assay [29]. In our assay,
the unzipping force of this duplex serves as a reference for
the discrimination between specific and non-specific
binding [26]. This force threshold establishes stringent as-
say conditions, which are difficult to obtain using standard
protocols, as only little modifications in wash stringencies
can be applied for protein interactions [30].
Both experiments clearly demonstrate that commer-
cially available antibody sandwiches can be easily inte-
grated in a double-chip assay. If a desired antibody sand-
wich cannot be obtained from commercial sources and a
new sandwich pair is needed, testing for an appropriate
pair is necessary. However, it is only necessary to screen
for a pair which performs well in a standard sandwich
980
Fig. 5 Standard curves for the IL-8 sandwich. The table summa-
rizes the mean values of 16 spots for each concentration (2 inde-
pendent experiments with 2 identical capture arrays containing 4
capture antibody spots). The limit of detection (LOD) was deter-
mined from the experimental data using the signal at zero analyte
concentration incremented by two-fold standard deviation of this
signal. For the double-chip experiment, the LOD is below 1 pg mL–1
and for the conventional setup (conv.), the LOD is little above 
10 pg mL–1. The mean values and the standard deviations of the
measured data (♦ double chip and E conv.) were plotted and the
double-chip data were fitted using 5PL logistic regression (–)
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ELISA format, meaning that both antibodies bind differ-
ent epitopes with appropriate affinity constants for the an-
alyte concentration of interest. Still, no screening for po-
tential cross-reactions is necessary, which is otherwise
most time-consuming and costly.
Not only could we demonstrate that our new assay for-
mat is highly specific, we could also provide an example
which demonstrates that the LOD of the double-chip as-
say is at least comparable to a conventional protein array
setup using the same capture array. In addition, the LOD
and the dynamic range are comparable to those obtained
in other cytokine assays [9, 11, 12, 13, 14, 15, 16, 31].
While many other assays use procedures for signal ampli-
fication, such as chemiluminescence [9, 11], RCA [15], or
TSA [31], or complicated instrumentation [16], here the
LOD is a direct consequence of the double-chip format it-
self. First, the detAbs are applied in a very high local con-
centration. Therefore, hindered diffusion and depletion of
antibodies near the chip surface do not limit the sensitiv-
ity. Second, as the contact is made immediately after in-
cubating the sample, there is no loss of bound antigen dur-
ing further incubation steps (e.g., of the secondary anti-
body). Third, the concentration of the detAb, applied to
the surface, is independent of the number of analytes to be
detected. In a conventional assay, the total concentration
of detAbs is increased with the number of analytes [19]
resulting in an increase of the background signal. Here,
the local application provides a constant amount of detAb,
which can interact with the capture surface. As mentioned
earlier, neither the spotting of the antibodies onto the ar-
rays nor the contact process was done in an automated
way. We believe that improvements in this field will
greatly reduce the variability of the assay in the future and
that even better values for the LOD or the limit of quan-
tification (LOQ) can be obtained.
Conclusions
In summary, specific and sensitive detection of different
analytes is possible in a multiplexing format with this new
double-chip assay. As a result of the local application of
detAbs, cross-talk between the different spots is effec-
tively eliminated and the complexity of a multi-analyte
protein assay is reduced to the simplicity of single analyte
ELISAs, where extensive screening for cross-reactivities
is usually not necessary. Here, the performance of the as-
say is independent of the degree of multiplexing. One of
the most promising applications of this new format will be
protein arrays for the detection of structurally related pro-
teins or disease markers, where multiple sets of optimized
antibody sandwiches are not commercially available.
Therefore, this new format will be extremely useful in all
areas in which the analysis of patterns of markers creates
additional information [32, 33, 34] for the drug develop-
ment process and for biomedical diagnostics (e.g., cell
signaling, early prediction of cancer, and differential can-
cer diagnostics).
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A parallel assay for the quantification of single-molecule binding
forces was developed based on differential unbinding force mea-
surements where ligand–receptor interactions are compared with
the unzipping forces of DNA hybrids. Using the DNA zippers as
molecular force sensors, the efficient discrimination between spe-
cific and nonspecific interactions was demonstrated for small
molecules binding to specific receptors, as well as for protein–
protein interactions on protein arrays. Finally, an antibody sand-
wich assay with different capture antibodies on one chip surface
and with the detection antibodies linked to a congruent surface via
the DNA zippers was used to capture and quantify a recombinant
hepatitis C antigen from solution. In this case, the DNA zippers
enable not only discrimination between specific and nonspecific
binding, but also allow for the local application of detection
antibodies, thereby eliminating false-positive results caused by
cross-reactive antibodies and nonspecific binding.
Previous studies have shown that unbinding forces betweenmolecular interaction partners provide novel and extremely
valuable information on the nature of this interaction: specific
versus nonspecific interactions and differences in binding modes
can be resolved, and even energetically equivalent interactions
can be discriminated by forced unbinding (1–5). Moreover,
because the binding partners are forced apart, the kinetics of the
experiment can be chosen according to assay requirements, and
even strong binders, where the spontaneous off-reaction takes
weeks or more, may be separated in fractions of seconds (6, 7).
Nevertheless, the widespread use of force-based discrimination
in bioanalytical applications has been hindered by the limited
throughput of these techniques and the high experimental
burden imposed by complicated and expensive instrumentation
like atomic force microscopes (AFM), optical traps, or the like
(8–12). Highly parallel micrometer and submicrometer canti-
lever arrays, which are currently being developed, might increase
the throughput of AFM-based force spectroscopy in the future
(13–15). In this study, however, we used a format that not only
measures unbinding forces on the single-molecule level in a
parallel format, but that is also compatible with standard chip
based assays. Here we briefly describe the assay. A more detailed
description of the assay is given elsewhere (16).
In standard single-molecule force spectroscopy assays, one of
the binding partners is linked to an actuator and the other to a
force sensor. The molecules are brought into contact to allow for
binding, and on separation the force is recorded as a function of
the separation of actuator and force sensor until the bond
ruptures (17). In all technical realizations of this principle, the
force resolution is limited by thermal fluctuations, which couple
into the system via the force sensors (18, 19). We have shown in
the past that miniaturization of the force sensors increases their
sensitivity (20). Consequently, we employ a single molecule as
force sensor in the new format, which is described here. To
further improve the force resolution, we implemented a differ-
ential measurement format, where the unbinding force of the
measured molecular bond is directly compared with the unbind-
ing force of a known reference bond. Both improvements are
merged in our Congruent Force Intermolecular Test (C-FIT)
format: a molecular chain consisting of the sample bond, a
known reference bond, which serves as force sensor, and a
reporter molecule, e.g., a f luorescence label, is formed. The ends
of this chain are covalently grafted to two surfaces via polymer
spacers. During separation of the two surfaces, the force along
the chain increases and the bonds are increasingly loaded with
the same force until the weaker of the two bonds ruptures. As a
result, after separation of the surfaces the reporter molecule is
found at the side of the ruptured chain, containing the stronger
bond. Thermal fluctuations broaden this yesno discrimination
by force differences on the order of kBTl, where l is the
characteristic width of the binding potential: the separation
between potential minimum and barrier (21).
Obviously, such experiments are primed to be carried out in
parallel by using a chip format, with identical molecular chains
within each spot and different types of molecules in different
spots of the chip. Counting the reporters on either surface, e.g.,
by counting fluorophores or alternatively measuring fluores-
cence intensities, then provides a measure for the relative
unbinding forces. Analogous to previous studies, bond rupture
probabilities may then be calculated taking into account molec-
ular details like spacer lengths and separation rates to correlate
the measured unbinding ratios to thermodynamically defined
properties such as equilibrium constants and off-rates (7, 21–23).
Methods
Immobilization of Proteins on Slides (Bottom Surface). Proteins and
antibodies were purchased from Roche Diagnostics, Biotrend
(Cologne, Germany), Calbiochem, Pierce, Biomol (Hamburg,
Germany), and pab productions (Hebertshausen, Germany).
Hepatitis C virus (HCV) antibodies and the corresponding
antigen were provided by Johnson & Johnson. CSS Aldehyde
slides (Genetix, Hampshire, U.K.) were incubated with 6 mM
HClNH2-PEG-COOH (3,400 gmol; Shearwater Polymers,
Huntsville, AL; PEG, polyethylene glycol). The resulting Schiff
bases were then reduced by using 1% aqueous NaBH4 (VWR
Scientific). Alternatively, epoxy slides (Quantifoil Micro Tools,
Jena, Germany) were treated with pure diamino PEG (2,000
gmol; Rapp Polymere, Tübingen, Germany) by melting the
diamino PEG and incubating it onto the surface at 75°C for 24 h.
The remaining amino groups were then converted into carboxy
groups by incubating the slides in a solution of 5 M glutaric
anhydride in dry DMF overnight (24). For both types of slides
the carboxy groups of the PEG were then activated with a
solution containing 50 mM 1-ethyl-3-(3-dimethylaminopropyl)-
carbodiimide hydrochloride (EDC; Sigma) and 50 mM N-
hydroxysuccinimide (NHS; Sigma). The proteins were spotted
immediately onto the activated surface. Antibodies were spotted
in a concentration of 200 gml. The antigens were spotted in
concentrations between 20 and 100 gml. After 1 h of incu-
bation, the slides were washed with PBS (Roche Diagnostics)
Abbreviations: HCV, hepatitis C virus; PDMS, poly(dimethylsiloxane); PEG, polyethylene
glycol.
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containing 0.05% Tween 20 (VWR Scientific). Free reactive
groups were blocked in PBS containing 2% BSA (Roth,
Karlsruhe, Germany) overnight.
For the sandwich assay the HCV antigen (Johnson & Johnson)
was diluted to a concentration of 500 ngml in PBS containing
0.4% BSA. This solution was incubated on the slide for 1 h before
washing in PBS-Tween 20 (PBST) and PBS.
Immobilization of the DNA Force Sensor Complex on Poly(dimethyl-
siloxane) (PDMS) (Top Surface). Microstructured PDMS (Sylgard
184, Dow Corning) surfaces were fabricated by using structured
5 silicon wafers as templates, according to standard procedures
(25). The PDMS structures consisted of 100  100-m pads
separated by 25-m-wide and 1-m-deep grooves to allow for
drainage of liquid during the contact process. After cross-
linking, the PDMS was cut into 1  1-cm pieces (thickness 1 mm)
and activated by water plasma treatment. The PDMS was then
derivatized with 3-aminopropyldimethylethoxysilane (ABCR,
Karlsruhe, Germany) to generate free amino groups and coated
with aqueous 18 mM NHS-PEG-COOH (5,000 gmol; Shear-
water Polymers) or 18 mM NHS-PEG-NHS (3,000 gmol; Rapp
Polymere). To bind the amino-labeled receptor oligonucleotide
(5-NH2-AAA AAA AAA ATC TCC GGC TTT ACG GCG
TAT-3; MWG Biotech, Ebersberg, Germany) to the carboxy-
modified surface, 50 mM EDC was added to the solution of the
receptor oligonucleotide (25 M) before it was spotted onto the
PEG surface. Subsequently, the samples were rinsed with 1
SSC (Sigma) containing 0.5% SDS (Sigma) and incubated with
an aqueous solution of 2% BSA, to reduce nonspecific binding.
Cy3-labeled unzip oligonucleotides (5-Cy3-ATA CGC CGT
AAA GCC GGA GAC AGA TAA GAC GCT ACA TGA AAA
AAA AAA AA-(haptene)-3; metabion, Martinsried, Ger-
many) were diluted to 2 M in 5 SSC and then hybridized for
60 min under a cover slide at room temperature. For all
experiments, where antibodies were connected to the DNA force
sensor, streptavidin was used to connect biotinylated antibodies
to a biotin label at the 3 end of the unzip oligonucleotide. After
incubating the PDMS surface with the attached DNA in 1 gml
streptavidin in PBS buffer containing 0.4% BSA for 1 h, the surface
was rinsed with PBST and PBS. Then, 4 gml biotinylated
antibodies were incubated for 1 h, followed by washing with
PBST and PBS.
Contact Process and Fluorescence Readout. For the contact process
a simple mechanical device was used to ensure that the two
surfaces were aligned correctly and were parallel to each other.
A force of 1.4 N was exerted to the 1-cm2 PDMS surface for
10 min before the two surfaces were separated carefully, rinsed
with double-distilled water, and dried with N2. The bottom
surface was then transferred to a GenePix 4000B microarray
fluorescence scanner (Axon Instruments, Foster City, CA).
Mean fluorescence transfer as well as background fluorescence
intensities were determined by using NIH IMAGE software (Na-
tional Institutes of Health, Bethesda; available at http:
rsb.info.nih.govnih-image).
Results and Discussion
Fig. 1 schematically highlights the implementation of this format,
which is similar to a microcontact printing setup (26–28), with
the particular goal of discriminating specific from nonspecific
interaction on a protein biochip. A short DNA duplex in unzip
geometry served as a force sensor. One DNA strand was
connected to a microstructured silicone elastomer surface (top
surface) via a PEG spacer. The other DNA strand, which also
carried the Cy3 fluorescence label, was attached to the ligand of
the test complex, here a digoxigenin molecule. This particular
type of force sensor was chosen for several reasons. It is known
to provide a sequence-dependent force standard; 14 pN in this
case (3, 29, 30). Because unzipping occurs in thermodynamic
equilibrium, as long as the pulling velocity is kept below 200
nms, the unzipping force is independent of the separation rate
and also independent of the duplex length (3, 30). The length
may therefore be chosen according to the assay requirements
such that the spontaneous off-rate is sufficiently slow to provide
thermal stability (31). Note that the force threshold can easily be
adapted by changing the base composition or the geometry of the
DNA force sensor. To get to defined threshold forces above 65
pN, which corresponds to the shearing of long DNA duplexes
(32, 33), nucleic acid derivatives like PNA or molecules such as
streptavidin and biotin can be used as force sensors.
In Fig. 1B, the digoxigenin-baring silicone surface was allowed
to adhere to a piece of a protein biochip with one spot of
covalently attached polyclonal anti-digoxigenin IgG, one spot of
streptavidin, and an untreated area. To displace the liquid
between the two surfaces and obtain a homogeneous contact, a
pressure of 14 kPa was exerted on the silicone surface. If one
assumes a grafting density of 1012 PEG molecules per square
centimeter, 14 kPa corresponds to a force of 1.4 pN per PEG, still
well within the range of entropic forces (34). It should be noted
that the adhesion of the polymer-coated silicone, and thus the
interaction of the molecules at the interface between the two
surfaces, is governed by local forces rather than the external
force. Therefore, local surface roughness and distortions are
compensated to a large degree by the softness of the polymer-
coated silicone. Although the mobility of the binding partners is
reduced by their polymeric attachment to the surfaces, the
Fig. 1. Experimental realization of the differential force test. (A) DNA
duplexes are connected to a microstructured silicone elastomer surface (top
surface) via PEG spacers. The spacers are covalently bound to the silicone and
in the next step are covalently attached to the 5 end of one of the DNA
strands. The complementary DNA strand contains a fluorescence label at the
5 end and a 3-digoxigenin label attached at the end of a poly(A) spacer
sequence. (B) The PDMS surface is brought into contact with a second chip
surface (bottom surface) containing spots of immobilized anti-digoxigenin
antibodies, streptavidin proteins, or just the PEG passivation layer. (C) On
separation of the two chip surfaces, the PEG spacers are extended and a force
is built up in the molecular chains between the two surfaces. (D) As the two
surfaces are further separated, the weakest molecular bond in each chain
breaks, and the fluorescence label remains connected to the stronger bond.
(E) After separation of the two surfaces, a fluorescence image of the bottom
surface reveals strong fluorescence intensity on the spot carrying the anti-
digoxigenin antibodies (Left), no fluorescence on the streptavidin spot (Cen-
ter), and very little fluorescence on the PEG-coated control area (Right). The
dark grids in the fluorescence images represent grooves of the microstruc-
tured PDMS. Note that in Left image the spots from the top and the bottom
surface do not overlap entirely. Areas where the two spots do not overlap can
be used as additional controls.
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reaction times are still faster than in corresponding conventional
assays, because the local concentration of the binding partners
in the gap between the two surfaces is extremely high. After 10
min in contact, the surfaces were separated (Fig. 1C), thereby
stretching the polymeric anchors and gradually building up the
force acting on the bonds and eventually rupturing the molecular
interactions under investigation (Fig. 1D). The macroscopic
force needed to pull the two surfaces apart is neither recorded
nor analyzed. The interaction force is measured intrinsically and
independently for each molecular bond. The asymmetry of the
binding forces results in an asymmetry of the transfer of the
reporter molecules, which is quantified, for example, by fluo-
rescence imaging. Fig. 1E shows the anti-digoxigenin spot
brightly illuminated by the Cy3 fluorescence. No fluorescence
can be detected on the streptavidin spot, and only a faint pattern
is recognizable on the untreated area. The dark grid stems from
a trench pattern at the surface of the silicone, which allows for
drainage of the liquid during contact formation and separation
of the surfaces.
This sequence not only demonstrates the basic principle of the
assay, but it furthermore helps to identify suitable reference
force levels for the discrimination of specific and nonspecific
interactions. This will play an important role in the following
experiments. Obviously, the 14 pN, which we chose as reference
force, are lower than this particular specific ligand–antibody
binding force, resulting in efficient transfer of reporter mole-
cules. At the same time this threshold is also high enough to
overcome nonspecific interaction with the protein-coated sur-
face of the streptavidin spot. The slight amount of transfer onto
the untreated surface indicates a weak but measurable interac-
tion, which, if needed, may be overcome by raising the threshold
force. It might, however, also be caused by a few, but strongly
interacting, molecules adhering to localized adhesion sites. In
this case, improved blocking strategies might overcome this
problem, as can be seen on the streptavidin spot.
Fig. 2 shows that the force threshold defined by the unzipping
duplex is appropriate for a number of systems. Several small,
haptene-like ligands were tested for their interaction with dif-
ferent proteins. The quantitative analysis (Fig. 2B) demonstrates
the high discrimination ratio and the low level of nonspecific
transfer. The fact that more fluorescence is observed on the
streptavidin spot than on the anti-biotin spot most likely reflects
a difference in the number of accessible binding sites after
immobilization, because streptavidin contains more binding sites
for biotin than the anti-biotin antibody. Furthermore, the anti-
biotin antibodies were polyclonal antibodies, and the batch used
may have also contained antibodies, which are not specific for
biotin. The anti-digoxigenin antibodies are also polyclonal an-
tibodies. However, a quantitative comparison of biotin transfer
levels to those of digoxigenin is not possible, because thermo-
dynamic data are not available. Nevertheless, according to
supplier specification the affinity-purified anti-biotin antibodies
showed an activity level well below 100%, whereas the affinity-
purified anti-digoxigenin antibodies showed 100% activity,
which is consistent with the higher transfer onto the anti-
digoxigenin spot.
Having demonstrated the functionality of this assay, protein–
protein interactions were then investigated. A set of four dif-
ferent antibodies was coupled to the DNA force sensors (Fig.
3A). The setup was assembled sequentially by covalently attach-
ing receptor oligonucleotides to the PEG-coated silicone sur-
face, then hybridizing the biotinylated unzip oligos and treating
the surface with streptavidin. Finally, the biotinylated antibodies
were attached to this pretreated surface (see Methods). The four
protein antigens were immobilized on the adjacent chip surface
by covalent attachment. Each antibody was tested against all
antigens. The fluorescent readings of the corresponding spots
are plotted in Fig. 3B. At the chosen reference force of 14 pN,
we generally found 13% of nonspecific interaction with other
proteins. The anti-rabbit antibody, which was the only polyclonal
antibody in this set of experiments, showed rather high nonspe-
cific interactions with GFP and human serum albumin (HSA).
Because polyclonal antibodies are obtained from immunized
animals (in this case goat), they also may contain fractions of
antibodies that are not specific for the target protein or fractions
that are specific for other proteins, like GFP or HSA. This may
then lead to nonspecific signals. Note, however, that in this case
the level of specific transfer onto rabbit antibodies was also
significantly higher than the specific signals of the other anti-
Fig. 2. Detection of specific haptene–protein interactions. (A) The transfer of two oligonucleotides coupled with different haptenes (biotin or digoxigenin)
and one oligonucleotide without haptene label (top surface) onto spots containing the respective binding partners, as well as proteins not specific for the
haptene (bottom surface), is determined. (B) Diagram showing the fluorescence intensities measured on (left to right) anti-digoxigenin, streptavidin, anti-biotin,
and anti-antitrypsin spots on the bottom surface. Red bars correspond to biotin on the top surface, green bars correspond to digoxigenin, and yellow bars
correspond to DNA without haptene. The ratio of specific to nonspecific transfer is always better than 50:1 for the two haptenes and their respective negative
controls (transfer onto a specific binding partner versus transfer of the same haptene onto another ‘‘nonspecific’’ molecule).
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bodies, resulting in 6% background signal for the anti-rabbit
antibody.
In the next step, we investigated the applicability of this
differential force test to sandwich immunoassays (Fig. 4). Two
different capture antibodies against a recombinant HCV anti-
gen, as well as a mixture thereof, were covalently anchored at
different spots on one chip surface (bottom surface). The HCV
antigen was allowed to bind from solution, and the amount of
bound antigen was then quantified by measuring the transfer of
two different anti-HCV detection antibodies, as well as the
mixture of both, from the second chip surface (top surface;
assembly as in Fig. 3). The results are shown in Fig. 4B. The
highest f luorescence intensities are observed on the spots with
the high-affinity capture antibody (C2). The lowest f luorescence
intensities are observed on spots with the capture antibody with
lower affinity (C1), whereas the spots with mixed capture
antibodies lie between the two. Furthermore, the fluorescence
intensities are always higher for the high-affinity detection
antibodies (D1) than for the low-affinity detection antibodies
(D2). However, here the maximum is observed for the mixed
system. This scenario is plausible, if one considers that the two
detection antibodies bind to two different epitopes of the
antigen, and therefore up to two antibodies can be transferred
to one bound antigen. A quantitative analysis of sample con-
Fig. 3. Detection of specific antibody–antigen interactions. (A) The antibodies were coupled to the DNA force sensor (top surface) via biotin and streptavidin.
Their corresponding antigens were immobilized on the bottom surface. Each antibody was tested against all antigens in the respective series (PDMS 1,
monoclonal anti--galactosidase; PDMS 2, monoclonal anti-GFP; PDMS 3, monoclonal anti-HSA; PDMS 4, polyclonal anti-rabbit). (B) Fluorescence intensities
measured on the bottom surface on spots containing (left to right) immobilized -galactosidase, GFP, HSA, and rabbit antibodies. Red bars correspond to
anti--galactosidase antibodies on the top surface, green bars correspond to anti-GFP, blue bars correspond to anti-HSA, and yellow bars correspond to
anti-rabbit antibodies. The ratio of specific to nonspecific transfer is always better than 7:1 for the four antibodies and their respective negative controls (transfer
onto a specific binding partner versus transfer of the same antibody onto another ‘‘nonspecific’’ molecule).
Fig. 4. An antibody sandwich assay for the detection of a hepatitis C virus antigen, based on the differential force test. (A) The detection antibodies are
connected to the top surface via a DNA force sensor and a PEG spacer (PDMS 1, D1; PDMS 2, D2; PDMS 3, mixture of D1 and D2). Specific capture antibodies (C1,
C2, and C1C2), as well as one antibody binding human serum albumin as a negative control, are immobilized on the bottom surface. The antigen is bound by
shaking the bottom surface in an antigen-containing solution. (B) Fluorescence intensities on the bottom surface on spots with (left to right) C1 capture
antibodies, C2 capture antibodies, a mixture of C1 and C2 antibodies, and the negative control. Green bars represent D1 detection antibodies on the top chip
surface, blue bars represent D2 detection antibodies, and striped bars represent a mixture of both. Specific to nonspecific ratios vary between 2.4:1 and 10.1:1
depending on the particular combination of sandwich antibodies, which were compared with the negative control.
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centrations was also possible with this set-up, and the detection
limit was comparable to a conventional sandwich setup, using the
same type of capture surface and applying the detection anti-
bodies from solution (data not shown).
In a more general context, this assay may be seen as a
technology where a molecular species is brought to a certain
position and delivered only if the interaction force at this
position exceeds a chosen threshold, i.e., to probe whether a
specific binding partner is present at a particular position. Here,
we have only begun to exploit the potential of this new assay
format. On the silicone surface (top), binding partners may be
patterned in register to the pattern of molecules on the capture
array (bottom); therefore, we have the option to probe each
antigen bound to a capture array with a second antigen-specific
binding partner. The second chip surface therefore allows for a
second dimension of specific encoding. This is in sharp contrast
to existing multiplexing formats, which rely either on only one
antigen-specific molecular interaction or apply the second bind-
ing partners in an arbitrary manner by incubation from buffer
solution (35–37). As a consequence, in conventional assays, the
nonspecific and false-positive signals grow geometrically with the
number of different molecular species probed in parallel (38)
and thus limit the multiplexing level that can be achieved
(39–43). In our case, nonspecific and false-positive signals are
independent of array size. This allows for a large number of
molecular interactions to be assessed in parallel by reducing the
complexity of a multimarker assay to the simplicity of a single-
marker ELISA.
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20. Viani, M. B., Schäffer, T. E., Chand, A., Rief, M., Gaub, H. E. & Hansma, P. K.
(1999) J. Appl. Phys. 86, 2258–2262.
21. Evans, E. & Ritchie, K. (1997) Biophys. J. 72, 1541–1555.
22. Evans, E. (1999) Biophys. Chem. 82, 83–97.
23. Schwesinger, F., Ros, R., Strunz, T., Anselmetti, D., Guntherodt, H. J.,
Honegger, A., Jermutus, L., Tiefenauer, L. & Pluckthun, A. (2000) Proc. Natl.
Acad. Sci. USA 97, 9972–9977.
24. Piehler, J., Brecht, A., Valiokas, R., Liedberg, B. & Gauglitz, G. (2000) Biosens.
Bioelectron. 15, 473–481.
25. Wilbur, J. L., Kumar, A., Kim, E. & Whitesides, G. M. (1994) Adv. Mater. 6,
600–604.
26. Bernard, A., Renault, J. P., Michel, B., Bosshard, H. R. & Delamarche, E.
(2000) Adv. Mater. 12, 1067–1070.
27. Bernard, A., Fitzli, D., Sonderegger, P., Delamarche, E., Michel, B., Bosshard,
H. R. & Biebuyck, H. (2001) Nat. Biotechnol. 19, 866–869.
28. Xia, Y. & Whitesides, G. M. (1998) Annu. Rev. Mater. Sci. 28, 153–184.
29. Essevaz-Roulet, B., Bockelmann, U. & Heslot, F. (1997) Proc. Natl. Acad. Sci.
USA 94, 11935–11940.
30. Bockelmann, U., Essevaz-Roulet, B. & Heslot, F. (1997) Phys. Rev. Lett. 79,
4489–4492.
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DNA: A Programmable
Force Sensor
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Direct quantification of biomolecular interaction by single-molecule force spec-
troscopy has evolved into a powerful tool for materials and life sciences. We
introduce an approach in which the unbinding forces required to break inter-
molecular bonds are measured in a differential format by comparison with a
known reference bond (here, a short DNA duplex). In addition to a marked
increase in sensitivity and force resolution, which enabled us to resolve single–
base pairmismatches, this concept allows for highly specific parallel assays. This
option was exploited to overcome cross-reactions of antibodies in a protein
biochip application.
Within the past decade, a variety of experimen-
tal tools based on applying and measuring pi-
conewton forces between single molecules
have been developed and have contributed to a
better understanding of the mechanics of bio-
molecules and molecular bonds (1–4). Force
measurements reveal detailed insights into
binding-potential landscapes and into function-
al aspects of the molecules under investigation,
and as a result, force has become a new struc-
tural and functional parameter in materials and
life sciences. Receptor-ligand pairs (5–8), pro-
tein and nucleic acid structures (9–15), and
even covalent bonds (16) have been investigat-
ed, and it has become evident that biomolecular
processes are governed by piconewton forces.
However, two major bottlenecks have hindered
the widespread use of single-molecule mechan-
ics: sizable instrumental effort and limited force
resolution. To our knowledge, no single–base
pair mismatch detection by single-molecule
force measurements has been reported, despite
numerous efforts. The best resolution to date
has been 10 base pairs (bp), obtained by shear-
ing and unzipping short oligomers by atomic
force micoscopy (AFM) (17, 18).
In conventional single-molecule force
spectroscopy, inter- or intramolecular forces
are exerted and measured with microscopic
force sensors like AFM cantilevers or beads
in optical or magnetic traps (19, 20). With
state-of-the-art instrumentation, the force res-
olution is limited only by thermal fluctuations
that are detected by the force sensor. Argu-
ments based on the fluctuation-dissipation
theorem predict that a reduction of the sensor
size should improve the signal-to-noise ratio
(21). This has been verified in experimental
studies using a new generation of small AFM
cantilevers (22). The logical extrapolation is
to replace the cantilever by a single elastic
molecule. To increase the precision of the
assay even further, we chose a differential
measurement format, where rupture forces of
two molecular complexes are directly com-
pared with each other. This differential for-
mat offers several advantages. Because of the
high symmetry of the assay, most external
disturbances cancel out (23). In addition, for
most applications, a precise measure of the
difference is more valuable than two absolute
values with their respective error bars, such
as the ranking of binders or a single–base
pair mismatch detection in a DNA sequence.
In our setup (Fig. 1), the cantilever spring
was replaced by a polymeric anchor and a
known molecular bond (reference bond) car-
rying a fluorescence label. The molecular
bond under investigation was directly com-
pared to this reference bond, which served as
a molecular force standard. During separation
of the two surfaces, the polymeric anchor was
stretched, and the force acting along the mo-
lecular chain consisting of the sample and
labeled reference complex built up gradually,
until the weaker of the two bonds ruptured.
The difference in the stability of the two
bonds breaks the symmetry in this experi-
ment. As a result, there is a higher probability
that the fluorescence label will end up on the
side of the stronger bond rather than on the
side of the weaker bond. This process can be
seen as a 1-bit analog-to-digital conversion
broadened by thermal fluctuations (24).
Many single-molecule force measurements
can be performed simultaneously, using two
congruent chip surfaces and different spots
containing the molecules of interest. Count-
ing the labels on each side, for instance, by
single-molecule optics, provides a quantita-
tive measure for the differences between the
distributions of the bond rupture probabilities
of the two molecular complexes. It is equiv-
alent to measuring the fluorescence intensi-
ties, which are proportional to the densities of
the fluorescence labels (25). Although a large
number of molecules are probed simultaneous-
ly, the actual force measurement is still per-
formed at the single-molecule level, because
each sample bond is probed individually by a
single reference bond.
Figure 1B illustrates the setup schematical-
ly. The rupture forces of two DNA strands with
different hybridization lengths (a 20-bp duplex
and a 25-bp duplex) are directly compared.
Both oligonucleotides are bridged with a con-
jugated 65-base oligonucleotide, carrying a ter-
minal Cy5 fluorescent label. The resulting 20-
bp duplex is coupled to an activated glass sur-
face, and the 25-bp duplex to a soft polydi-
methylsiloxane (PDMS) stamp (26–28), both
by means of polyethylene glycol (PEG) spac-
ers. Figure 1C shows fluorescence images of
the glass surface containing the capture oligo-
nucleotide and the labeled sample oligonucleo-
tide before the two surfaces were brought into
contact and separated again, and both glass
(bottom) and PDMS (top) after the separation
of the two surfaces. Because the PDMS stamp
has a grid pattern of trenches to ease the water
flux at the surface during separation, the trans-
ferred labels form a checkerboard pattern on the
PDMS. No transfer occurred in the trenches, so
that here the initial label density was main-
tained on the glass surface, whereas in the
contact areas (squares), labels were transferred
from the glass to the PDMS side.
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A direct quantification of the fluorescent
label density is limited by the different optical
and chemical properties of the two surfaces—
glass chip and PDMS stamp—which influence
the quantum yield and the excitation efficiency
of the label. In addition, the coupling efficien-
cies to the two chip surfaces may differ. How-
ever, the symmetry of the experiment can be
restored by placing the two molecules of inter-
est on the same side of the assay and measuring
both against a common reference on the other
side (29). This is the format chosen for the
following experiments, where single–base pair
mismatches and different binding modes of
DNA were investigated. A quantitative analysis
of the experiment that is shown in Fig. 1 is
provided in fig. S1.
To investigate the force resolution of the
differential force test, we measured the reduc-
tion of the unbinding forces caused by a
single–base pair mismatch in a 20-bp DNA
duplex. Figure 2A illustrates the experimen-
tal setup and shows the superposition of the
histograms of fluorescence intensities, ob-
tained on the PDMS surface, after separating
the two chips. The main peaks of the two
histograms are clearly separated and are to a
good approximation of Gaussian shape, indi-
cating a homogeneous surface coverage with
statistical distribution of the bond-rupture
process. The spike (to the left) stems from the
trenches of the grid and reflects the fluores-
cence background. The mean fluorescence
intensities were determined by fitting Gauss-
ian distributions to the histogram peaks. The
ratio of these intensities, which directly rep-
resents the ratio of the bond-rupture proba-
bilities of mismatch to perfect match was
found to be 1.7. Because the half width of the
two peaks is less than one-third of the differ-
ence of the peak values, a quantitative single-
nucleotide polymorphism assay with high
precision is possible. The experiment was
conducted in a buffer solution containing 150
mM NaCl at room temperature. Under these
conditions, thermal off-rates are extremely
low (30), and discrimination between mis-
match and perfect match sequences is diffi-
cult to obtain in conventional equilibrium
binding assays (31, 32). This high thermal
stability ensures that in the force-based assay,
the data are not obscured by spontaneous
strand-separation events or differences in hy-
bridization efficiencies (33).
On conventional DNA chips, single–base
pair mismatches are detected by identifying
differences in the thermal off-rate or the equi-
librium constant. In both cases, stringent con-
ditions are established by reducing the salt
concentration (or alternatively increasing
temperature) such that the DNA duplexes to
be analyzed either dissociate at different time
scales or bind with distinguishable binding
ratios (34). Because both ionic strength and
temperature are global parameters, a delicate
compromise of these parameters has to be
chosen to establish satisfactory ambient con-
ditions for all the different spots on the chip.
These global boundary conditions impose se-
vere limitations on the sequences that can be
tested in parallel on the same chip and require
large numbers of additional control spots (35,
36). In contrast, in the differential force for-
Fig. 1. (A) Conventional, AFM-based single-
molecule force spectroscopy, in which the rup-
ture force required to break a molecular bond,
such as a DNA duplex (red), is measured with a
cantilever spring (blue). (B) The differential
force test, in which the rupture force of a
sample bond (red) is measured by comparing it
with a known reference bond (blue), which
serves as a molecular force standard. Upon
loading the chain of polymer spacers, sample
bond, and reference bond, the weaker bond has
a higher probability of rupturing than the stron-
ger one. Consequently, most of the probed
fluorescence labels (green) end up with the
stronger bond after separating the two surfac-
es. (C) (left) Cy5 fluorescence image of a spot
containing the molecular chains of polymer
spacers, sample, and reference duplexes before
connecting the biotinylated reference duplexes
to the second chip surface. (middle) Cy5
fluorescence image of both chip surfaces—
microstructured PDMS (top) and glass (bot-
tom)—after separating them again. (right)
PDMS surface at single-molecule resolution af-
ter separating the two surfaces. The image was
obtained by TIRF.
Fig. 2. (A) Histograms of a perfectly matching (PM) 20-bp DNA duplex (left) as compared with a
20-bp duplex that has a single–base pair mismatch (MM). Both duplexes were probed with a 20-bp
reference complex that is reverse to the perfectly matching 20-bp duplex. Both sample duplexes are
identical, except for a single base mutation (G 3 C) that was introduced at position 13 of the
capture oligonucleotide. (B) Histograms of identical 25-bp DNA duplexes in both shear (left) and
unzip geometry (right), both of which have been probed with an identical 25-bp duplex in unzip
geometry. I, mean fluorescence intensity; rD, discrimination ratio.
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mat, the stringency imposed by the reference
complex is a local boundary condition. Both
the sequence and the length of the reference
complex on the stamp may be chosen for
every sample spot on the chip accordingly,
allowing optimum force resolution and back-
ground discrimination for every spot. Ther-
modynamic stringency is global, whereas
mechanical stringency is local. The combina-
tion of maximum resolution and local strin-
gency is desirable for the precise quantifica-
tion of interactions.
Figure 2B highlights an additional and
unique feature of force-based assays: the dis-
crimination among energetically and kinetically
equivalent interactions. Both hybrids, the one in
shear geometry and the one in unzip geometry,
have identical sequences and, therefore, have
the same binding energy, as well as the same
thermal on-rates and off-rates. However, upon
forced dissociation, the complex in unzip ge-
ometry has a probability of rupturing that is
more than 15 times as high as that of the
complex in shear geometry, as can be derived
from the peak positions of the histograms in
Fig. 2B. This pronounced difference is consis-
tent with earlier measurements (13, 17, 37, 38)
in which unzipping forces of 14 pN and values
that were more than three times as high for the
shear geometry were measured under compara-
ble conditions (39).
The discrimination between different bind-
ing modes, as illustrated above, and the concept
of mechanical stringency offer striking advan-
tages when applied to the field of protein arrays.
In this field, it is crucial to discriminate between
specific and nonspecific interactions, and it is
difficult to define a common set of stringent
ambient conditions for many different proteins
(40, 41). Proteins typically interact with each
other specifically over well-defined binding
sites, whereas nonspecific interactions with oth-
er proteins and with surfaces occur over larger
surface areas (42). As shown in Fig. 2B, dis-
crimination between these two binding modes
can then be reliably achieved using a low-force
but high-affinity force sensor, such as a DNA
duplex in unzip conformation. Figure 3 shows
that the threshold force defined by such a DNA
duplex in unzipping geometry is well suited to
discriminate between specific and nonspecific
binding for a variety of antibody-antigen inter-
actions. At the same time, the affinity is high
enough to provide a stable anchor. The antibod-
ies can be safely “delivered” to their respective
antigens. In addition, if needed, other threshold
forces can easily be programmed into the DNA
reference complex by changing the base com-
position or the binding geometry.
The advantages of the force-based deliv-
ery of antibodies become more apparent
when applied to capture arrays based on a
sandwich format. In conventional sandwich
arrays, each detection antibody can interact
with all spots of the array. Therefore, each
analyte molecule that is bound to the array
can be decorated by detection antibodies,
even the ones that are bound nonspecifically
or because of cross-reactive capture antibod-
ies (43). Consequently, the nonspecific back-
ground and the number of false-positives
grow geometrically with the number of spots
on the chip, which severely limits the multi-
plexing capabilities of protein capture arrays
(44). The differential force assay allows for
the local application of specific detection an-
tibodies, and the second chip surface there-
fore provides for a second dimension of spe-
cific encoding (45). Figure 4 shows an exam-
ple of a cross-reactive capture antibody that is
specific for both human and murine interleu-
kin-5 (IL-5). In a conventional protein array,
discrimination between human and murine
antigens is not possible (Fig. 4A) with this
capture antibody, and the assay generates
false-positive results (46). In our assay, the
second chip surface (top surface) allows the
definition of two specific spots for the two
different antigens, even if the same cross-
reactive capture antibody is used in both
spots of the capture surface (bottom). Specif-
ic detection and reliable discrimination of
both antigens are now possible in a single
step. This illustrates the potential of our assay
to overcome a major bottleneck in the field of
protein biochips, namely, the lack of speci-
ficity caused by nonspecific interactions and
cross-reactions (47, 48).
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Glucokinase (GK) plays a key role in whole-body glucose homeostasis by
catalyzing the phosphorylation of glucose in cells that express this enzyme, such
as pancreatic  cells and hepatocytes.We describe a class of antidiabetic agents
that act as nonessential, mixed-type GK activators (GKAs) that increase the
glucose affinity and maximum velocity (Vmax) of GK. GKAs augment both
hepatic glucosemetabolism and glucose-induced insulin secretion from isolated
rodent pancreatic islets, consistent with the expression and function of GK in
both cell types. In several rodent models of type 2 diabetes mellitus, GKAs
lowered blood glucose levels, improved the results of glucose tolerance tests,
and increased hepatic glucose uptake. These findings may lead to the devel-
opment of new drug therapies for diabetes.
Glucose homeostasis is lost in type 2 diabetes
because of combined defects in both insulin
secretion and insulin action (1, 2). The char-
acterization of patients with abnormal glyce-
mic control due to either gain- or loss-of-
function mutations in GK has provided new
insights into the pathogenesis of type 2 dia-
betes. Loss-of-function mutations in the gene
encoding GK have been linked to maturity-
onset diabetes of the young type 2 (MODY2),
an autosomal dominant form of diabetes mel-
litus characterized by early onset and mild
chronic fasting hyperglycemia (3, 4).
MODY2 patients display impaired glucose
responsiveness of  cells, decreased net ac-
cumulation of glycogen, and increased hepat-
ic glucose production after meals (5, 6). The
GK mutations found in MODY2 patients re-
sult in decreased activity of this enzyme as a
result of reduction in its Vmax and/or reduced
affinity toward its substrates, glucose and
adenosine triphosphate (ATP) (7–11). In con-
trast, gain-of-function GK mutations, which
increase the catalytic activity of GK, cause
persistent hyperinsulinemic hypoglycemia of
infancy as a result of lowering the threshold
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